Unlock the full potential of your medical coding capabilities with the CPT® Advanced Coding Pack from the American Medical Association (AMA). Designed for professional medical coders, auditors, and billers like you, this comprehensive suite of resources provides everything you need to navigate the complexities of the CPT code set with confidence and precision.
Advanced Coding Pack includes:
CPT Assistant - Newsletter with official education and guidance
CPT Knowledge Base - Commonly asked coding questions answered by the experts
CPT Vignettes - Comprehensive clinical examples.
Add to your Find-A-Code subscription for $300 / person
Learn More and Subscribe
GB55 Chronic tubulo-interstitial nephritis International Classification of Diseases for Mortality and Morbidity Statistics, 11th Revision, v2024-01 A disease characterised by inflammation of and damage to tubules and/or the interstitium of the kidney, interstitial scarring, fibrosis and tubule atrophy resulting in progressive chronic renal insufficiency
exclusions code elsewhere sections/codes in this section (GB55-GB55) postcoordination Add Stem and/or Extension codes to form a cluster code which adds detail to the condition.
Laterality - only one may be selected [select] XK9J Bilateral XK8G Left XK9K Right XK70 Unilateral, unspecified Infectious agent - multiple selections are allowed [select] XN4E7 Leptospira weilii – XN3BQ Streptococcus salivarius XN77E Leptospira wolffii – XN9FP Streptococcus sanguinis XN5UB Leptospira genomospecies 1 (alstonii) – XN0XM Streptococcus sobrinus XN2JD Leptotrichia – XN5SE Streptococcus suis XN734 Leptotrichia buccalis – XN4LM Streptococcus thermophilus XN4GY Leptotrichia goodfellowii – XN1TV Streptococcus uberis XN0SF Leptotrichia hofstadii – XN0Z2 Streptococcus vestibularis XN4SA Leptotrichia hongkongensis XN7PP Tropheryma XN7NF Leptotrichia shahii XN5P4 Tropheryma whipplei XN6QY Leptotrichia trevisanii XN0SE Clostridioides difficile XN5SN Leptotrichia wadei XN87X Bacteria, neither Gram Negative nor Gram Positive XN90V Moraxella XN2DX Borrelia XN8G6 Morganella XN7GL Borrelia afzelii XN1W2 Mycoplasma XN13C Borrelia burgdorferi XN3NR Mycoplasma fermentans XN4VZ Borrelia garinii XN9UG Mycoplasma genitalium XN3PD Borrelia hermsii XN674 Mycoplasma hyorhinis XN2P3 Borrelia miyamotoi XN3AD Mycoplasma penetrans XN6VH Borrelia parkeri XN4NV Mycoplasma pneumoniae XN5R4 Borrelia recurrentis XN69X Neisseria XN140 Borrelia vincentii XN59Y Neisseria gonorrhoeae XN2NR Mycobacterium XN1DV Neisseria meningitidis XN6YB Mycobacterium africanum – XN3CR Neisseria meningitidis serogroup A XN8AB Mycobacterium bovis – XN8FU Neisseria meningitidis serogroup B XN8N3 Mycobacterium canettii – XN7EM Neisseria meningitidis serogroup C XN4MR Mycobacterium caprae – XN03X Neisseria meningitidis serogroup W XN9H9 Mycobacterium colombiense – XN0C2 Neisseria meningitidis serogroup X XN8FC Mycobacterium indicus pranii – XN5H0 Neisseria meningitidis serogroup Y XN5TS Mycobacterium leprae XN8ST Neorickettsia XN3T2 Mycobacterium microti XN7C8 Neorickettsia sennetsu XN7H2 Mycobacterium pinnipedii XN3U2 Pasteurella XN1N2 Mycobacterium tuberculosis XN30D Pasteurella multocida XN96Q Non-tuberculous mycobacterium XN1ZM Pleisiomonas – XN3L9 Mycobacterium kansasii XN3BS Proteus – XN5C1 Mycobacterium malmoense XN9ZF Proteus mirabilis – XN53D Mycobacterium xenopi XN9DS Proteus morganii – XN6PL Mycobacterium asiaticum XN7PE Proteus penneri – XN4MW Mycobacterium simiae XN118 Proteus vulgaris – XN975 Mycobacterium szulgai XN7R2 Providencia – XN74T Mycobacterium scrofulaceum XN2PG Providencia rettgeri – XN7YR Mycobacterium haemophilum XN022 Pseudomonas – XN8ZX Mycobacterium fortuitum XN5L6 Pseudomonas aeruginosa – XN8RB Mycobacterium marinum XN3JP Pseudomonas oryzihabitans – XN9M0 Mycobacterium ulcerans XN52E Pseudomonas mallei – XN3D3 Mycobacterium chelonei XN8J7 Pseudomonas plecoglossicida – XN97H Mycobacterium avium complex XN8AA Pseudomonas pseudomallei –– XN5LZ Mycobacterium avium XN4YH Rickettsia ––– XN8FF Mycobacterium avium hominissuis XN9YP Rickettsia africae ––– XN5NW Mycobacterium avium paratuberculosis XN7WV Rickettsia akari ––– XN145 Mycobacterium avium silvaticum XN23V Rickettsia australis –– XN3ZQ Mycobacterium intracellulare XN8U4 Rickettsia conorii –– XN077 Mycobacterium chimaera XN6W8 Rickettsia felis – XN4TQ Mycobacterium abscessus complex XN9NE Rickettsia helvetica –– XN7V4 Mycobacterium abscessus subsp. abscessus XN5NY Rickettsia hoogstraalii –– XN5SW Mycobacterium abscessus subsp. massiliense XN3XV Rickettsia japonica –– XN017 Mycobacterium abscessus subsp. bolletii XN8SY Rickettsia prowazekii – XN44M Mycobacterium chelonae XN33Q Rickettsia rickettsii XN1N6 Rickettsia sibirica XN2AR Rickettsia typhi XN0QE Salmonellae XN5VC Salmonella enterica spp. – XN0UV Salmonella Paratyphi –– XN1K5 Salmonella paratyphi A –– XN322 Salmonella paratyphi B –– XN5TR Salmonella paratyphi C – XN4AM Salmonella Typhi – XN7U5 Salmonella Panama – XN97K Salmonella Weltevreden – XN13V Salmonella Wandsworth – XN3DF Salmonella Virchow – XN4QY Salmonella Give – XN3AE Salmonella Gaminara – XN0N5 Salmonella Agona – XN5SM Salmonella Kiambu – XN3TU Salmonella Thompson – XN15L Salmonella Typhimurium – XN8SF Salmonella Saintpaul – XN2MU Salmonella Stanley – XN0LX Salmonella Strathcona – XN5WE Salmonella Senftenberg – XN291 Salmonella Tennessee – XN87G Salmonella Newport – XN5TM Salmonella Hartford – XN1QX Salmonella Oranienburg – XN2SZ Salmonella Poona – XN36N Salmonella Kedougou – XN5LV Salmonella Litchfield – XN4LH Salmonella Mbandaka – XN1FK Salmonella Montevideo – XN3UH Salmonella Mikawasima – XN7QM Salmonella Concord – XN8RF Salmonella Cubana – XN39C Salmonella Infantis – XN6JL Salmonella Havana – XN1W7 Salmonella Enteritidis – XN0Q7 Salmonella Bareilly – XN4MS Salmonella Braenderup – XN3KA Salmonella Brandenburg – XN0NU Salmonella Choleraesuis – XN910 Salmonella Bredeney – XN52S Salmonella Nchanga – XN8F6 Salmonella Lille – XN7EC Salmonella Sandiego – XN2DJ Salmonella enterica subspecies enterica serovar 4,5,12:i:- – XN7PN Salmonella enterica subspecies enterica serovar 4,[5],12:i:- XN2DW Salmonella bongori spp XN71D Serratia spp XN2V6 Serratia marcescens XN7HG Shigella spp XN7Y2 Shigella flexneri XN8RN Shigella boydii XN285 Shigella dysenteriae XN9M9 Shigella sonnei XN23Z Spirillum XN0J7 Spirillum minus XN78V Spirillum pulli XN17K Spirillum volutans XN96A Spirillum winogradskyi XN708 Streptobacillus XN91U Streptobacillus moniliformis XN1L0 Stenotrophomonas XN0AD Stenotrophomonas maltophilia XN36C Treponema XN76V Treponema carateum XN711 Treponema pallidum – XN6AL Treponema pallidum carateum – XN35Z Treponema pallidum endemicum – XN030 Treponema pallidum pallidum – XN46P Treponema pallidum pertenue XN1R2 Ureaplasma XN8RL Vibrio XN7N1 Vibrio cholerae – XN8P1 Vibrio cholerae O1, biovar cholerae – XN62R Vibrio cholerae O1, biovar eltor – XN8KD Vibrio cholerae O139 XN1AA Vibrio parahaemolyticus XN44G Vibrio vulnificus XN4QG Yersinia XN91V Yersinia enterocolitica XN6QS Yersinia pestis XN6K8 Yersinia pseudotuberculosis XN65H Bacteroides XN2R7 Bacteroides fragilis XN9EB Cronobacter XN74M Bacteria XN2YF Cronobacter sakazakii XN5PZ Gram Negative Bacteria XN9AS Brevundimonas XN25B Acinetobacter XN8W4 Brevundimonas diminuta XN8LS Acinetobacter baumannii XN2F0 Brevundimonas vesicularis XN5YN Acinetobacter junii XN1J7 Aeromonas XN0DS Acinetobacter nosocomialis XN40Z Aeromonas hydrophila XN2QH Acinetobacter pittii XN0XY Aeromonas caviae XN048 Anaplasma XN4X0 Herbaspirillum XN1MH Anaplasma phagocytophilum XN7QA Herbaspirillum huttiense XN3NJ Bartonella XN706 Elizabethkingia XN0W4 Bartonella bacilliformis XN6BA Elizabethkingia anophelis XN3F6 Bartonella clarridgeiae XN6C4 Elizabethkingia meningoseptica XN5J5 Bartonella elizabethae XN15X Ralstonia XN5SH Bartonella grahamii XN6AH Ralstonia picketti XN862 Bartonella henselae XN694 Ralstonia mannitolilytica XN302 Bartonella koehlerae XN9VM Ralstonia insidiosa XN14D Bartonella quintana XN3NY Raoultella XN43H Bartonella rochalimae XN0MD Raoultella ornithinolytica XN6KD Bartonella vinsonii XN6PA Orientia XN94Y Bartonella washoensis XN675 Orientia tsutsugamushi XN9W3 Bordetella XN2QM Gram Positive Bacteria XN173 Bordetella bronchiseptica XN3G0 Actinomyces XN23B Bordetella pertussis XN0GV Actinomyces gerencseriae XN7LQ Bordetella parapertussis XN15T Actinomyces israelii XN22N Brucella XN8HN Actinomyces species XN7A8 Brucella abortus XN8EK Actinomycetales XN84J Brucella canis XN8P7 Actinomadura XN7ZW Brucella melitensis XN9ZE Bacillus XN3UP Brucella suis XN94F Bacillus anthracis XN01M Burkholderia XN8PY Bacillus cereus XN351 Burkholderia gladioli XN33F Bifidobacterium XN6Y3 Burkholderia mallei XN0PT Bifidobacterium dentium XN3LD Burkholderia pseudomallei XN198 Clostridium XN335 Burkholderia cepacia complex XN2JN Clostridium botulinum – XN06D Burkholderia stabilis XN7J5 Clostridium perfringens – XN0ZW Burkholderia anthina XN4LP Clostridium sordellii – XN15B Burkholderia contaminans XN5NQ Clostridium tetani XN7US Campylobacter XN3NT Corynebacterium XN0BA Campylobacter coli XN9N1 Corynebacterium diphtheriae XN3EN Campylobacter fetus XN78S Corynebacterium minutissimum XN4Q5 Campylobacter jejuni XN752 Corynebacterium striatum XN27H Chlamydia XN3MP Corynebacterium tenuis XN9EE Chlamydia pneumoniae XN1F7 Enterococcus XN4S7 Chlamydia psittaci XN2H4 Enterococcus faecalis XN4Q4 Chlamydia trachomatis XN51E Enterococcus faecium XN0FZ Citrobacter XN0DT Enterococcus avium XN0M3 Citrobacter freundii XN3XY Enterococcus casseliflavus XN5H6 Coxiella XN724 Enterococcus durans XN0QS Coxiella burnetii XN8BQ Enterococcus gallinarum XN9M7 Ehrlichia XN4ZZ Enterococcus mundtii XN293 Ehrlichia canis XN3QK Enterococcus raffinosus XN4GW Ehrlichia chaffeensis XN494 Erysipelothrix XN2YH Ehrlichia ewingii XN4FJ Erysipelothrix rhusiopathiae XN1VF Eikenella XN4D1 Listeria XN9W5 Enterobacter XN39H Listeria ivanovii XN3YM Enterobacter cloacae XN602 Listeria monocytogenes XN4WC Escherichia XN20K Nocardia XN6P4 Escherichia coli XN2BK Nocardia asteroides – XN88S Enteroinvasive Escherichia coli XN1LG Nocardia brasiliensis – XN2U0 Enteropathogenic Escherichia coli XN5M7 Propionibacterium – XN81Z Enterotoxigenic Escherichia coli XN27L Propionibacterium propionicus – XN108 Shiga toxin-producing Escherichia coli XN9ZG Staphylococcus –– XN5NF Enterohaemorrhagic Escherichia coli XN6BM Staphylococcus aureus – XN55V Enteroaggregative Escherichia coli – XN4B5 Panton-Valentine Leukocidin–producing Staphylococcus aureus XN6MP Escherichia hermannii XN0PR Staphylococcus auricularis XN2S7 Pseudescherichia vulneris XN0H1 Staphylococcus capitis XN94G Francisella XN99G Staphylococcus caprae XN6HJ Francisella philomiragia XN95B Staphylococcus cohnii XN0BX Francisella tularensis XN8KJ Staphylococcus epidermidis – XN4ZY Francisella novicida XN2GD Staphylococcus haemolyticus XN4LF Fusobacterium XN09P Staphylococcus leei XN7B1 Fusobacterium necrophorum XN4N7 Staphylococcus lugdunensis XN5MA Fusobacterium novum XN8WC Staphylococcus pasteuri XN4P8 Fusobacterium nucleatum XN6FH Staphylococcus pettenkoferi XN911 Fusobacterium polymorphum XN9X8 Staphylococcus schleiferi XN2HK Haemophilus XN2HN Staphylococcus sciuri XN6MB Haemophilus ducreyi XN7RE Staphylococcus simulans XN1P6 Haemophilus influenzae XN4C9 Staphylococcus warneri – XN1BX Haemophilus influenzae aegyptius XN7TQ Staphylococcus xylosus – XN0FG Haemophilus influenzae type B XN567 Staphylococcus hominis XN6XR Helicobacter XN3NM Streptococcus XN0YS Helicobacter bilis XN1V3 Alpha-hemolytic Streptococcus XN0TD Helicobacter bizzozeronii – XN3PW Streptococcus pneumoniae XN42L Helicobacter canis – XN9LA Streptococcus viridans XN354 Helicobacter cinaedi XN1AF Beta-haemolytic Streptococcus XN6JN Helicobacter felis XN2NS Gamma-haemolytic Streptococcus XN9X3 Helicobacter ganmani XN6LP Streptococcus, group A XN8PN Helicobacter hepaticus – XN7YG Streptococcus pyogenes XN3DY Helicobacter pylori XN2M1 Streptococcus, group B XN9D7 Helicobacter salomonis – XN0KC Streptococcus agalactiae XN079 Helicobacter suis XN518 Group C Streptococcus XN620 Klebsiella – XN0TY Streptococcus zooepidemicus XN027 Klebsiella granulomatis XN5KC Streptococcus, group D XN7WL Klebsiella oxytoca – XN6KJ Streptococcus bovis XN741 Klebsiella pneumoniae – XN625 Streptococcus equinus XN7EJ Kingella kingae XN8BJ Group E Streptococcus XN3SZ Legionella XN6BB Group F Streptococcus XN14Z Legionella longbeachae XN84N Group G Streptococcus XN9YS Legionella pneumophila – XN8UN Streptococcus dysgalactiae XN9RA Leptospira XN40Y Group H Streptococcus XN1R8 Leptospira alexanderi – XN39R Streptococcus anginosus XN7D2 Leptospira borgpetersenii – XN3L7 Streptococcus canis XN9K9 Leptospira broomii – XN0FR Streptococcus constellatus XN5HC Leptospira fainei – XN4PA Streptococcus iniae XN20F Leptospira inadai – XN67P Streptococcus intermedius XN78P Leptospira interrogans – XN5BP Streptococcus mitis XN110 Leptospira kirschneri – XN2RH Streptococcus mutans XN481 Leptospira kmetyi – XN4B2 Streptococcus oralis XN6NU Leptospira licerasiae – XN18T Streptococcus parasanguinis XN4KP Leptospira noguchii – XN58W Streptococcus peroris XN01X Leptospira santarosai – XN6KE Streptococcus pseudopneumoniae XN4FL Leptospira species – XN5DB Streptococcus ratti XN2VN Gammaherpesvirinae XN0R2 Epstein-Barr virus XN7NE Rhadinovirus XN487 Human immunodeficiency virus XN8LD Human immunodeficiency virus type 1 XN71W Human immunodeficiency virus type 2 XN8JY Human papillomavirus XN2KP Human papillomavirus 45 XN6LA Human papillomavirus 1 XN2FC Human papillomavirus 2 XN7DE Human papillomavirus 6 XN7T9 Human papillomavirus 11 XN2NK Human papillomavirus 16 XN97Y Human papillomavirus 18 XN3HA Human papillomavirus 31 XN1WJ Human T-cell lymphotropic virus XN5SG Influenza virus XN8WJ Influenza A virus XN297 Influenza A H1N1 virus XN4TT Influenza A H5N1 virus XN7JR Influenza A H5N6 virus XN35G Influenza A H7N9 virus XN2J2 Influenza A H1 virus XN9Z9 Influenza A H1N1v virus XN3VG Influenza A H1N2v virus XN9SG Influenza A H1N1 pdm2009 virus XN3UJ Influenza A H1pdm09N2 2:6 reassortant influenza virus XN02Z Swine influenza A H1N1 virus XN16M Influenza A H1N2 variant XN79W Influenza A H2N2 virus XN8WA Influenza A H3 virus XN6WE Influenza A H3N2 virus XN476 Swine influenza A H3N2 virus XN3UU Influenza A H3N2 Panama/2007/99 virus XN9HE Influenza A H3N2 Moscow/10/99 virus XN9FE Influenza A H3N2v virus XN81W Equine influenza A H3N8 virus XN6MR Influenza A H5 virus XN5DQ Influenza A H5N2 virus XN6MY Influenza A H5N8 virus XN0AS Influenza A H6N1 virus XN9GE Influenza A H7N2 virus XN2SA Influenza A H7N2 variant XN8Q3 Influenza A H7N3 virus XN5WA Influenza A H7N4 virus XN8YT Influenza A H7N7 virus XN71C Influenza A H9 virus XN412 Influenza A H9N2 virus XN5SY Influenza A H10N3 virus XN66Y Influenza A H10N7 virus XN0MW Influenza A H10N8 virus XN8SG Influenza B virus XN8U3 Influenza C virus XN67Q Influenza D virus XN33B Lyssavirus XN796 Rabies virus XN3BH Virus XN8R7 Orthopolyomavirus XN000 Adenovirus XN7UP John Cunningham virus XN0R0 Atadenovirus XN82V Paramyxovirus XN05K Aviadenovirus XN98T Henipavirus XN728 Ichtadenovirus XN5PM Cedar Virus XN93P Mastadenovirus XN53N Hendra virus XN13L Siadenovirus XN931 Nipah virus XN6ME Alphavirus XN513 Human metapneumovirus XN0SK Aura virus XN186 Measles virus XN434 Babanki virus XN22H Mumps virus XN5KQ Barmah Forest virus XN6CR Parainfluenza virus XN6XS Bebaru virus XN4QJ Rubulavirus XN0UF Cabassou virus XN7X8 Parvovirus XN4ZB Chikungunya virus XN8PS Erythrovirus XN78T Eastern equine encephalitis virus XN447 Bocaparvovirus XN26A Everglades virus XN8W9 Pneumovirus XN87D Kyzylagach virus XN275 Human respiratory syncytial virus XN5ZC Mayaro virus XN9WH Polyomavirus XN1VS Middelburg virus XN0TQ BK polyoma virus XN34P Mosso das Pedras virus XN7UC Poxvirus XN7PD Mucambo virus XN32K Orthopoxvirus XN0H9 Ndumu virus XN3Y3 Buffalopox virus XN9WS Ockelbo virus XN0AU Cowpox virus XN6AD o'nyong nyong virus XN2GM Monkeypox virus XN240 Paramana virus – XN4L3 Monkeypox virus Clade I XN3YZ Pixuna virus – XN1BH Monkeypox virus Clade II XN79Q Río Negro virus –– XN00B Monkeypox virus Clade IIa XN49A Ross River virus –– XN7VR Monkeypox virus Clade IIb XN4D3 Salmon pancreatic disease virus XN4Q0 Variola virus XN3D4 Semliki Forest virus XN06N Vaccinia virus XN0D6 Sindbis virus XN1M0 Parapox virus XN132 Sleeping Disease virus XN7JF bovine papular stomatitis virus XN5MK Southern elephant seal virus XN8E5 Orf virus XN4ER Tonate virus XN8JR pseudocowpox virus XN2B3 Trocara virus XN0CV Yatapox virus XN445 Venezuelan equine encephalitis virus XN0K5 tanapox virus XN8PC Whataroa virus XN81C yaba monkey tumour virus XN2CK Western equine encephalitis virus XN5G8 Molluscipoxvirus XN1BE Arbovirus XN7YE Molluscum contagiosum virus XN5VQ La Crosse virus XN22T Reovirus XN8AC Arenavirus XN6FR Retrovirus XN2WG Chapare virus XN2R0 Alpharetrovirus XN56K Guanarito virus XN0TH Betaretrovirus XN2ZL Junín virus XN787 Deltaretrovirus XN0CU Lassa virus XN6HX Epsilonretrovirus XN77P Lujo virus XN4K8 Gammaretrovirus XN4ZL Lymphocytic choriomeningitis virus XN5R7 Lentivirus XN45B Machupo virus XN6JB Oncovirus XN55S Sabiá virus XN6N7 Rotavirus XN5VM Bornavirus XN6TN Rotavirus A XN395 Borna disease virus 1 XN55H Rotavirus B XN125 variegated squirrel bornavirus 1 XN0F5 Rotavirus C XN7S5 Bunyavirus XN29P Rotavirus D XN9UC Amur virus XN71N Rotavirus E XN17V Crimean-Congo haemorrhagic fever virus XN2F7 Rubivirus XN16H Dobrava virus XN2WE Rubella virus XN2QZ gōu virus XN7R4 Astrovirus XN3GW Hantaan virus XN6T9 Vesiculovirus XN8UR Kurkino virus XN2BR Chandipura virus XN8AF Muju virus XN9XS Vesicular stomatitis virus XN4S8 Orthobunyavirus XN09U Cristoli virus XN4U2 Oropouche orthobunyavirus XN28L Puumala virus XN9PD Saaremaa virus XN3PV Seoul virus XN95V Sochi virus XN0E0 Soochong virus XN9G5 Tula virus XN2VY Anajatuba virus XN4AP Andes virus XN2C8 Araucária virus XN2WJ bayou virus XN0A0 Bermejo virus XN66E Black Creek Canal virus XN8LW Blue River virus XN18Y Castelo dos Sonhos virus XN6XF El Moro Canyon virus XN8G9 Juquitiba virus XN6P0 Laguna Negra virus XN2CJ Lechiguanas virus XN2BW Maciel virus XN3WK Monongahela virus XN5SF Muleshoe virus XN9VX New York virus XN9BY Orán virus XN5JV Paranoá virus XN65X Pergamino virus XN2VC Río Mamoré virus XN7R1 sin nombre virus XN057 Tunari virus XN8AQ Araraquara virus XN5VU Phlebovirus XN2YW Punta Toro virus XN7AS Rift Valley fever phlebovirus XN72W Sicilian phlebovirus XN7FG Naples phlebovirus XN3V9 Toscana phlebovirus XN3BT Dabie bandavirus XN9RK Calicivirus XN4EB Lagovirus XN8L1 Nebovirus XN3Y2 Norovirus XN9EH Sapovirus XN0R6 Vesivirus XN83D Coronavirus XN0UA Human coronavirus 229E XN9KN Human coronavirus HKU1 XN7CX Human coronavirus OC43 XN3BD Middle East respiratory syndrome coronavirus XN5V7 Pipistrellus bat coronavirus HKU5 XN1N9 Rousettus bat coronavirus HKU9 XN1V8 Severe Acute Respiratory Syndrome coronavirus XN1GJ Tylonycteris bat coronavirus HKU4 XN109 SARS-CoV-2 XN0HL SARS-CoV-2 Alpha XN4Q7 SARS-CoV-2 Beta XN5BQ SARS-CoV-2 Gamma XN8V6 SARS-CoV-2 Delta XN1GK SARS-CoV-2 Epsilon XN3ZE SARS-CoV-2 Zeta XN2V4 SARS-CoV-2 Eta XN4Q1 SARS-CoV-2 Theta XN3UD SARS-CoV-2 Iota XN9LB SARS-CoV-2 Kappa XN6AM SARS-CoV-2 Lambda XN39J SARS-CoV-2 Mu XN161 SARS-CoV-2 Omicron – XN8Z4 BA.5 – XN4UD BQ.1 – XN51Y XBB –– XN72A XBB.1.5 –– XN201 XBB.1.16 –– XN8RW EG.5 –– XN031 BA2.86 – XN3QV BA.1 – XN53K BA.2 XN2P0 Enterovirus XN3MC Coxsackievirus XN2TU Echovirus XN3M0 Poliovirus XN6KZ Wild poliovirus type 1 XN9CF Wild poliovirus type 2 XN97R Wild poliovirus type 3 XN2T1 Circulating vaccine-derived poliovirus type 1 XN1XN Circulating vaccine-derived poliovirus type 2 XN7UU Circulating vaccine-derived poliovirus type 3 XN19Z Rhinovirus XN6R5 Filovirus XN2LW Genus Ebolavirus XN1EN Ebola virus XN8JT Bundibugyo virus XN9QG Reston virus XN13U Sudan virus XN8TT Taï Forest virus XN12Y Bombali virus XN4XZ Genus Marburgvirus XN3F2 Marburg virus XN5M2 Ravn virus XN0AC Flavivirus XN4CA Dengue virus XN22Z Dengue virus 1 XN4RL Dengue virus 2 XN9XQ Dengue virus 3 XN2EQ Dengue virus 4 XN9ZK Japanese encephalitis virus XN5QW Saint Louis encephalitis virus XN0L1 Tick-borne encephalitis virus XN1MT Tick-borne encephalitis virus-European subtype XN8WB Tick-borne encephalitis virus-Far Eastern subtype XN4LG Tick-borne encephalitis virus-Siberian subtype XN4E1 West Nile virus XN9S3 Yellow fever virus XN1H2 Zika virus XN7C2 Rocio virus XN7W2 Alkhurma hemorrhagic fever virus XN2JR Kyasanur Forest disease virus XN41M Hepatitis virus XN5XD GB virus C XN40D Hepatitis A virus XN0GA Hepatitis B virus XN1EZ Hepatitis C virus XN99N Hepatitis D virus XN7TG Hepatitis E virus XN6BW Hepatitis F virus XN7V1 Human herpesvirus XN6DH Ictalurvirus XN9QL Pityriasis Rosea virus XN465 Alphaherpesvirinae XN42C Mardivirus XN41T Herpes simplex virus-1 XN5V1 Herpes simplex virus-2 XN0TA Varicella zoster virus XN4P4 Iltovirus XN8TA Betaherpesvirinae XN3SQ Cytomegalovirus XN5FN Muromegalovirus XN1GF Roseolavirus – XN9NM Roseolavirus A – XN8AM Roseolavirus B XN8AY Fungi XN0WC Aspergillus XN6Q9 Aspergillus clavatus XN6B8 Aspergillus flavus XN5Z7 Aspergillus fumigatus XN25K Aspergillus terreus XN7Q2 Aspergillus niger XN4XX Basidiobolus XN4RM Basidiobolus ranarum XN08A Blastomyces XN14F Blastomyces dermatitidis XN3CL Candida XN31P Candida albicans XN72N Candida auris XN0RY Candida haemulonii XN066 Chromomycosis XN106 Chrysosporium XN8W1 Chrysosporium parvum XN7Q9 Coccidioides XN53F Coccidioides immitis XN5TT Coccidioides posadasii XN62A Conidiobolus XN3KM Conidiobolus coronatus XN4AQ Conidiobolus incongruus XN69C Cryptococcus XN0LE Cryptococcus gattii XN3EH Cryptococcus neoformans XN7WW Dermatophyte fungi XN655 Anthropophilic dermatophytes XN2T0 Epidermophyton floccosum XN3YF Microsporum audouinii XN2R2 Microsporum ferrugineum XN8M6 Trichophyton concentricum XN628 Trichophyton gourvilii XN8BW Trichophyton interdigitale XN96H Trichophyton megninii XN2JF Trichophyton rubrum XN53A Trichophyton schoenleinii XN135 Trichophyton soudanense XN1K6 Trichophyton tonsurans XN31R Trichophyton violaceum XN8BF Trichophyton yaoundei XN2SY Zoophilic dermatophytes XN5ER Microsporum canis XN6NM Microsporum equinum XN5GR Microsporum gallinae XN3WX Microsporum nanum XN7JK Microsporum persicolor XN3YG Trichophyton equinum XN4DQ Trichophyton mentagrophytes XN4H4 Trichophyton simii XN69S Trichophyton verrucosum XN1Z2 Geophilic dermatophytes XN2VZ Microsporum gypseum XN7TP Microsporum praecox XN3AG Geotrichum XN0ES Geotrichum candidum XN9LU Histoplasma XN8VH Histoplasma capsulatum XN7YN Histoplasma duboisii XN119 Hortaea XN0EF Hortaea werneckii XN3CM Lacazia XN3NU Lacazia loboi XN9ZX Loboa XN43L Malassezia XN25C Malassezia furfur XN0TE Malassezia globosa fungus XN9ZV Microsporidia XN1NU Mucor XN6QM Rhizopus XN9KP Rhizopus arrhizus XN7RH Paracoccidioides XN5UX Paracoccidioides brasiliensis XN79A Talaromyces XN1ZF Penicillium XN7JJ Penicillium notatum XN0LD Talaromyces marneffei XN4YW Piedraia XN6H7 Piedraia hortae XN5XK Pneumocystidomycetes XN3NS Pseudallescheria XN6BV Pseudallescheria boydii XN720 Rhinosporidium XN18W Rhinosporidium seeberi XN200 Sporothrix XN6GM Sporothrix schenckii XN766 Trichosporon XN0X5 Fusarium XN55Z Fusarium sporotrichioides XN7KH Fusarium incaratum-equiseti XN1FQ Fusarium chlamydosporum XN5KR Fusarium dimerum XN6XG Fusarium fujikuroi XN3HT Fusarium oxysporum XN0E6 Fusarium solani XN16V Alternaria alternata XN8XY Cladosporium herbarum XN7TH Epicoccum purpurascens XN79P Mucor racemosus XN6EG Phoma XN4FM Stemphylium botryosum XN93N Curvularia lunata XN0W9 Exserohilum XN26M Exserohilum rostratum XN9SM Exserohilum longirostratum XN9LC Exserohilum mcginnisii XN4XH Sarocladium XN8VN Sarocladium kiliense XN7ZD Sarocladium strictum XN1H0 Echinococcus granulosus XN0K1 Echinococcus multilocularis XN6TQ Echinococcus oligarthrus XN9LQ Echinococcus vogeli XN801 Echinostoma XN1DG Enterobius XN4AR Enterobius vermicularis XN1H3 Fasciola XN90A Fasciola gigantica XN7X9 Fasciola hepatica XN35Y Fasciolopsis XN024 Fasciolopsis buski XN0H2 Gnathostoma XN8DD Gnathostoma hispidum XN8GS Gnathostoma spinigerum XN23M Heterophyes XN69Y Hookworm XN629 Hymenolepis XN9S5 Hymenolepis nana XN8ZQ Loa XN1QQ Loa loa XN5Z0 Mansonella XN6PZ Mansonella ozzardi XN8AX Mansonella perstans XN0JQ Mansonella streptocerca XN123 Metagonimus XN3E8 Nanophyetus XN9T3 Necator XN8K8 Necator americanus XN7L5 Oesophagostomum XN0NZ Oesophagostomum bifurcum XN9R1 Onchocerca XN8T4 Onchocerca volvulus XN91W Opisthorchis XN27A Paragonimus XN0A6 Paragonimus westermani XN9NR Phylum Nemata XN78L Schistosoma XN86N Schistosoma haematobium – XN90N Schistosoma matthei XN9FK Schistosoma intercalatum XN1ZJ Schistosoma japonicum XN8HD Schistosoma mansoni XN9T7 Schistosoma mekongi XN5B9 Sparganum XN89M Spirometra XN07X Strongyloides XN1KQ Strongyloides stercoralis XN5RB Syngamus XN04L Syngamus trachea XN0D8 Taenia XN871 Taenia saginata XN8XE Taenia solium XN8DL Ternidens XN2L3 Toxocara XN7MR Toxocara canis XN54C Toxocara cati XN597 Trichinella XN34A Trichinella spiralis XN025 Trichostrongylus XN4K7 Trichostrongylus colubriformis XN4MM Trichuris XN6UA Trichuris trichiura XN0H3 Wuchereria XN3V2 Wuchereria bancrofti XN2DD Halicephalobus XN10L Halicephalobus gingivalis XN0HM Acanthamoeba XN7S2 Amoeba XN9YX Babesia XN7ZS Balantidium XN3H4 Balantidium coli XN6UY Blastocystis XN1M7 Blastocystis hominis XN1XA Coccidia XN8LE Cryptosporidium XN0NC Cryptosporidium canis XN5SZ Cryptosporidium felis XN4ZT Cryptosporidium hominis XN4VU Cryptosporidium meleagridis XN4MN Cryptosporidium muris XN9BP Cryptosporidium parvum XN7VL Cyclospora XN4BR Cyclospora cayetanensis XN3S1 Entamoeba XN82F Entamoeba histolytica XN6H5 Giardia XN94Z Giardia lamblia XN4Y2 Isospora XN9ZT Isospora belli XN8JE Leishmania XN87Z Leishmania aethiopica XN6DJ Leishmania brasiliensis XN1M5 Leishmania donovani infantum – XN3HN Leishmania chagasii XN7EU Leishmania major XN1EE Leishmania mexicana XN95N Leishmania tropica XN1M1 Naegleria XN6EV Naegleria fowleri XN5FW Plasmodium XN69B Plasmodium falciparum XN7K1 Plasmodium malariae XN5WD Plasmodium ovale XN217 Plasmodium vivax XN93K Plasmodium knowlesi XN12A Plasmodium cynomolgi XN92F Sarcocystis XN7HC Toxoplasma XN896 Toxoplasma gondii XN316 Trichomonas XN7YM Trichomonas vaginalis XN9H4 Trypanosoma XN0C1 Trypanosoma brucei – XN7TC Trypanosoma brucei gambiense – XN5C7 Trypanosoma brucei rhodesiense XN56V Trypanosoma cruzi XN7XH Dientamoeba XN86U Dientamoeba fragilis XN30L Retortamonas XN9K3 Retortamonas intestinalis XN4BE Chilomastix XN0UD Chilomastix mesnili XN4RB Demodex XN9EL Dermanyssus XN59U Vandellia cirrhosa XN857 Infestation by beetle XN00Z Insect larva XN2K0 Leech XN9MA Linguatula serrata XN0ZB Liponyssoides XN0D5 Pediculus XN84U Phthirus XN3E3 Sarcoptes XN5YU Sarcoptes scabiei var. hominis XN7Z8 Trombicula XN6VS Tunga XN2GY Porocephalidae XN8CT Screwworm XN4JW New World screwworm XN8TR Old World screwworm XN9S1 Parasites XN9CG Ancylostoma XN5V8 Ancylostoma duodenal XN7A5 Angiostrongylus XN2UG Angiostrongylus cantonensis XN23C Angiostrongylus costaricensis XN574 Anisakis XN9HA Anisakis marina XN9PQ Ascaris XN97M Ascaris lumbricoides XN0JL Brugia XN5RM Brugia malayi XN80F Brugia timori XN8T0 Capillaria XN9DT Capillaria philippinensis XN9GC Clonorchis XN5SV Clonorchis sinensis XN3QD Dicrocoelium XN6EF Diphyllobothrium XN67S Diphyllobothrium latum XN7UT Diphyllobothrium species XN570 Dipylidium XN20Y Dipylidium caninum XN15W Dirofilaria XN3BX Dirofilaria immitis XN7JS Dirofilaria repens XN7A6 Dracunculus XN9Q5 Dracunculus medinensis XN84K Echinococcus XN7AM Prion XN42T Prototheca XN47C Pythium Has causing condition - a selection is required - multiple selections are allowed [select] 2A00 Primary neoplasms of brain – 2A00.0 Gliomas of brain – 2A00.1 Embryonal tumours of brain – 2A00.2 Tumours of neuroepithelial tissue of brain – 2A00.3 Central neurocytoma of brain – 2A00.4 Astroblastoma of the brain – 2A00.5 Primary neoplasm of brain of unknown or unspecified type –– 2A00.00 Glioblastoma of brain –– 2A00.0Y Other specified gliomas of brain –– 2A00.0Z Gliomas of brain, unspecified –– 2A00.10 Medulloblastoma of brain –– 2A00.11 Central primitive neuroectodermal tumour –– 2A00.1Y Other specified embryonal tumours of brain –– 2A00.1Z Embryonal tumours of brain, unspecified –– 2A00.20 Tumours of the pineal gland or pineal region –– 2A00.21 Mixed neuronal-glial tumours –– 2A00.22 Choroid plexus tumours –– 2A00.2Y Other specified tumours of neuroepithelial tissue of brain –– 2A00.2Z Tumours of neuroepithelial tissue of brain, unspecified 2A01 Primary neoplasms of meninges – 2A01.0 Meningiomas – 2A01.1 Mesenchymal tumours of meninges – 2A01.2 Primary neoplasm of meninges of unknown or unspecified type –– 2A01.00 Primary malignant meningioma –– 2A01.0Y Other specified meningiomas –– 2A01.0Z Meningiomas, unspecified 2A02 Primary neoplasm of spinal cord, cranial nerves or remaining parts of central nervous system – 2A02.0 Gliomas of spinal cord, cranial nerves or other parts of the central nervous system – 2A02.1 Tumours of cranial or paraspinal nerves – 2A02.2 Primary neoplasm of spinal cord of unknown or unspecified type – 2A02.3 Benign neoplasm of cranial nerves – 2A02.4 Benign neoplasm of spinal cord –– 2A02.00 Glioblastoma of spinal cord, cranial nerves or other parts of central nervous system –– 2A02.0Y Other specified gliomas of spinal cord, cranial nerves or other parts of the central nervous system –– 2A02.0Z Gliomas of spinal cord, cranial nerves or other parts of the central nervous system, unspecified –– 2A02.10 Malignant peripheral nerve sheath tumour of cranial or paraspinal nerves –– 2A02.11 Paraspinal neuroblastoma –– 2A02.12 Malignant neoplasm of the optic nerve –– 2A02.1Y Other specified tumours of cranial or paraspinal nerves –– 2A02.1Z Tumours of cranial or paraspinal nerves, unspecified 2A0Z Other and unspecified neoplasms of brain or central nervous system – 2A20 Non mast cell myeloproliferative neoplasms –– 2A20.0 Chronic myelogenous leukaemia, BCR-ABL1-positive –– 2A20.1 Chronic neutrophilic leukaemia –– 2A20.2 Primary myelofibrosis –– 2A20.3 Chronic eosinophilic leukaemia, not elsewhere classified –– 2A20.4 Polycythaemia vera –– 2A20.5 Non mast cell myeloproliferative neoplasm, unclassifiable –– 2A20.Y Other specified non mast cell myeloproliferative neoplasms –– 2A20.Z Non mast cell myeloproliferative neoplasms, unspecified ––– 2A20.00 Chronic myelogenous leukaemia with blast crisis ––– 2A20.01 Chronic myelogenous leukaemia, Philadelphia chromosome (Ph1) positive ––– 2A20.02 Chronic myelogenous leukaemia, t(9:22)(q34; q11) ––– 2A20.03 Naegeli-type monocytic leukaemia ––– 2A20.0Y Other specified chronic myelogenous leukaemia, BCR-ABL1-positive ––– 2A20.0Z Chronic myelogenous leukaemia, BCR-ABL1-positive, unspecified – 2A21 Mastocytosis –– 2A21.0 Systemic mastocytosis –– 2A21.1 Cutaneous mastocytosis –– 2A21.2 Mast cell sarcoma –– 2A21.3 Extracutaneous mastocytoma –– 2A21.Y Other specified mastocytosis –– 2A21.Z Mastocytosis, unspecified ––– 2A21.00 Mast cell leukaemia ––– 2A21.0Y Other specified systemic mastocytosis ––– 2A21.0Z Systemic mastocytosis, unspecified ––– 2A21.10 Urticaria pigmentosa ––– 2A21.1Y Other specified cutaneous mastocytosis ––– 2A21.1Z Cutaneous mastocytosis, unspecified – 2A22 Other and unspecified myeloproliferative neoplasms – 2A30 Refractory anaemia – 2A31 Refractory neutropaenia – 2A32 Refractory thrombocytopenia – 2A33 Refractory anaemia with ring sideroblasts – 2A34 Refractory cytopenia with multi-lineage dysplasia – 2A35 Refractory anaemia with excess of blasts – 2A36 Myelodysplastic syndrome with isolated del(5q) – 2A37 Myelodysplastic syndrome, unclassifiable – 2A38 Refractory cytopenia of childhood – 2A3Y Other specified myelodysplastic syndromes – 2A3Z Myelodysplastic syndromes, unspecified – 2A40 Chronic myelomonocytic leukaemia – 2A41 Atypical chronic myeloid leukaemia, BCR-ABL1-negative – 2A42 Juvenile myelomonocytic leukaemia –– 2A42.0 Juvenile myelomonocytic leukaemia in complete remission –– 2A42.Y Other specified juvenile myelomonocytic leukaemia –– 2A42.Z Juvenile myelomonocytic leukaemia, unspecified – 2A43 Refractory anaemia with ring sideroblasts associated with marked thrombocytosis – 2A44 Myeloproliferative and myelodysplastic disease, unclassifiable – 2A4Y Other specified myelodysplastic and myeloproliferative neoplasms – 2A4Z Myelodysplastic and myeloproliferative neoplasms, unspecified – 2A50 Myeloid/lymphoid neoplasm associated with PDGFRA rearrangement – 2A51 Myeloid neoplasm associated with PDGFRB rearrangement – 2A52 Myeloid or lymphoid neoplasms with FGFR1 abnormalities – 2A5Z Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1, unspecified 2A60 Acute myeloid leukaemias and related precursor neoplasms – 2A60.0 Acute myeloid leukaemia with recurrent genetic abnormalities – 2A60.1 Acute myeloid leukaemia with myelodysplasia-related changes – 2A60.2 Therapy-related myeloid neoplasms – 2A60.3 Acute myeloid leukaemia, not elsewhere classified by criteria of other types – 2A60.4 Myeloid proliferation associated with Down syndrome – 2A60.5 Blastic plasmacytoid dendritic cell neoplasm – 2A60.Y Other specified acute myeloid leukaemias and related precursor neoplasms – 2A60.Z Acute myeloid leukaemias and related precursor neoplasms, unspecified –– 2A60.20 Therapy related acute myeloid leukaemia or myelodysplastic syndrome –– 2A60.2Y Other specified therapy-related myeloid neoplasms –– 2A60.2Z Therapy-related myeloid neoplasms, unspecified –– 2A60.30 Acute myeloid leukaemia with minimal differentiation –– 2A60.31 Acute myeloid leukaemia without maturation –– 2A60.32 Acute myeloid leukaemia with maturation –– 2A60.33 Acute myelomonocytic leukaemia –– 2A60.34 Acute monoblastic or monocytic leukaemia –– 2A60.35 Acute erythroid leukaemia –– 2A60.36 Acute megakaryoblastic leukaemia –– 2A60.37 Acute basophilic leukaemia –– 2A60.38 Acute panmyelosis with myelofibrosis –– 2A60.39 Myeloid sarcoma –– 2A60.3Y Other specified acute myeloid leukaemia, not elsewhere classified by criteria of other types –– 2A60.3Z Acute myeloid leukaemia, unspecified –– 2A60.40 Transient abnormal myelopoiesis –– 2A60.41 Myeloid leukaemia associated with Down syndrome –– 2A60.4Y Other specified myeloid proliferation associated with Down syndrome –– 2A60.4Z Myeloid proliferation associated with Down syndrome, unspecified 2A61 Acute leukaemias of ambiguous lineage – 2A70 Precursor B-lymphoblastic neoplasms –– 2A70.0 B lymphoblastic leukaemia or lymphoma, not elsewhere classified –– 2A70.1 B lymphoblastic leukaemia or lymphoma with t(9:22) (q34;q11.2); BCR-ABL1 –– 2A70.Y Other B-lymphoblastic leukaemia/lymphoma with recurrent genetic abnormalities – 2A71 Precursor T-lymphoblastic neoplasms – 2A7Z Precursor lymphoid neoplasms, unspecified – 2A80 Follicular lymphoma –– 2A80.0 Follicular lymphoma grade 1 –– 2A80.1 Follicular lymphoma grade 2 –– 2A80.2 Follicular lymphoma grade 3 –– 2A80.3 Primary cutaneous follicle centre lymphoma –– 2A80.4 Paediatric type follicular lymphoma –– 2A80.5 Follicular lymphoma in situ –– 2A80.6 Follicular lymphoma of small intestine –– 2A80.Y Other specified follicular lymphoma –– 2A80.Z Follicular lymphoma, unspecified – 2A81 Diffuse large B-cell lymphomas –– 2A81.0 Primary mediastinal large B-cell lymphoma –– 2A81.1 Intravascular large B-cell lymphoma –– 2A81.2 Plasmablastic lymphoma –– 2A81.3 Lymphomatoid granulomatosis –– 2A81.4 T-cell/histiocyte rich large B-cell lymphoma –– 2A81.5 Primary diffuse large B-cell lymphoma of central nervous system –– 2A81.6 Epstein-Barr Virus-positive diffuse large B-cell lymphoma of the elderly –– 2A81.7 Diffuse large B-cell lymphoma associated with chronic inflammation –– 2A81.8 ALK-positive large B-cell lymphoma –– 2A81.9 Primary effusion lymphoma –– 2A81.A Primary cutaneous diffuse large B-cell lymphoma, leg type –– 2A81.Y Other specified diffuse large B-cell lymphomas –– 2A81.Z Diffuse large B-cell lymphoma, not otherwise specified – 2A82 Mature B-cell neoplasm with leukaemic behaviour –– 2A82.0 Chronic lymphocytic leukaemia or small lymphocytic lymphoma –– 2A82.1 B-cell prolymphocytic leukaemia –– 2A82.2 Hairy-cell leukaemia –– 2A82.3 Splenic B-cell lymphoma or leukaemia, unclassifiable –– 2A82.Y Other specified mature B-cell neoplasm with leukaemic behaviour –– 2A82.Z Mature B-cell neoplasm with leukaemic behaviour, unspecified ––– 2A82.00 Chronic lymphocytic leukaemia of B-cell type ––– 2A82.0Y Other specified chronic lymphocytic leukaemia or small lymphocytic lymphoma ––– 2A82.0Z Chronic lymphocytic leukaemia or small lymphocytic lymphoma, unspecified ––– 2A82.10 B-cell prolymphocytic leukaemia in complete remission ––– 2A82.1Y Other specified b-cell prolymphocytic leukaemia ––– 2A82.1Z B-cell prolymphocytic leukaemia, unspecified – 2A83 Plasma cell neoplasms –– 2A83.0 Monoclonal gammopathy of undetermined significance –– 2A83.1 Plasma cell myeloma –– 2A83.2 Solitary plasmacytoma –– 2A83.3 Extraosseous plasmacytoma –– 2A83.4 Plasma cell leukaemia –– 2A83.5 Monoclonal immunoglobulin deposition disease –– 2A83.Y Other specified multiple myeloma and plasma cell neoplasms –– 2A83.Z Plasma cell neoplasm, unspecified ––– 2A83.50 Heavy chain deposition disease ––– 2A83.51 Light and heavy chain deposition disease ––– 2A83.52 Light chain deposition disease – 2A84 Heavy chain diseases or malignant immunoproliferative diseases –– 2A84.0 Alpha heavy chain disease –– 2A84.1 Gamma heavy chain disease –– 2A84.2 Mu heavy chain disease –– 2A84.Y Other specified malignant immunoproliferative diseases –– 2A84.Z Heavy chain diseases, unspecified – 2A85 Other specified mature B-cell neoplasms or lymphoma –– 2A85.0 Nodal marginal zone lymphoma –– 2A85.1 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue of stomach –– 2A85.2 Extranodal marginal zone B-cell lymphoma, primary site skin –– 2A85.3 Extranodal marginal zone B-cell lymphoma, primary site excluding stomach or skin –– 2A85.4 Lymphoplasmacytic lymphoma –– 2A85.5 Mantle cell lymphoma –– 2A85.6 Burkitt lymphoma including Burkitt leukaemia –– 2A85.Y Further specified mature B-cell neoplasms or lymphoma – 2A86 B-cell lymphoma, mixed features –– 2A86.0 Malignant lymphoma of B cell type, not elsewhere classified –– 2A86.1 B-cell lymphoma unclassifiable with features intermediate between Burkitt lymphoma and diffuse large B-cell lymphoma –– 2A86.2 B-cell lymphoma unclassifiable with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma –– 2A86.Y Other specified B-cell lymphoma, mixed features –– 2A86.Z B-cell lymphoma, mixed features, unspecified – 2A8Z Mature B-cell neoplasms, unspecified – 2A90 Mature T-cell lymphoma, specified types, nodal or systemic –– 2A90.0 T-cell prolymphocytic leukaemia –– 2A90.1 T-cell large granular lymphocytic leukaemia –– 2A90.2 Chronic lymphoproliferative disorders of NK-cells –– 2A90.3 Aggressive NK cell leukaemia –– 2A90.4 Systemic Epstein-Barr Virus-positive T-cell lymphoma of childhood –– 2A90.5 Adult T-cell lymphoma or leukaemia, human T-cell lymphotropic virus type 1-associated –– 2A90.6 Extranodal NK/T-cell lymphoma, nasal type –– 2A90.7 Enteropathy associated T-cell lymphoma –– 2A90.8 Hepatosplenic T-cell lymphoma –– 2A90.9 Angioimmunoblastic T-cell lymphoma –– 2A90.A Anaplastic large cell lymphoma, ALK-positive –– 2A90.B Anaplastic large cell lymphoma, ALK-negative –– 2A90.C Peripheral T-cell lymphoma, not otherwise specified –– 2B00 Subcutaneous panniculitis-like T-cell lymphoma –– 2B01 Mycosis fungoides –– 2B02 Sézary syndrome –– 2B03 Primary cutaneous CD30-positive T-cell lymphoproliferative disorders ––– 2B03.0 Primary cutaneous CD30-positive anaplastic large cell lymphoma ––– 2B03.1 Lymphomatoid papulosis –– 2B0Y Other specified primary cutaneous mature T-cell or NK-cell lymphomas and lymphoproliferative disorders –– 2B0Z Primary cutaneous T-cell lymphoma of undetermined or unspecified type – 2B2Y Other specified mature T-cell or NK-cell neoplasms – 2B2Z Mature T-cell or NK-cell neoplasms, unspecified 2B30 Hodgkin lymphoma – 2B30.0 Nodular lymphocyte predominant Hodgkin lymphoma – 2B30.1 Classical Hodgkin lymphoma – 2B30.Z Hodgkin lymphoma, unspecified –– 2B30.10 Nodular sclerosis classical Hodgkin lymphoma –– 2B30.11 Lymphocyte-rich classical Hodgkin lymphoma –– 2B30.12 Mixed cellularity classical Hodgkin lymphoma –– 2B30.13 Lymphocyte depleted classical Hodgkin lymphoma –– 2B30.1Z Classical Hodgkin lymphoma, unspecified 2B31 Histiocytic or dendritic cell neoplasms – 2B31.0 Juvenile xanthogranuloma – 2B31.1 Histiocytic sarcoma – 2B31.2 Langerhans cell histiocytosis – 2B31.3 Langerhans cell sarcoma – 2B31.4 Interdigitating dendritic cell sarcoma – 2B31.5 Follicular dendritic cell sarcoma – 2B31.6 Indeterminate cell histiocytosis – 2B31.7 Fibroblastic reticular cell tumour – 2B31.Y Other specified histiocytic or dendritic cell neoplasms – 2B31.Z Histiocytic or dendritic cell neoplasms, unspecified –– 2B31.20 Langerhans cell histiocytosis involving the skin –– 2B31.2Y Other specified Langerhans cell histiocytosis –– 2B31.2Z Langerhans cell histiocytosis, unspecified 2B32 Immunodeficiency-associated lymphoproliferative disorders – 2B32.0 Post-transplant lymphoproliferative disorder, early lesion – 2B32.1 Reactive plasmacytic hyperplasia – 2B32.2 Post-transplant lymphoproliferative disorder, Infectious mononucleosis-like – 2B32.3 Polymorphic post-transplant lymphoproliferative disorder – 2B32.Y Other specified immunodeficiency-associated lymphoproliferative disorders – 2B32.Z Immunodeficiency-associated lymphoproliferative disorders, unspecified 2B33 Malignant haematopoietic neoplasms without further specification – 2B33.0 Acute leukaemia, not elsewhere classified – 2B33.1 Myeloid leukaemia – 2B33.2 Chronic myeloid leukaemia, not elsewhere classified – 2B33.3 Lymphoid leukaemia, not elsewhere classified – 2B33.4 Leukaemia, unspecified – 2B33.5 Malignant lymphoma, not elsewhere classified – 2B33.Y Other malignant haematopoietic neoplasms without further specification 2B3Z Neoplasms of haematopoietic or lymphoid tissues, unspecified –– 2B50 Chondrosarcoma, primary site ––– 2B50.0 Chondrosarcoma of bone or articular cartilage of limbs ––– 2B50.1 Chondrosarcoma of bone or articular cartilage of pelvis ––– 2B50.2 Chondrosarcoma of bone or articular cartilage of ribs, sternum or clavicle ––– 2B50.Y Chondrosarcoma of bone or articular cartilage of other specified sites ––– 2B50.Z Chondrosarcoma of bone or articular cartilage of unspecified sites –– 2B51 Osteosarcoma, primary site ––– 2B51.0 Osteosarcoma of bone or articular cartilage of jaw ––– 2B51.1 Osteosarcoma of bone or articular cartilage of limbs ––– 2B51.2 Osteosarcoma of bone or articular cartilage of pelvis ––– 2B51.Y Osteosarcoma of bone and articular cartilage of other specified sites ––– 2B51.Z Osteosarcoma of bone and articular cartilage of unspecified sites –– 2B52 Ewing sarcoma, primary site ––– 2B52.0 Ewing sarcoma of bone or articular cartilage of limbs ––– 2B52.1 Ewing sarcoma of bone or articular cartilage of pelvis ––– 2B52.2 Ewing sarcoma of bone or articular cartilage of ribs ––– 2B52.3 Ewing sarcoma of soft tissue ––– 2B52.Y Ewing sarcoma of bone and articular cartilage of other specified sites ––– 2B52.Z Ewing sarcoma of bone and articular cartilage of unspecified sites –– 2B53 Fibroblastic or myofibroblastic tumour, primary site ––– 2B53.0 Myxofibrosarcoma, primary site ––– 2B53.1 Fibroblastic or myofibroblastic tumour of skin ––– 2B53.Y Other specified fibroblastic or myofibroblastic tumour, primary site ––– 2B53.Z Fibroblastic or myofibroblastic tumour, primary site, unspecified –– 2B54 Unclassified pleomorphic sarcoma, primary site ––– 2B54.0 Unclassified pleomorphic sarcoma of skin ––– 2B54.1 Unclassified pleomorphic sarcoma of retroperitoneum or peritoneum ––– 2B54.Y Unclassified pleomorphic sarcoma, primary site, other specified site ––– 2B54.Z Unclassified pleomorphic sarcoma, primary site, unspecified site –– 2B55 Rhabdomyosarcoma, primary site ––– 2B55.0 Rhabdomyosarcoma of the oral cavity or pharynx ––– 2B55.1 Rhabdomyosarcoma of respiratory or intrathoracic organs ––– 2B55.2 Rhabdomyosarcoma of male genital organs ––– 2B55.Y Rhabdomyosarcoma, other specified primary site ––– 2B55.Z Rhabdomyosarcoma, unspecified primary site –– 2B56 Angiosarcoma, primary site ––– 2B56.0 Angiosarcoma of heart ––– 2B56.1 Angiosarcoma of skin ––– 2B56.2 Angiosarcoma of breast ––– 2B56.3 Angiosarcoma of liver ––– 2B56.Y Angiosarcoma, other specified primary site ––– 2B56.Z Angiosarcoma, unspecified primary site –– 2B57 Kaposi sarcoma, primary site ––– 2B57.0 Kaposi sarcoma of lung ––– 2B57.1 Kaposi sarcoma of skin ––– 2B57.2 Kaposi sarcoma of gastrointestinal sites ––– 2B57.Y Kaposi sarcoma of other specified primary sites ––– 2B57.Z Kaposi sarcoma of unspecified primary site –– 2B58 Leiomyosarcoma, primary site ––– 2B58.0 Leiomyosarcoma of retroperitoneum or peritoneum ––– 2B58.1 Leiomyosarcoma of uterus ––– 2B58.2 Leiomyosarcoma of stomach ––– 2B58.Y Leiomyosarcoma, other specified primary site ––– 2B58.Z Leiomyosarcoma, unspecified primary site –– 2B59 Liposarcoma, primary site ––– 2B59.0 Liposarcoma of soft tissue of limb ––– 2B59.1 Liposarcoma of retroperitoneum or peritoneum ––– 2B59.2 Liposarcoma of male genital organs ––– 2B59.Y Liposarcoma, other specified primary site ––– 2B59.Z Liposarcoma, unspecified primary site –– 2B5A Synovial sarcoma, primary site ––– 2B5A.0 Synovial sarcoma of soft tissues of limb ––– 2B5A.1 Synovial sarcoma of respiratory or intra-thoracic organs ––– 2B5A.Y Synovial sarcoma, other specified primary site ––– 2B5A.Z Synovial sarcoma, unspecified primary site –– 2B5B Gastrointestinal stromal tumour, primary site ––– 2B5B.0 Gastrointestinal stromal tumour of stomach ––– 2B5B.1 Gastrointestinal stromal tumour of small intestine ––– 2B5B.Y Gastrointestinal stromal tumour of other gastrointestinal sites ––– 2B5B.Z Gastrointestinal stromal tumour of unspecified gastrointestinal sites –– 2B5C Endometrial stromal sarcoma, primary site –– 2B5D Malignant mixed epithelial mesenchymal tumour, primary site ––– 2B5D.0 Malignant mixed epithelial mesenchymal tumour of ovary ––– 2B5D.1 Malignant mixed epithelial and mesenchymal tumour of corpus uteri ––– 2B5D.Y Malignant mixed epithelial mesenchymal tumour, other specified primary site ––– 2B5D.Z Malignant mixed epithelial mesenchymal tumour, unspecified primary site –– 2B5E Malignant nerve sheath tumour of peripheral nerves or autonomic nervous system, primary site –– 2B5F Sarcoma, not elsewhere classified, primary site ––– 2B5F.0 Sarcoma, not elsewhere classified of uterus ––– 2B5F.1 Sarcoma, not elsewhere classified of retroperitoneum or peritoneum ––– 2B5F.2 Sarcoma, not elsewhere classified of other specified sites ––– 2B5F.3 Sarcoma, not elsewhere classified, primary site unknown –––– 2B5F.10 Myosarcomas of omentum –––– 2B5F.1Y Other specified sarcoma, not elsewhere classified of retroperitoneum or peritoneum –––– 2B5F.1Z Sarcoma, not elsewhere classified of retroperitoneum or peritoneum, unspecified –– 2B5G Myosarcoma of uterus, part not specified –– 2B5H Well differentiated lipomatous tumour, primary site –– 2B5J Malignant miscellaneous tumours of bone or articular cartilage of other or unspecified sites –– 2B5K Unspecified malignant soft tissue tumours or sarcomas of bone or articular cartilage of other or unspecified sites –– 2B5Y Other specified malignant mesenchymal neoplasms –– 2B5Z Malignant mesenchymal neoplasm of unspecified type –– 2B60 Malignant neoplasms of lip ––– 2B60.0 Basal cell carcinoma of lip ––– 2B60.1 Squamous cell carcinoma of lip ––– 2B60.Y Other specified malignant neoplasms of lip ––– 2B60.Z Malignant neoplasms of lip, unspecified –– 2B61 Malignant neoplasms of base of tongue ––– 2B61.0 Squamous cell carcinoma of the base of the tongue ––– 2B61.Y Other specified malignant neoplasms of base of tongue ––– 2B61.Z Malignant neoplasms of base of tongue, unspecified –– 2B62 Malignant neoplasms of other or unspecified parts of tongue ––– 2B62.0 Squamous cell carcinoma of other or unspecified parts of tongue ––– 2B62.1 Malignant neoplasms of lingual tonsil ––– 2B62.Y Other specified malignant neoplasms of other and unspecified parts of tongue ––– 2B62.Z Malignant neoplasms of other or unspecified parts of tongue, unspecified –––– 2B62.10 Squamous cell carcinoma of lingual tonsil –––– 2B62.1Z Malignant neoplasms of lingual tonsil, unspecified –– 2B63 Malignant neoplasms of gum ––– 2B63.0 Squamous cell carcinoma of gum ––– 2B63.Y Other specified malignant neoplasm of gum ––– 2B63.Z Malignant neoplasms of gum, unspecified –– 2B64 Malignant neoplasms of floor of mouth ––– 2B64.0 Squamous cell carcinoma of floor of mouth ––– 2B64.Y Other specified malignant neoplasm of floor of mouth ––– 2B64.Z Malignant neoplasms of floor of mouth, unspecified –– 2B65 Malignant neoplasms of palate ––– 2B65.0 Adenocarcinoma of palate ––– 2B65.1 Squamous cell carcinoma of palate ––– 2B65.Y Other specified malignant neoplasm of palate ––– 2B65.Z Malignant neoplasms of palate, unspecified –– 2B66 Malignant neoplasms of other or unspecified parts of mouth ––– 2B66.0 Squamous cell carcinoma of other or unspecified parts of mouth ––– 2B66.Y Other specified malignant neoplasms of other and unspecified parts of mouth ––– 2B66.Z Malignant neoplasms of other or unspecified parts of mouth, unspecified –– 2B67 Malignant neoplasms of parotid gland ––– 2B67.0 Adenocarcinoma of parotid gland ––– 2B67.1 Squamous cell carcinoma of parotid gland ––– 2B67.Y Other specified malignant neoplasms of parotid gland ––– 2B67.Z Malignant neoplasms of parotid gland, unspecified –– 2B68 Malignant neoplasms of submandibular or sublingual glands ––– 2B68.0 Adenocarcinoma of submandibular or sublingual glands ––– 2B68.1 Squamous cell carcinoma of submandibular or sublingual glands ––– 2B68.2 Other specified malignant neoplasms of submandibular or sublingual glands ––– 2B68.Z Malignant neoplasms of submandibular or sublingual glands, unspecified –– 2B69 Malignant neoplasms of tonsil ––– 2B69.0 Squamous cell carcinoma of tonsil ––– 2B69.1 Other specified malignant neoplasms of tonsil ––– 2B69.Z Malignant neoplasms of tonsil, unspecified –– 2B6A Malignant neoplasms of oropharynx ––– 2B6A.0 Squamous cell carcinoma of oropharynx ––– 2B6A.Y Other specified malignant neoplasms of oropharynx ––– 2B6A.Z Malignant neoplasms of oropharynx, unspecified –– 2B6B Malignant neoplasms of nasopharynx ––– 2B6B.0 Squamous cell carcinoma of nasopharynx ––– 2B6B.1 Malignant epithelial neoplasms of nasopharynx, unspecified type ––– 2B6B.2 Malignant neoplasms of pharyngeal tonsil ––– 2B6B.Y Other specified malignant neoplasms of nasopharynx ––– 2B6B.Z Malignant neoplasms of nasopharynx, unspecified –––– 2B6B.20 Squamous cell carcinoma of pharyngeal tonsil –––– 2B6B.21 Other or unspecified malignant epithelial neoplasm of pharyngeal tonsil –––– 2B6B.2Y Other specified malignant neoplasms of pharyngeal tonsil –––– 2B6B.2Z Malignant neoplasm of pharyngeal tonsil without mention of type –– 2B6C Malignant neoplasms of piriform sinus ––– 2B6C.0 Squamous cell carcinoma of piriform sinus ––– 2B6C.Y Other specified malignant neoplasms of piriform sinus ––– 2B6C.Z Malignant neoplasms of piriform sinus, unspecified –– 2B6D Malignant neoplasms of hypopharynx ––– 2B6D.0 Squamous cell carcinoma of hypopharynx and variants ––– 2B6D.Y Other specified malignant neoplasms of hypopharynx ––– 2B6D.Z Malignant neoplasms of hypopharynx, unspecified –– 2B6E Malignant neoplasms of other or ill-defined sites in the lip, oral cavity or pharynx ––– 2B6E.0 Squamous cell carcinoma of other or ill-defined sites in the lip, oral cavity or pharynx ––– 2B6E.Y Other specified malignant neoplasms of other or ill-defined sites in the lip, oral cavity or pharynx ––– 2B6E.Z Malignant neoplasms of other or ill-defined sites in the lip, oral cavity or pharynx, unspecified –– 2B6Y Other specified malignant neoplasms of lip, oral cavity or pharynx –– 2B70 Malignant neoplasms of oesophagus ––– 2B70.0 Adenocarcinoma of oesophagus ––– 2B70.1 Squamous cell carcinoma of oesophagus ––– 2B70.Y Other specified malignant neoplasms of oesophagus ––– 2B70.Z Malignant neoplasms of oesophagus, unspecified –––– 2B70.00 Barrett adenocarcinoma –––– 2B70.0Y Other specified adenocarcinoma of oesophagus –––– 2B70.0Z Adenocarcinoma of oesophagus, unspecified –– 2B71 Malignant neoplasms of oesophagogastric junction ––– 2B71.0 Adenocarcinoma of oesophagogastric junction ––– 2B71.Y Other specified malignant neoplasm of oesophagogastric junction ––– 2B71.Z Malignant neoplasms of oesophagogastric junction, unspecified –– 2B72 Malignant neoplasms of stomach ––– 2B72.0 Adenocarcinoma of stomach ––– 2B72.1 Malignant neuroendocrine neoplasm of stomach ––– 2B72.Y Other specified malignant neoplasms of stomach ––– 2B72.Z Malignant neoplasms of stomach, unspecified ––– 2B80 Malignant neoplasms of small intestine –––– 2B80.0 Malignant neoplasms of duodenum –––– 2B80.1 Malignant neoplasms of jejunum or ileum –––– 2B80.2 Malignant neoplasms of small intestine, site unspecified –––– 2B80.Y Other specified malignant neoplasms of small intestine –––– 2B80.Z Malignant neoplasms of small intestine, unspecified ––––– 2B80.00 Adenocarcinoma of duodenum ––––– 2B80.01 Neuroendocrine neoplasm of duodenum ––––– 2B80.0Y Other specified malignant neoplasms of the duodenum ––––– 2B80.0Z Malignant neoplasms of duodenum, unspecified ––––– 2B80.10 Adenocarcinoma of jejunum or ileum ––––– 2B80.11 Neuroendocrine neoplasms of jejunum or ileum ––––– 2B80.1Y Other specified malignant neoplasms of jejunum or ileum ––––– 2B80.1Z Malignant neoplasms of jejunum or ileum, unspecified ––––– 2B80.20 Adenocarcinoma of small intestine, site unspecified ––––– 2B80.21 Neuroendocrine neoplasms of small intestine, site unspecified ––––– 2B80.2Y Other specified malignant neoplasms of small intestine, site unspecified ––– 2B81 Malignant neoplasms of appendix –––– 2B81.0 Adenocarcinoma of appendix –––– 2B81.2 Neuroendocrine neoplasms of appendix –––– 2B81.Y Other specified malignant neoplasms of appendix –––– 2B81.Z Malignant neoplasms of appendix, unspecified ––––– 2B81.00 Mucinous adenocarcinoma of appendix –––– 2B90 Malignant neoplasms of colon ––––– 2B90.0 Malignant neoplasm of ascending colon and right flexure of colon ––––– 2B90.1 Malignant neoplasm of descending colon and splenic flexure of colon ––––– 2B90.2 Malignant neoplasm of transverse colon ––––– 2B90.3 Malignant neoplasm of sigmoid colon ––––– 2B90.Y Other specified malignant neoplasms of colon ––––– 2B90.Z Malignant neoplasms of colon, unspecified –––––– 2B90.00 Adenocarcinoma of ascending colon or right flexure of colon –––––– 2B90.0Y Other specified malignant neoplasm of ascending colon and right flexure of colon –––––– 2B90.0Z Malignant neoplasm of ascending colon and right flexure of colon, unspecified –––––– 2B90.10 Adenocarcinoma of descending colon or splenic flexure of colon –––––– 2B90.1Y Other specified malignant neoplasm of descending colon and splenic flexure of colon –––––– 2B90.1Z Malignant neoplasm of descending colon and splenic flexure of colon, unspecified –––––– 2B90.20 Adenocarcinoma of transverse colon –––––– 2B90.2Y Other specified malignant neoplasm of transverse colon –––––– 2B90.2Z Malignant neoplasm of transverse colon, unspecified –––––– 2B90.30 Adenocarcinoma of sigmoid colon –––––– 2B90.3Y Other specified malignant neoplasm of sigmoid colon –––––– 2B90.3Z Malignant neoplasm of sigmoid colon, unspecified –––– 2B91 Malignant neoplasms of rectosigmoid junction ––––– 2B91.0 Adenocarcinoma of rectosigmoid junction ––––– 2B91.Y Other specified malignant neoplasms of rectosigmoid junction ––––– 2B91.Z Malignant neoplasms of rectosigmoid junction, unspecified –––– 2B92 Malignant neoplasms of rectum ––––– 2B92.0 Adenocarcinomas of rectum ––––– 2B92.1 Neuroendocrine neoplasms of rectum ––––– 2B92.Y Other specified malignant neoplasms of rectum ––––– 2B92.Z Malignant neoplasms of rectum, unspecified –––– 2B93 Malignant neoplasms of large intestine, site unspecified ––––– 2B93.0 Adenocarcinoma of large intestine, site unspecified ––––– 2B93.Y Other specified malignant neoplasms of large intestine, site unspecified ––––– 2B93.Z Malignant neoplasms of large intestine, site and type unspecified –––– 2B9Y Other specified malignant neoplasms of large intestine ––– 2C00 Malignant neoplasms of anus or anal canal –––– 2C00.0 Adenocarcinoma of anus or anal canal –––– 2C00.1 Melanoma of anus or anal canal –––– 2C00.2 Neuroendocrine neoplasm of anus or anal canal –––– 2C00.3 Squamous cell carcinoma of anus or anal canal –––– 2C00.Y Other specified malignant neoplasms of anus and anal canal –––– 2C00.Z Malignant neoplasms of anus or anal canal, unspecified ––– 2C0Y Other specified malignant neoplasms of intestine ––– 2C0Z Malignant neoplasms of intestine, unspecified –– 2C10 Malignant neoplasm of pancreas ––– 2C10.0 Adenocarcinoma of pancreas ––– 2C10.1 Neuroendocrine neoplasms of pancreas ––– 2C10.Y Other specified malignant neoplasms of pancreas ––– 2C10.Z Malignant neoplasm of pancreas, unspecified –– 2C11 Malignant neoplasms of other or ill-defined digestive organs ––– 2C11.0 Adenocarcinoma of other or ill-defined digestive organs ––– 2C11.1 Mucinous carcinoma of other or ill-defined digestive organs ––– 2C11.2 Other specified malignant neoplasms of other or ill-defined digestive organs ––– 2C11.Z Malignant neoplasms of other or ill-defined digestive organs, unspecified –– 2C12 Malignant neoplasms of liver or intrahepatic bile ducts ––– 2C12.0 Malignant neoplasm of liver ––– 2C12.1 Malignant neoplasm of intrahepatic bile ducts –––– 2C12.00 Combined hepatocellular-cholangiocarcinoma –––– 2C12.01 Hepatoblastoma –––– 2C12.02 Hepatocellular carcinoma of liver –––– 2C12.03 Mesothelial carcinoma of liver –––– 2C12.0Y Other specified malignant neoplasm of liver –––– 2C12.0Z Malignant neoplasm of liver, unspecified –––– 2C12.10 Intrahepatic cholangiocarcinoma –––– 2C12.1Y Other specified malignant neoplasms of intrahepatic bile ducts –––– 2C12.1Z Malignant neoplasm of intrahepatic bile ducts, unspecified –– 2C13 Malignant neoplasms of gallbladder ––– 2C13.0 Adenocarcinoma of the gallbladder ––– 2C13.Y Other specified malignant neoplasm of gallbladder ––– 2C13.Z Malignant neoplasms of gallbladder, unspecified –– 2C14 Malignant neoplasms of proximal biliary tract, cystic duct ––– 2C14.0 Adenocarcinoma of proximal biliary tract, cystic duct ––– 2C14.1 Mucinous cystic neoplasm with associated invasive carcinoma of cystic duct ––– 2C14.2 Neuroendocrine neoplasms of cystic duct ––– 2C14.Y Other specified malignant neoplasms of biliary tract, cystic duct ––– 2C14.Z Malignant neoplasms of proximal biliary tract, cystic duct, unspecified –– 2C15 Malignant neoplasms of biliary tract, distal bile duct ––– 2C15.0 Adenocarcinoma of biliary tract, distal bile duct ––– 2C15.1 Mucinous cystic neoplasm with associated invasive carcinoma of distal bile duct ––– 2C15.2 Neuroendocrine neoplasms of distal bile duct ––– 2C15.Y Other specified malignant neoplasms of biliary tract, distal bile duct ––– 2C15.Z Malignant neoplasms of biliary tract, distal bile duct, unspecified –– 2C16 Malignant neoplasms of ampulla of Vater ––– 2C16.0 Adenocarcinoma of ampulla of Vater ––– 2C16.1 Neuroendocrine neoplasms of ampulla of Vater ––– 2C16.Y Other specified malignant neoplasms of ampulla of Vater ––– 2C16.Z Malignant neoplasms of ampulla of Vater, unspecified –– 2C17 Malignant neoplasms of other or unspecified parts of biliary tract ––– 2C17.0 Adenocarcinoma of other or unspecified parts of biliary tract ––– 2C17.1 Mucinous cystic neoplasm with associated invasive carcinoma of other or unspecified parts of biliary tract ––– 2C17.2 Neuroendocrine neoplasms of other or unspecified parts of biliary tract ––– 2C17.Y Other specified malignant neoplasms of overlapping lesion of biliary tract ––– 2C17.Z Malignant neoplasms of other or unspecified parts of biliary tract, unspecified –– 2C18 Malignant neoplasms of perihilar bile duct ––– 2C18.0 Hilar cholangiocarcinoma ––– 2C18.1 Mucinous cystic neoplasm with associated invasive carcinoma of perihilar bile duct ––– 2C18.2 Neuroendocrine neoplasm of perihilar bile duct ––– 2C18.Y Other specified malignant neoplasms of perihilar bile duct ––– 2C18.Z Malignant neoplasms of perihilar bile duct, unspecified –– 2C1Z Malignant neoplasms of digestive organs, unspecified –– 2C20 Malignant neoplasms of nasal cavity ––– 2C20.0 Adenocarcinoma of nasal cavity ––– 2C20.1 Malignant neuroepitheliomatous neoplasm of nasal cavity ––– 2C20.2 Melanoma of nasal cavity ––– 2C20.3 Olfactory neuroblastoma ––– 2C20.4 Squamous cell carcinoma of nasal cavity ––– 2C20.Y Other specified malignant neoplasm of nasal cavity ––– 2C20.Z Malignant neoplasms of nasal cavity, unspecified –– 2C21 Malignant neoplasms of middle ear ––– 2C21.0 Adenocarcinoma of middle ear ––– 2C21.1 Squamous cell carcinoma of middle ear ––– 2C21.2 Unspecified malignant epithelial neoplasm of middle ear ––– 2C21.Y Other specified malignant neoplasm of middle ear ––– 2C21.Z Malignant neoplasms of middle ear, unspecified –– 2C22 Malignant neoplasms of accessory sinuses ––– 2C22.0 Adenocarcinoma of accessory sinuses ––– 2C22.1 Squamous cell carcinoma of accessory sinuses ––– 2C22.2 Malignant epithelial neoplasms of accessory sinuses, unspecified type ––– 2C22.3 Melanomas of accessory sinuses ––– 2C22.Y Other specified malignant neoplasms of accessory sinuses ––– 2C22.Z Malignant neoplasms of accessory sinuses, unspecified –––– 2C22.10 Squamous cell carcinoma of sphenoidal sinus –––– 2C22.1Y Squamous cell carcinoma of other specified accessory sinuses –– 2C23 Malignant neoplasms of larynx ––– 2C23.1 Malignant neoplasms of glottis of larynx ––– 2C23.2 Malignant neoplasms of supraglottis of larynx ––– 2C23.3 Malignant neoplasms of subglottis of larynx ––– 2C23.4 Malignant neoplasm of laryngeal cartilage ––– 2C23.5 Malignant neoplasm of overlapping lesion of larynx ––– 2C23.Z Malignant neoplasms of larynx, unspecified –––– 2C23.10 Squamous cell carcinoma of larynx, glottis –––– 2C23.1Y Other specified malignant neoplasms of larynx, glottis –––– 2C23.20 Squamous cell carcinoma of larynx, supraglottis –––– 2C23.2Y Other specified malignant neoplasms of larynx, supraglottis –––– 2C23.30 Squamous cell carcinoma of larynx, subglottis –––– 2C23.31 Adenocarcinoma of larynx, subglottis –––– 2C23.3Y Other specified malignant neoplasms of larynx, subglottis –– 2C24 Malignant neoplasms of trachea ––– 2C24.0 Adenocarcinoma of trachea ––– 2C24.1 Squamous cell carcinoma of trachea ––– 2C24.2 Malignant epithelial neoplasms of trachea, unspecified type ––– 2C24.Y Other specified malignant neoplasms of trachea ––– 2C24.Z Malignant neoplasms of trachea, unspecified –– 2C25 Malignant neoplasms of bronchus or lung ––– 2C25.0 Adenocarcinoma of bronchus or lung ––– 2C25.1 Small cell carcinoma of bronchus or lung ––– 2C25.2 Squamous cell carcinoma of bronchus or lung ––– 2C25.3 Large cell carcinoma of bronchus or lung ––– 2C25.4 Carcinoid or other malignant neuroendocrine neoplasms of bronchus or lung ––– 2C25.5 Unspecified malignant epithelial neoplasm of bronchus or lung ––– 2C25.Y Other specified malignant neoplasms of bronchus or lung ––– 2C25.Z Malignant neoplasms of bronchus or lung, unspecified –– 2C26 Malignant neoplasms of the pleura ––– 2C26.0 Mesothelioma of pleura ––– 2C26.Y Other specified malignant neoplasms of the pleura ––– 2C26.Z Malignant neoplasms of the pleura, unspecified –– 2C27 Malignant neoplasms of thymus ––– 2C27.0 Carcinoma of thymus ––– 2C27.1 Carcinoid tumour or other neuroendocrine neoplasms of thymus ––– 2C27.2 Malignant thymoma ––– 2C27.Y Other specified malignant neoplasms of thymus ––– 2C27.Z Malignant neoplasms of thymus, unspecified –– 2C28 Malignant neoplasms of heart, mediastinum or non-mesothelioma of pleura ––– 2C28.0 Malignant germ cell neoplasms of heart, mediastinum or non-mesothelioma of pleura ––– 2C28.1 Other specified malignant neoplasms of heart, mediastinum or non-mesothelioma of pleura ––– 2C28.Z Malignant neoplasms of heart, mediastinum or non-mesothelioma of pleura, unspecified –– 2C29 Malignant neoplasms of other or ill-defined sites in the respiratory system or intrathoracic organs ––– 2C29.0 Squamous cell carcinomas of other and ill-defined sites in the respiratory system and intrathoracic organs ––– 2C29.1 Other specified malignant neoplasms of other or ill-defined sites in the respiratory system or intrathoracic organs ––– 2C29.Z Malignant neoplasms of other or ill-defined sites in the respiratory system or intrathoracic organs, unspecified –– 2C2Y Other specified malignant neoplasms of middle ear, respiratory or intrathoracic organs –– 2C2Z Malignant neoplasms of middle ear, respiratory or intrathoracic organs, unspecified –– 2C30 Melanoma of skin ––– 2C30.0 Superficial spreading melanoma, primary ––– 2C30.1 Nodular melanoma, primary ––– 2C30.2 Lentigo maligna melanoma, primary ––– 2C30.3 Acral lentiginous melanoma, primary ––– 2C30.Y Other specified melanoma of skin ––– 2C30.Z Melanoma of skin, unspecified –– 2C31 Squamous cell carcinoma of skin ––– 2C31.0 Verrucous squamous cell carcinoma of skin ––– 2C31.1 Keratoacanthoma ––– 2C31.Z Cutaneous squamous cell carcinoma –– 2C32 Basal cell carcinoma of skin ––– 2C32.0 Nodular basal cell carcinoma of skin ––– 2C32.1 Sclerosing basal cell carcinoma of skin ––– 2C32.2 Superficial basal cell carcinoma of skin ––– 2C32.Y Other specified basal cell carcinoma of skin ––– 2C32.Z Basal cell carcinoma of skin, unspecified –– 2C33 Adnexal carcinoma of skin –– 2C34 Cutaneous neuroendocrine carcinoma –– 2C35 Cutaneous sarcoma –– 2C3Y Other specified malignant neoplasms of skin –– 2C3Z Malignant neoplasm of skin of unknown or unspecified type –– 2C40 Malignant neuroepitheliomatous neoplasms of peripheral nerves or autonomic nervous system –– 2C41 Malignant perineurioma –– 2C4Y Other specified malignant neoplasms of peripheral nerves and autonomic nervous system –– 2C4Z Malignant neoplasms of peripheral nerves or autonomic nervous system, unspecified –– 2C50 Malignant neoplasms of retroperitoneum ––– 2C50.0 Cystic, mucinous or serous carcinoma of retroperitoneum ––– 2C50.Y Other specified malignant neoplasms of retroperitoneum ––– 2C50.Z Malignant neoplasms of retroperitoneum, unspecified –– 2C51 Malignant neoplasms of peritoneum ––– 2C51.0 Adenocarcinomas of peritoneum ––– 2C51.1 Cystic, mucinous or serous carcinoma of peritoneum ––– 2C51.2 Mesotheliomas of peritoneum ––– 2C51.Y Other specified malignant neoplasms of peritoneum ––– 2C51.Z Malignant neoplasms of peritoneum, unspecified –––– 2C51.20 Mesothelioma of mesocolon –––– 2C51.21 Mesothelioma of mesentery –––– 2C51.2Y Mesotheliomas of other specified sites of peritoneum –––– 2C51.2Z Mesotheliomas of peritoneum, site unspecified –– 2C52 Malignant neoplasms of omentum ––– 2C52.0 Cystic, mucinous or serous carcinoma of omentum ––– 2C52.Y Other specified malignant neoplasms of omentum ––– 2C52.Z Malignant neoplasms of omentum, unspecified –– 2C53 Malignant neoplasm involving overlapping sites of retroperitoneum, peritoneum or omentum ––– 2C53.0 Adenocarcinoma involving overlapping sites of retroperitoneum, peritoneum or omentum ––– 2C53.1 Mesothelioma involving overlapping sites of retroperitoneum, peritoneum or omentum ––– 2C53.Y Other specified malignant neoplasm involving overlapping sites of retroperitoneum, peritoneum or omentum ––– 2C53.Z Malignant neoplasm involving overlapping sites of retroperitoneum, peritoneum or omentum, unspecified –– 2C5Y Other specified malignant neoplasms of retroperitoneum, peritoneum or omentum –– 2C5Z Malignant neoplasms of retroperitoneum, peritoneum or omentum, unspecified –– 2C60 Carcinoma of breast, specialised type –– 2C61 Invasive carcinoma of breast ––– 2C61.0 Invasive ductal carcinoma of breast ––– 2C61.1 Invasive lobular carcinoma of breast ––– 2C61.2 Invasive pleomorphic lobular carcinoma of breast ––– 2C61.3 Invasive carcinoma of breast with mixed ductal and lobular features ––– 2C61.4 Invasive carcinoma of breast, unidentifiable type –– 2C62 Inflammatory carcinoma of breast –– 2C63 Malignant phyllodes tumour of breast –– 2C64 Solid papillary carcinoma of breast with evidence of invasion –– 2C65 Hereditary breast and ovarian cancer syndrome –– 2C6Y Other specified malignant neoplasms of breast –– 2C6Z Malignant neoplasms of breast, unspecified –– 2C70 Malignant neoplasms of vulva ––– 2C70.0 Basal cell carcinoma of vulva ––– 2C70.1 Melanoma of vulva ––– 2C70.2 Squamous cell carcinoma of vulva ––– 2C70.Y Other specified malignant neoplasms of vulva ––– 2C70.Z Malignant neoplasms of vulva, unspecified –– 2C71 Malignant neoplasms of vagina ––– 2C71.0 Adenocarcinoma of vagina ––– 2C71.1 Melanoma of vagina ––– 2C71.2 Squamous cell carcinoma of vagina ––– 2C71.Y Other specified malignant neoplasms of vagina ––– 2C71.Z Malignant neoplasms of vagina, unspecified –– 2C72 Malignant neoplasms of uterine ligament, parametrium, or uterine adnexa ––– 2C72.0 Adenocarcinoma of uterine ligament, parametrium, or uterine adnexa ––– 2C72.1 Mucinous or serous carcinoma of uterine ligament, parametrium, or uterine adnexa ––– 2C72.3 Carcinosarcomas of uterine ligament, parametrium, or uterine adnexa ––– 2C72.Y Other specified malignant neoplasms of uterine ligament, parametrium, and uterine adnexa ––– 2C72.Z Malignant neoplasms of uterine ligament, parametrium, or uterine adnexa, unspecified –– 2C73 Malignant neoplasms of ovary ––– 2C73.0 Carcinomas of ovary ––– 2C73.1 Dysgerminoma of ovary ––– 2C73.2 Granulosa cell malignant tumour of ovary ––– 2C73.3 Malignant teratoma of ovary ––– 2C73.4 Serous cystadenoma, borderline malignancy of ovary ––– 2C73.5 Endodermal sinus tumour, unspecified site, female ––– 2C73.Y Other specified malignant neoplasms of the ovary ––– 2C73.Z Malignant neoplasms of ovary, unspecified –––– 2C73.00 Clear cell adenocarcinoma of ovary –––– 2C73.01 Endometrioid adenocarcinoma of ovary –––– 2C73.02 Low grade serous adenocarcinoma of ovary –––– 2C73.03 High grade serous adenocarcinoma of ovary –––– 2C73.04 Mucinous adenocarcinoma of ovary –––– 2C73.0Y Other specified carcinomas of ovary –––– 2C73.0Z Carcinomas of ovary, unspecified –– 2C74 Malignant neoplasms of fallopian tube ––– 2C74.0 Adenocarcinoma of fallopian tube ––– 2C74.Y Other specified malignant neoplasms of fallopian tube ––– 2C74.Z Malignant neoplasms of fallopian tube, unspecified –– 2C75 Malignant neoplasms of placenta ––– 2C75.0 Malignant trophoblastic neoplasms of placenta ––– 2C75.Y Other specified malignant neoplasms of placenta ––– 2C75.Z Malignant neoplasms of placenta, unspecified –– 2C76 Malignant neoplasms of corpus uteri ––– 2C76.0 Endometrial endometrioid adenocarcinoma ––– 2C76.1 Endometrial mucinous adenocarcinoma ––– 2C76.2 Endometrial clear cell adenocarcinoma ––– 2C76.3 Endometrial serous adenocarcinoma ––– 2C76.4 Endometrial mixed adenocarcinoma ––– 2C76.Y Other specified malignant neoplasms of corpus uteri ––– 2C76.Z Malignant neoplasms of corpus uteri, unspecified –––– 2C76.40 Endometrial squamous cell carcinoma –––– 2C76.41 Endometrial small cell carcinoma –––– 2C76.42 Endometrial undifferentiated carcinoma –––– 2C76.43 Carcinosarcoma of uterus –––– 2C76.4Z Endometrial mixed adenocarcinoma, unspecified –– 2C77 Malignant neoplasms of cervix uteri ––– 2C77.0 Squamous cell carcinoma of cervix uteri ––– 2C77.1 Adenocarcinoma of cervix uteri ––– 2C77.2 Adenosquamous carcinoma of cervix uteri ––– 2C77.3 Neuroendocrine carcinoma of cervix uteri ––– 2C77.Y Other specified malignant neoplasms of cervix uteri ––– 2C77.Z Malignant neoplasms of cervix uteri, unspecified –– 2C78 Malignant neoplasms of uterus, part not specified –– 2C79 Malignant neoplasm involving overlapping sites of female genital organs –– 2C7Y Other specified malignant neoplasms of female genital organs –– 2C7Z Malignant neoplasms of female genital organs, unspecified –– 2C80 Malignant neoplasms of testis ––– 2C80.2 Germ cell tumour of testis ––– 2C80.Y Other specified malignant neoplasms of testis ––– 2C80.Z Malignant neoplasms of testis, unspecified –– 2C81 Malignant neoplasms of penis ––– 2C81.0 Squamous cell carcinoma of penis ––– 2C81.1 Melanoma of penis ––– 2C81.Y Other specified malignant neoplasm of penis ––– 2C81.Z Malignant neoplasms of penis, unspecified –– 2C82 Malignant neoplasms of prostate ––– 2C82.0 Adenocarcinoma of prostate ––– 2C82.Y Other specified malignant neoplasms of prostate ––– 2C82.Z Malignant neoplasms of prostate, unspecified –– 2C83 Malignant neoplasms of scrotum ––– 2C83.0 Squamous cell carcinoma of scrotum ––– 2C83.Y Other specified malignant neoplasms of scrotum ––– 2C83.Z Malignant neoplasms of scrotum, unspecified –– 2C84 Malignant neoplasms of other specified male genital organs –– 2C8Z Malignant neoplasms of male genital organs, unspecified –– 2C90 Malignant neoplasms of kidney, except renal pelvis ––– 2C90.0 Renal cell carcinoma of kidney, except renal pelvis ––– 2C90.Y Other specified malignant neoplasms of kidney, except renal pelvis ––– 2C90.Z Malignant neoplasms of kidney, except renal pelvis, unspecified –– 2C91 Malignant neoplasms of renal pelvis ––– 2C91.0 Urothelial carcinoma of renal pelvis ––– 2C91.Y Other specified malignant neoplasms of renal pelvis ––– 2C91.Z Malignant neoplasms of renal pelvis, unspecified –– 2C92 Malignant neoplasms of ureter ––– 2C92.0 Urothelial carcinoma of ureter ––– 2C92.Y Other specified malignant neoplasms of ureter ––– 2C92.Z Malignant neoplasms of ureter, unspecified –– 2C93 Malignant neoplasms of urethra or paraurethral gland ––– 2C93.0 Adenocarcinoma of urethra or paraurethral gland ––– 2C93.1 Squamous cell carcinoma of urethra or paraurethral gland ––– 2C93.2 Urothelial carcinoma of urethra or paraurethral gland ––– 2C93.Y Other specified malignant neoplasms of urethra and paraurethral gland ––– 2C93.Z Malignant neoplasms of urethra or paraurethral gland, unspecified –– 2C94 Malignant neoplasms of bladder ––– 2C94.0 Adenocarcinoma of urinary bladder ––– 2C94.1 Squamous cell carcinoma of urinary bladder ––– 2C94.2 Urothelial carcinoma of bladder ––– 2C94.Y Other specified malignant neoplasms of bladder ––– 2C94.Z Malignant neoplasms of bladder, unspecified –– 2C95 Malignant neoplasm involving overlapping sites of urinary organs ––– 2C95.0 Adenocarcinoma involving overlapping sites of urinary organs ––– 2C95.1 Squamous cell carcinomas involving overlapping sites of urinary organs ––– 2C95.2 Urothelial carcinoma involving overlapping sites of urinary organs ––– 2C95.Y Other specified malignant neoplasms of overlapping lesion of urinary organs ––– 2C95.Z Malignant neoplasm involving overlapping sites of urinary organs, unspecified –– 2C9Y Other specified malignant neoplasms of urinary tract –– 2C9Z Malignant neoplasms of urinary tract, unspecified –– 2D00 Malignant neoplasm of conjunctiva ––– 2D00.0 Melanoma of conjunctiva ––– 2D00.1 Malignant neoplasm of caruncle ––– 2D00.2 Squamous cell carcinoma of conjunctiva ––– 2D00.Y Other specified malignant neoplasm of conjunctiva ––– 2D00.Z Malignant neoplasm of conjunctiva, unspecified –– 2D01 Malignant neoplasm of cornea ––– 2D01.0 Melanoma of cornea ––– 2D01.1 Squamous cell carcinoma of cornea ––– 2D01.Y Other specified malignant neoplasms of cornea ––– 2D01.Z Malignant neoplasm of cornea, unspecified –– 2D02 Malignant neoplasm of retina ––– 2D02.0 Adenocarcinoma of retinal pigment epithelium ––– 2D02.1 Malignant neuroepithelial tumours of retina ––– 2D02.2 Retinoblastoma ––– 2D02.Y Other specified malignant neoplasm of retina ––– 2D02.Z Malignant neoplasm of retina, unspecified –– 2D03 Malignant neoplasm of lacrimal apparatus ––– 2D03.0 Adenocarcinoma of the lacrimal apparatus ––– 2D03.1 Mucoepidermoid carcinoma of lacrimal apparatus ––– 2D03.2 Squamous cell carcinoma of the lacrimal apparatus ––– 2D03.Y Other specified malignant neoplasm of lacrimal apparatus ––– 2D03.Z Malignant neoplasm of lacrimal apparatus, unspecified –– 2D04 Malignant neoplasm of orbit –– 2D05 Malignant neoplasm of choroid ––– 2D05.0 Melanoma of choroid ––– 2D05.Y Other specified malignant neoplasm of choroid ––– 2D05.Z Malignant neoplasm of choroid, unspecified –– 2D06 Malignant neoplasm of ciliary body ––– 2D06.0 Adenocarcinoma of ciliary epithelium ––– 2D06.1 Malignant medulloepithelioma of ciliary body ––– 2D06.3 Malignant neuroepithelial tumours of ciliary body ––– 2D06.4 Melanoma of ciliary body ––– 2D06.Y Other specified malignant neoplasm of ciliary body ––– 2D06.Z Malignant neoplasm of ciliary body, unspecified –– 2D07 Malignant neoplasm of iris ––– 2D07.0 Adenocarcinoma of iris epithelium ––– 2D07.1 Malignant neuroepithelial tumours of iris ––– 2D07.2 Melanoma of iris ––– 2D07.Y Other specified malignant neoplasm of iris ––– 2D07.Z Malignant neoplasm of iris, unspecified –– 2D0Y Other specified malignant neoplasms of eye and ocular adnexa –– 2D0Z Malignant neoplasms of eye or ocular adnexa, unspecified –– 2D10 Malignant neoplasms of thyroid gland ––– 2D10.0 Follicular carcinoma of thyroid gland ––– 2D10.1 Papillary carcinoma of thyroid gland ––– 2D10.2 Poorly differentiated carcinoma of thyroid gland ––– 2D10.3 Undifferentiated carcinoma of thyroid gland ––– 2D10.4 Medullary carcinoma of thyroid gland ––– 2D10.Y Other specified malignant neoplasms of thyroid gland ––– 2D10.Z Malignant neoplasms of thyroid gland, unspecified –– 2D11 Malignant neoplasms of adrenal gland ––– 2D11.0 Adenocarcinoma of adrenal gland ––– 2D11.1 Malignant phaeochromocytoma of adrenal gland ––– 2D11.2 Neuroblastoma of adrenal gland ––– 2D11.Y Other specified malignant neoplasms of adrenal gland ––– 2D11.Z Malignant neoplasms of adrenal gland, unspecified –– 2D12 Malignant neoplasms of other endocrine glands or related structures ––– 2D12.0 Malignant epithelial neoplasms of other endocrine glands or related structures, unspecified type ––– 2D12.1 Adenocarcinoma of other endocrine glands or related structures ––– 2D12.Y Other specified malignant neoplasms of other endocrine glands or related structures ––– 2D12.Z Malignant neoplasms of other endocrine glands or related structures, unspecified –– 2D1Z Malignant neoplasms of endocrine glands, unspecified – 2D3Y Other specified malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic, central nervous system or related tissues – 2D3Z Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic, central nervous system or related tissues, unspecified – 2D40 Adenocarcinoma of unspecified site – 2D41 Unspecified carcinoma of unspecified site – 2D42 Malignant neoplasms of ill-defined sites – 2D43 Malignant neoplasms of independent, multiple primary sites – 2D44 Malignant neoplasm, primary site unknown, so stated – 2D4Y Other specified malignant neoplasms of unspecified primary sites – 2D4Z Unspecified malignant neoplasms of unspecified sites – 2D50 Malignant neoplasm metastasis in brain – 2D51 Malignant neoplasm metastasis in meninges – 2D52 Malignant neoplasm metastasis in spinal cord, cranial nerves or remaining parts of central nervous system –– 2D60 Malignant neoplasm metastasis in lymph node of a single region ––– 2D60.0 Malignant neoplasm metastasis in lymph nodes of head, face or neck ––– 2D60.1 Malignant neoplasm metastasis in intrathoracic lymph nodes ––– 2D60.2 Malignant neoplasm metastasis in intra-abdominal lymph nodes ––– 2D60.3 Malignant neoplasm metastasis in axillary lymph nodes ––– 2D60.4 Malignant neoplasm metastasis in inguinal lymph nodes ––– 2D60.5 Malignant neoplasm metastasis in intrapelvic lymph nodes ––– 2D60.Y Other specified malignant neoplasm metastasis in lymph node of a single region ––– 2D60.Z Malignant neoplasm metastasis in lymph node of a single region, unspecified –– 2D61 Malignant neoplasm metastases in lymph nodes of multiple regions –– 2D6Z Metastatic malignant neoplasm to unspecified lymph node –– 2D70 Malignant neoplasm metastasis in lung –– 2D71 Malignant neoplasm metastasis in mediastinum –– 2D72 Malignant neoplasm metastasis in pleura –– 2D73 Malignant neoplasm metastasis in upper respiratory tract organs –– 2D7Y Malignant neoplasm metastasis in other specified thoracic organs –– 2D7Z Malignant neoplasm metastasis in thoracic or respiratory organs, unspecified –– 2D80 Malignant neoplasm metastasis in liver or intrahepatic bile duct ––– 2D80.0 Malignant neoplasm metastasis in liver ––– 2D80.1 Malignant neoplasm metastasis in intrahepatic bile duct –– 2D81 Malignant neoplasm metastasis in pancreas –– 2D82 Malignant neoplasm metastasis in extrahepatic bile ducts –– 2D83 Malignant neoplasm metastasis in ampulla of Vater –– 2D84 Malignant neoplasm metastasis in the small intestine –– 2D85 Malignant neoplasm metastasis in large intestine –– 2D86 Malignant neoplasm metastasis in anus –– 2D8Y Malignant neoplasm metastasis in other specified digestive system organ –– 2D8Z Malignant neoplasm metastasis in unspecified digestive system organ –– 2D90 Malignant neoplasm metastasis in retroperitoneum –– 2D91 Malignant neoplasm metastasis in peritoneum –– 2E00 Malignant neoplasm metastasis in kidney or renal pelvis –– 2E01 Malignant neoplasm metastasis in bladder –– 2E02 Malignant neoplasm metastasis in other or unspecified urinary system organs –– 2E03 Malignant neoplasm metastasis in bone or bone marrow –– 2E04 Malignant neoplasm metastasis in soft tissue –– 2E05 Malignant neoplasm metastasis in female reproductive system ––– 2E05.0 Malignant neoplasm metastasis in ovary ––– 2E05.Y Malignant neoplasm metastasis in other female reproductive system organs ––– 2E05.Z Malignant neoplasm metastasis in female reproductive system, unspecified –– 2E06 Malignant neoplasm metastasis in male genital organs –– 2E07 Malignant neoplasm metastasis in adrenal gland –– 2E08 Metastatic malignant neoplasm involving skin –– 2E09 Malignant neoplasm metastasis in peripheral nervous system –– 2E0Y Malignant neoplasm metastasis in other specified sites – 2E2Z Malignant neoplasm metastasis, unspecified 2E60 Carcinoma in situ of oral cavity, oesophagus or stomach – 2E60.0 Carcinoma in situ of lip, oral cavity or pharynx – 2E60.1 Carcinoma in situ of oesophagus – 2E60.2 Carcinoma in situ of stomach 2E61 Carcinoma in situ of other or unspecified digestive organs – 2E61.0 Carcinoma in situ of colon – 2E61.1 Carcinoma in situ of rectum – 2E61.2 Carcinoma in situ of anal canal – 2E61.3 Carcinoma in situ of gallbladder, biliary tract or ampulla of Vater – 2E61.Y Carcinoma in situ of other specified digestive organs – 2E61.Z Carcinoma in situ of unspecified digestive organs 2E62 Carcinoma in situ of middle ear or respiratory system – 2E62.0 Carcinoma in situ of larynx – 2E62.1 Carcinoma in situ of trachea – 2E62.2 Carcinoma in situ of bronchus or lung – 2E62.Y Carcinoma in situ of other specified sites of middle ear and respiratory system – 2E62.Z Carcinoma in situ of unspecified sites of middle ear and respiratory system 2E63 Melanoma in situ neoplasms – 2E63.0 Melanoma in situ of skin – 2E63.1 Melanoma in situ of conjunctiva – 2E63.Y Melanoma in situ neoplasms, other specified site – 2E63.Z Melanoma in situ neoplasms, unspecified site –– 2E63.00 Lentigo maligna –– 2E63.0Z Melanoma in situ of skin, unspecified 2E64 Carcinoma in situ of skin – 2E64.0 Intraepidermal squamous cell carcinoma – 2E64.1 Extramammary Paget disease of skin – 2E64.2 Carcinoma in situ of anal margin or perianal skin – 2E64.Y Other specified carcinoma in situ of skin – 2E64.Z Carcinoma in situ of skin, unspecified –– 2E64.00 Bowen disease of skin –– 2E64.01 Actinic intraepidermal squamous cell carcinoma –– 2E64.0Y Other specified intraepidermal squamous cell carcinoma –– 2E64.0Z Intraepidermal squamous cell carcinoma, unspecified 2E65 Carcinoma in situ of breast – 2E65.0 Lobular carcinoma in situ of breast – 2E65.1 Lobular carcinoma in situ of breast, pleomorphic subtype – 2E65.2 Ductal carcinoma in situ of breast – 2E65.3 Ductal carcinoma in situ of breast, comedo subtype – 2E65.4 Mixed ductal and lobular carcinoma in situ of breast – 2E65.5 Paget disease of nipple – 2E65.Y Other specified carcinoma in situ of breast – 2E65.Z Carcinoma in situ of breast, unspecified 2E66 Carcinoma in situ of cervix uteri – 2E66.2 High grade squamous intraepithelial lesion of cervix uteri – 2E66.Y Other specified carcinoma in situ of cervix uteri – 2E66.Z Carcinoma in situ of cervix uteri, unspecified 2E67 Carcinoma in situ of other or unspecified genital organs – 2E67.0 Carcinoma in situ of endometrium – 2E67.1 Carcinoma in situ of vulva – 2E67.2 Carcinoma in situ of vagina – 2E67.3 Carcinoma in situ of other or unspecified female genital organs – 2E67.4 Carcinoma in situ of penis – 2E67.5 High grade intraepithelial lesion of prostate – 2E67.6 Carcinoma in situ of other or unspecified male genital organs –– 2E67.11 Vulvar Paget disease –– 2E67.12 Vulvar intraepithelial neoplasia, HPV-independent –– 2E67.13 High grade squamous intraepithelial lesion of vulva, HPV-associated –– 2E67.22 High grade squamous intraepithelial lesion of vagina –– 2E67.2Y Other specified carcinoma in situ of vagina –– 2E67.2Z Carcinoma in situ of vagina, unspecified –– 2E67.40 Squamous cell carcinoma in situ of skin of penis –– 2E67.41 Squamous cell carcinoma in situ of mucocutaneous epithelium of penis 2E68 Carcinoma in situ of bladder 2E69 Carcinoma in situ of other or unspecified urinary organs 2E6A Carcinoma in situ of the eye or ocular adnexa – 2E6A.0 Carcinoma in situ of the conjunctiva – 2E6A.1 Carcinoma in situ of the cornea – 2E6A.Y Carcinoma in situ of other and unspecified part of the eye and adnexa 2E6B Carcinoma in situ of thyroid and other endocrine glands 2E6Y Carcinoma in situ of other specified site 2E6Z Carcinoma in situ of unspecified site – 2E80 Benign lipomatous neoplasm –– 2E80.0 Lipoma –– 2E80.1 Lipoblastoma –– 2E80.Y Other specified benign lipomatous neoplasm –– 2E80.Z Benign lipomatous neoplasm, unspecified ––– 2E80.00 Superficial subcutaneous lipoma ––– 2E80.01 Deep subfascial lipoma ––– 2E80.02 Deep internal or visceral lipoma ––– 2E80.0Y Lipoma, other specified site ––– 2E80.0Z Lipoma, unspecified site – 2E81 Benign vascular neoplasms –– 2E81.0 Neoplastic haemangioma –– 2E81.1 Benign lymphatic neoplasms –– 2E81.2 Benign vascular neoplasms of infancy and childhood –– 2E81.Y Other specified benign vascular neoplasms –– 2E81.Z Benign vascular neoplasms, unspecified ––– 2E81.00 Umbilical cord haemangioma ––– 2E81.01 Conjunctival haemangioma or haemolymphangioma ––– 2E81.0Y Neoplastic haemangioma of other specified site ––– 2E81.0Z Neoplastic haemangioma, unspecified site ––– 2E81.10 Disseminated lymphangiomatosis ––– 2E81.11 Acquired progressive lymphangioma ––– 2E81.1Y Other specified benign lymphatic neoplasms ––– 2E81.1Z Benign lymphatic neoplasms, unspecified ––– 2E81.20 Focal infantile haemangioma ––– 2E81.21 Multifocal infantile haemangioma ––– 2E81.2Y Other specified benign vascular neoplasms of infancy and childhood ––– 2E81.2Z Benign vascular neoplasms of infancy and childhood, unspecified – 2E82 Benign chondrogenic tumours –– 2E82.0 Benign chondrogenic tumours of bone or articular cartilage of limbs –– 2E82.1 Benign chondrogenic tumours of bone or articular cartilage of other specified sites –– 2E82.Z Benign chondrogenic tumours, site unspecified – 2E83 Benign osteogenic tumours –– 2E83.0 Benign osteogenic tumours of bone or articular cartilage of skull or face –– 2E83.1 Benign osteogenic tumours of bone or articular cartilage of lower jaw –– 2E83.2 Benign osteogenic tumours of bone or articular cartilage of vertebral column –– 2E83.3 Benign osteogenic tumours of bone or articular cartilage of ribs, sternum or clavicle –– 2E83.4 Benign osteogenic tumours of bone or articular cartilage of pelvic bones, sacrum or coccyx –– 2E83.5 Benign osteogenic tumours of bone or articular cartilage of limbs –– 2E83.Y Benign osteogenic tumour of other specified site –– 2E83.Z Benign osteogenic tumour of unspecified site – 2E84 Benign fibrogenic or myofibrogenic tumour –– 2E84.0 Benign fibrogenic or myofibrogenic tumour of skin –– 2E84.Y Benign fibrogenic or myofibrogenic tumour of other specified sites –– 2E84.Z Benign fibrogenic or myofibrogenic tumour, site unknown – 2E85 Benign fibrohistiocytic tumour –– 2E85.0 Benign fibrohistiocytic tumour of soft tissues of limbs –– 2E85.1 Benign fibrohistiocytic tumour of retroperitoneum or peritoneum –– 2E85.2 Benign fibrohistiocytic tumour of skin –– 2E85.Y Benign fibrohistiocytic tumour of other specified sites –– 2E85.Z Benign fibrohistiocytic tumour, site unspecified – 2E86 Benign smooth muscle or skeletal muscle tumour –– 2E86.0 Leiomyoma of uterus –– 2E86.1 Leiomyoma of other or unspecified sites –– 2E86.2 Rhabdomyoma –– 2E86.Y Other specified benign smooth muscle or skeletal muscle tumour –– 2E86.Z Benign smooth muscle or skeletal muscle tumour, unspecified – 2E87 Benign gastrointestinal stromal tumour – 2E88 Benign endometrial stromal nodule – 2E89 Benign mesenchymal tumours of uncertain differentiation –– 2E89.0 Benign tumours of uncertain differentiation, bone or cartilage –– 2E89.1 Benign tumours of uncertain differentiation, soft tissue –– 2E89.Y Benign mesenchymal tumours of uncertain differentiation of other specified site –– 2E89.Z Benign mesenchymal tumours of uncertain differentiation of unspecified site – 2E8A Other mixed or unspecified benign mesenchymal tumours – 2E8Y Other specified benign mesenchymal neoplasm – 2E8Z Benign mesenchymal neoplasms, unspecified – 2E90 Benign neoplasm of lip, oral cavity or pharynx –– 2E90.0 Benign neoplasm of lip –– 2E90.1 Benign neoplasm of tongue –– 2E90.2 Benign neoplasm of floor of mouth –– 2E90.3 Benign neoplasm of other or unspecified parts of mouth –– 2E90.4 Benign neoplasm of tonsil –– 2E90.5 Benign neoplasm of oropharynx –– 2E90.6 Benign neoplasm of nasopharynx –– 2E90.7 Benign neoplasm of hypopharynx –– 2E90.8 Benign neoplasm of pharynx, unspecified – 2E91 Benign neoplasm of major salivary glands –– 2E91.0 Benign neoplasm of parotid gland –– 2E91.1 Benign neoplasm of other specified major salivary glands –– 2E91.Z Benign neoplasm of unspecified major salivary glands – 2E92 Benign neoplasm of digestive organs –– 2E92.0 Benign neoplasm of oesophagus –– 2E92.1 Benign neoplasm of stomach –– 2E92.2 Benign neoplasm of duodenum –– 2E92.3 Benign neoplasm of other or unspecified parts of small intestine –– 2E92.4 Benign neoplasm of the large intestine –– 2E92.5 Benign neoplasm of anus or anal canal –– 2E92.6 Benign neoplasm of gallbladder, extrahepatic bile ducts or ampulla of Vater –– 2E92.7 Benign neoplasm of liver or intrahepatic bile ducts –– 2E92.8 Benign neoplasm of pancreas –– 2E92.9 Benign neoplasm of endocrine pancreas –– 2E92.Y Benign neoplasm of other specified digestive organs –– 2E92.Z Benign neoplasm of unspecified digestive organs ––– 2E92.40 Polyposis syndrome ––– 2E92.4Y Other specified benign neoplasm of the large intestine ––– 2E92.4Z Benign neoplasm of the large intestine, unspecified –– 2F00 Benign neoplasm of middle ear or respiratory system ––– 2F00.0 Middle ear endocrine tumour ––– 2F00.1 Recurrent respiratory papillomatosis ––– 2F00.2 Laryngeal endocrine tumour ––– 2F00.Y Other specified benign neoplasm of middle ear or respiratory system ––– 2F00.Z Benign neoplasm of middle ear or respiratory system, unspecified –– 2F01 Benign neoplasm of intrathoracic organs –– 2F0Y Benign neoplasms of other specified respiratory and intrathoracic organs –– 2F0Z Benign neoplasms of unspecified respiratory and intrathoracic organs – 2F10 Benign neoplasm of mesothelial tissue –– 2F20 Benign cutaneous melanocytic neoplasms ––– 2F20.0 Common acquired melanocytic naevus ––– 2F20.1 Atypical melanocytic naevus ––– 2F20.2 Congenital melanocytic naevus ––– 2F20.3 Generalised eruptive melanocytic naevi ––– 2F20.Y Other specific types of melanocytic naevus ––– 2F20.Z Melanocytic naevus, unspecified –––– 2F20.00 Multiple benign melanocytic naevi –––– 2F20.0Y Other specified common acquired melanocytic naevus –––– 2F20.0Z Common acquired melanocytic naevus, unspecified –––– 2F20.20 Giant congenital melanocytic naevus –––– 2F20.2Y Other specified congenital melanocytic naevus –––– 2F20.2Z Congenital melanocytic naevus, unspecified –– 2F21 Benign keratinocytic acanthomas ––– 2F21.0 Seborrhoeic keratosis ––– 2F21.Y Other specified benign keratinocytic acanthomas –– 2F22 Benign neoplasms of epidermal appendages –– 2F23 Benign dermal fibrous or fibrohistiocytic neoplasms ––– 2F23.0 Dermatofibroma ––– 2F23.Y Other specified benign dermal fibrous or fibrohistiocytic neoplasms –– 2F24 Benign cutaneous neoplasms of neural or nerve sheath origin –– 2F25 Cherry angioma –– 2F26 Lobular capillary haemangioma –– 2F2Y Other specified benign cutaneous neoplasms –– 2F2Z Benign cutaneous neoplasm of unspecified type – 2F30 Benign neoplasm of breast –– 2F30.0 Tubular adenoma of breast –– 2F30.1 Lactating adenoma of breast –– 2F30.2 Intraductal papilloma of breast –– 2F30.3 Benign phyllodes tumour of breast –– 2F30.4 Fibromatosis of breast –– 2F30.5 Fibroadenoma of breast –– 2F30.6 Extensive adenomatosis of nipple –– 2F30.Y Other specified benign neoplasm of breast –– 2F30.Z Benign neoplasm of breast, unspecified – 2F31 Benign non-mesenchymal neoplasms of uterus –– 2F31.0 Benign non-mesenchymal neoplasm of uterus, cervix uteri –– 2F31.1 Benign non-mesenchymal neoplasm of uterus, corpus uteri –– 2F31.2 Benign non-mesenchymal neoplasms of uterus, other parts – 2F32 Benign neoplasm of ovary –– 2F32.0 Cystic teratoma –– 2F32.1 Ovarian fibroma –– 2F32.2 Meigs' syndrome –– 2F32.3 Serous ovarian cystadenoma –– 2F32.Y Other specified benign neoplasm of ovary –– 2F32.Z Benign neoplasm of ovary, unspecified – 2F33 Benign neoplasm of other or unspecified female genital organs – 2F34 Benign neoplasm of male genital organs – 2F35 Benign neoplasm of urinary organs – 2F36 Benign neoplasm of eye or ocular adnexa –– 2F36.0 Benign neoplasm of choroid –– 2F36.1 Benign neoplasm of iris –– 2F36.2 Benign neoplasm of ciliary body –– 2F36.3 Teratoma of orbit –– 2F36.4 Cysts of eyelid –– 2F36.Y Other specified benign neoplasm of eye or ocular adnexa –– 2F36.Z Benign neoplasm of eye or ocular adnexa, unspecified – 2F37 Benign neoplasm of endocrine glands –– 2F37.0 Non-secreting pituitary adenoma –– 2F37.Y Other specified benign neoplasm of endocrine glands –– 2F37.Z Benign neoplasm of endocrine glands, unspecified – 2F3Y Benign non-mesenchymal neoplasms of other specified site – 2F3Z Benign non-mesenchymal neoplasms of unspecified site 2F5Y Other specified benign neoplasms, except of lymphoid, haematopoietic, central nervous system or related tissues 2F5Z Benign neoplasms, except of lymphoid, haematopoietic, central nervous system or related tissues, unspecified 2F70 Neoplasms of uncertain behaviour of oral cavity or digestive organs – 2F70.0 Neoplasms of uncertain behaviour of lip, oral cavity or pharynx – 2F70.1 Neoplasms of uncertain behaviour of stomach – 2F70.2 Neoplasms of uncertain behaviour of small intestine – 2F70.3 Neoplasms of uncertain behaviour of colon – 2F70.4 Neoplasms of uncertain behaviour of rectum – 2F70.5 Neoplasms of uncertain behaviour of liver, gallbladder or bile ducts – 2F70.Y Neoplasms of uncertain behaviour of oral cavity and digestive organs, other specified site – 2F70.Z Neoplasms of uncertain behaviour of oral cavity and digestive organs, unspecified site 2F71 Neoplasms of uncertain behaviour of middle ear, respiratory or intrathoracic organs – 2F71.0 Neoplasms of uncertain behaviour of thymus – 2F71.1 Neoplasms of uncertain behaviour of larynx – 2F71.2 Neoplasms of uncertain behaviour of pleura – 2F71.3 Neoplasms of uncertain behaviour of trachea, bronchus or lung – 2F71.4 Neoplasms of uncertain behaviour of mediastinum – 2F71.Y Neoplasms of uncertain behaviour of middle ear, respiratory and intrathoracic organs, other specified site – 2F71.Z Neoplasms of uncertain behaviour of middle ear, respiratory and intrathoracic organs, unspecified site 2F72 Neoplasms of uncertain behaviour of skin – 2F72.1 Spitzoid tumour of uncertain malignant potential – 2F72.2 Melanocytic naevus with severe melanocytic dysplasia – 2F72.Y Other specified neoplasms of uncertain behaviour of skin 2F73 Neoplasms of uncertain behaviour of retroperitoneum 2F74 Neoplasms of uncertain behaviour of peritoneum 2F75 Neoplasms of uncertain behaviour of breast 2F76 Neoplasms of uncertain behaviour of female genital organs 2F77 Neoplasms of uncertain behaviour of male genital organs 2F78 Neoplasms of uncertain behaviour of urinary organs 2F79 Neoplasms of uncertain behaviour of eye or ocular adnexa 2F7A Neoplasms of uncertain behaviour of endocrine glands – 2F7A.0 Multiple polyglandular tumours – 2F7A.Y Other specified neoplasms of uncertain behaviour of endocrine glands – 2F7A.Z Neoplasms of uncertain behaviour of endocrine glands, unspecified 2F7B Neoplasms of uncertain behaviour of bone or articular cartilage 2F7C Neoplasms of uncertain behaviour of connective or other soft tissue 2F7Y Neoplasms of uncertain behaviour of other specified site 2F7Z Neoplasms of uncertain behaviour of unspecified site 2F90 Neoplasms of unknown behaviour of oral cavity or digestive organs – 2F90.0 Neoplasms of unknown behaviour of colon – 2F90.1 Neoplasms of unknown behaviour of rectum – 2F90.Y Neoplasms of unknown behaviour of oral cavity and digestive organs, other specified site – 2F90.Z Neoplasms of unknown behaviour of oral cavity and digestive organs, unspecified site 2F91 Neoplasms of unknown behaviour of middle ear, respiratory or intrathoracic organs – 2F91.0 Neoplasms of unknown behaviour of larynx – 2F91.1 Neoplasms of unknown behaviour of trachea, bronchus or lung – 2F91.Y Neoplasms of unknown behaviour of other specified respiratory organ, intrathoracic organ or middle ear – 2F91.Z Neoplasms of unknown behaviour of unspecified respiratory organ or intrathoracic organ 2F92 Neoplasms of unknown behaviour of skin 2F93 Neoplasms of unknown behaviour of retroperitoneum 2F94 Neoplasms of unknown behaviour of peritoneum 2F95 Neoplasms of unknown behaviour of breast 2F96 Neoplasms of unknown behaviour of female genital organs 2F97 Neoplasms of unknown behaviour of male genital organs 2F98 Neoplasms of unknown behaviour of urinary organs 2F99 Neoplasms of unknown behaviour of eye or ocular adnexa 2F9A Neoplasms of unknown behaviour of endocrine glands 2F9B Neoplasms of unknown behaviour of bone or articular cartilage 2F9C Neoplasms of unknown behaviour of connective or other soft tissue 2F9Y Neoplasms of unknown behaviour of other specified site 2F9Z Neoplasms of unknown behaviour of unspecified site – 3A00 Iron deficiency anaemia –– 3A00.0 Acquired iron deficiency anaemia due to blood loss –– 3A00.1 Acquired iron deficiency anaemia due to low intake –– 3A00.2 Acquired iron deficiency anaemia due to decreased absorption –– 3A00.3 Acquired iron deficiency anaemia due to increased requirement –– 3A00.Y Other specified iron deficiency anaemia –– 3A00.Z Iron deficiency anaemia, unspecified ––– 3A00.01 Chronic posthaemorrhagic anaemia ––– 3A00.0Z Acquired iron deficiency anaemia due to blood loss, unspecified – 3A01 Megaloblastic anaemia due to vitamin B12 deficiency –– 3A01.0 Hereditary vitamin B12 deficiency anaemia –– 3A01.1 Neonatal vitamin B12 deficiency anaemia –– 3A01.2 Vitamin B12 deficiency anaemia due to low intake –– 3A01.3 Vitamin B12 deficiency anaemia due to intrinsic factor deficiency –– 3A01.4 Vitamin B12 deficiency anaemia due to intestinal disease –– 3A01.5 Drug-induced vitamin B12 deficiency anaemia –– 3A01.Y Other specified megaloblastic anaemia due to vitamin B12 deficiency –– 3A01.Z Megaloblastic anaemia due to vitamin B12 deficiency, unspecified ––– 3A01.30 Pernicious anaemia ––– 3A01.3Y Other specified vitamin B12 deficiency anaemia due to intrinsic factor deficiency – 3A02 Folate deficiency anaemia –– 3A02.0 Hereditary folate deficiency anaemia –– 3A02.1 Folate deficiency anaemia due to low intake –– 3A02.2 Folate deficiency anaemia due to increased requirements –– 3A02.3 Folate deficiency anaemia due to decreased intestinal absorption –– 3A02.4 Drug-induced folate deficiency anaemia –– 3A02.Y Other specified folate deficiency anaemia –– 3A02.Z Folate deficiency anaemia, unspecified – 3A03 Other nutritional or metabolic anaemias –– 3A03.0 Hereditary orotic aciduria –– 3A03.1 Protein deficiency anaemia –– 3A03.2 Scorbutic anaemia –– 3A03.3 Copper deficiency anaemia –– 3A03.4 Acquired other vitamin B deficiency anaemia –– 3A03.5 Acquired vitamin A deficiency anaemia –– 3A03.6 Acquired vitamin E deficiency anaemia –– 3A03.Y Other and unspecified nutritional or metabolic anaemia ––– 3A03.40 Acquired pyridoxine deficiency anaemia ––– 3A03.41 Acquired riboflavin deficiency anaemia ––– 3A03.42 Acquired thiamine deficiency anaemia ––– 3A03.4Y Other specified acquired other vitamin B deficiency anaemia –– 3A10 Hereditary haemolytic anaemia ––– 3A10.0 Haemolytic anaemias due to hexose monophosphate shunt or glutathione metabolism anomalies ––– 3A10.1 Haemolytic anaemia due to adenosine deaminase excess ––– 3A10.2 Hereditary elliptocytosis ––– 3A10.3 Familial pseudohyperkalaemia ––– 3A10.Y Other specified hereditary haemolytic anaemia ––– 3A10.Z Hereditary haemolytic anaemia, unspecified –––– 3A10.00 Haemolytic anaemia due to glucose-6-phosphate dehydrogenase deficiency –––– 3A10.0Y Other specified haemolytic anaemias due to hexose monophosphate shunt or glutathione metabolism anomalies –––– 3A10.0Z Haemolytic anaemias due to hexose monophosphate shunt or glutathione metabolism anomalies, unspecified –– 3A1Y Other specified congenital haemolytic anaemia –– 3A20 Acquired haemolytic anaemia, immune ––– 3A20.0 Autoimmune haemolytic anaemia, warm type ––– 3A20.1 Autoimmune haemolytic anaemia, cold type ––– 3A20.2 Autoimmune haemolytic anaemia, mixed type, cold and warm ––– 3A20.3 Paroxysmal cold haemoglobinuria ––– 3A20.4 Alloimmune haemolytic anaemia ––– 3A20.5 Evans syndrome ––– 3A20.Y Other specified acquired haemolytic anaemia, immune –– 3A21 Acquired haemolytic anaemia, non-immune ––– 3A21.0 Paroxysmal nocturnal haemoglobinuria ––– 3A21.1 Microangiopathic haemolytic anaemia ––– 3A21.2 Haemolytic uraemic syndrome ––– 3A21.Y Other specified acquired haemolytic anaemia, non-immune –– 3A2Z Acquired haemolytic anaemia, unspecified – 3A4Z Haemolytic anaemias, unspecified 3A50 Thalassaemias – 3A50.0 Alpha thalassaemia – 3A50.1 Alpha thalassaemia related syndromes – 3A50.2 Beta thalassaemia – 3A50.3 Delta, delta-beta or gamma-delta-beta thalassaemia – 3A50.4 Hereditary persistence of fetal haemoglobin – 3A50.Y Other specified thalassaemias – 3A50.Z Thalassaemias, unspecified –– 3A50.00 Mild alpha thalassaemia diseases –– 3A50.01 Thalassaemic alpha-chain variants –– 3A50.02 Haemoglobin H disease (– α/– – included) –– 3A50.03 Homozygous or compound heterozygous alpha0 thalassaemia –– 3A50.0Y Other specified alpha thalassaemia –– 3A50.0Z Alpha thalassaemia, unspecified 3A51 Sickle cell disorders or other haemoglobinopathies – 3A51.0 Sickle cell trait – 3A51.1 Sickle cell disease without crisis – 3A51.2 Sickle cell disease with crisis – 3A51.3 Compound heterozygous sickling disorders without crisis – 3A51.4 Compound heterozygous sickling disorders with crisis – 3A51.5 Haemoglobin C disease – 3A51.6 Haemoglobin D disease – 3A51.7 High affinity haemoglobin – 3A51.8 Low affinity haemoglobin – 3A51.9 Haemoglobin O disease – 3A51.A Haemoglobin E disease – 3A51.B Haemoglobin C/beta thalassaemia compound heterozygosity – 3A51.Y Other specified sickle cell disorders or other haemoglobinopathies – 3A51.Z Sickle cell disorders or other haemoglobinopathies, unspecified – 3A60 Congenital pure red cell aplasia –– 3A60.0 Congenital non-inherited pure red cell aplasia –– 3A60.1 Hereditary pure red cell aplasia –– 3A60.Z Congenital pure red cell aplasia, unspecified – 3A61 Acquired pure red cell aplasia –– 3A61.0 Acute acquired pure red cell aplasia –– 3A61.1 Chronic acquired pure red cell aplasia –– 3A61.Y Other specified acquired pure red cell aplasia –– 3A61.Z Acquired pure red cell aplasia, unspecified – 3A6Z Pure red cell aplasia, unspecified 3A70 Aplastic anaemia – 3A70.0 Congenital aplastic anaemia – 3A70.1 Acquired aplastic anaemias – 3A70.Z Aplastic anaemia, unspecified –– 3A70.10 Drug-induced aplastic anaemia –– 3A70.11 Aplastic anaemia due to other external agents –– 3A70.12 Idiopathic aplastic anaemia –– 3A70.1Y Other specified acquired aplastic anaemias –– 3A70.1Z Acquired aplastic anaemias, unspecified 3A71 Anaemia due to chronic disease – 3A71.0 Anaemia in neoplastic disease – 3A71.1 Anaemia in chronic infectious diseases – 3A71.2 Anaemia in chronic kidney disease – 3A71.Y Anaemia due to other specified chronic disease – 3A71.Z Anaemia due to chronic disease, unspecified 3A72 Sideroblastic anaemia – 3A72.0 Congenital sideroblastic anaemias – 3A72.1 Acquired sideroblastic anaemias – 3A72.Z Sideroblastic anaemia, unspecified –– 3A72.00 Hereditary sideroblastic anaemias –– 3A72.01 Hereditary syndromic sideroblastic anaemia –– 3A72.0Y Other specified congenital sideroblastic anaemias –– 3A72.0Z Congenital sideroblastic anaemias, unspecified 3A73 Congenital dyserythropoietic anaemia – 3A80 Congenital polycythaemia –– 3A80.0 Primary inherited erythrocytosis –– 3A80.Y Other specified congenital polycythaemia –– 3A80.Z Congenital polycythaemia, unspecified – 3A81 Acquired polycythaemia –– 3A81.0 Polycythaemia due to hypoxia, including high altitude –– 3A81.1 Polycythaemia due to over-transfusion or blood doping –– 3A81.2 Relative polycythaemia –– 3A81.Y Other specified acquired polycythaemia –– 3A81.Z Acquired polycythaemia, unspecified – 3A8Z Polycythaemia, unspecified 3A90 Anaemia due to acute disease 3A91 Congenital methaemoglobinaemia 3A92 Hereditary methaemoglobinaemia 3A93 Acquired methaemoglobinaemia 3A94 Acute posthaemorrhagic anaemia 3A9Y Other specified anaemias or erythrocyte disorders 3A9Z Anaemias or other erythrocyte disorders, unspecified –– 3B10 Hereditary factor VIII deficiency ––– 3B10.0 Haemophilia A ––– 3B10.1 Hereditary factor VIII deficiency with anti-factor VIII inhibitor ––– 3B10.Y Other specified hereditary factor VIII deficiency ––– 3B10.Z Hereditary factor VIII deficiency, unspecified –– 3B11 Hereditary factor IX deficiency ––– 3B11.0 Haemophilia B ––– 3B11.Y Other specified hereditary factor IX deficiency ––– 3B11.Z Hereditary factor IX deficiency, unspecified –– 3B12 Von Willebrand disease –– 3B13 Haemophilia C –– 3B14 Other inherited coagulation factor deficiency with bleeding tendency ––– 3B14.0 Hereditary deficiency of factor I ––– 3B14.1 Hereditary factor X deficiency ––– 3B14.2 Combined deficiency of vitamin K-dependent clotting factors ––– 3B14.Z Other inherited coagulation factor deficiency with bleeding tendency, unspecified –– 3B15 Inherited coagulation factor deficiency without bleeding tendency –– 3B1Z Congenital or constitutional haemorrhagic condition, unspecified –– 3B20 Disseminated intravascular coagulation –– 3B21 Haemorrhagic disorder due to circulating anticoagulants and coagulation factors ––– 3B21.0 Haemorrhage due to thrombin inhibitor other than heparin ––– 3B21.1 Haemorrhage due to factor Xa inhibitor ––– 3B21.Y Haemorrhagic disorder due to other specified circulating anticoagulants ––– 3B21.Z Haemorrhagic disorder due to unspecified circulating anticoagulants –– 3B22 Acquired haemophilia –– 3B2Y Other specified haemorrhagic diseases due to acquired coagulation factor defects – 3B4Z Coagulation defects, unspecified – 3B50 Inherited fibrinolytic defects –– 3B50.0 Congenital alpha-2 antiplasmin deficiency –– 3B50.1 Congenital plasminogen activator inhibitor type 1 deficiency –– 3B50.Y Other specified inherited fibrinolytic defects –– 3B50.Z Inherited fibrinolytic defects, unspecified – 3B51 Acquired fibrinolytic defects 3B60 Non-thrombocytopenic purpura – 3B60.0 Hereditary vascular purpura – 3B60.1 Acquired vascular purpura 3B61 Thrombophilia – 3B61.0 Hereditary thrombophilia – 3B61.1 Acquired thrombophilia – 3B61.Y Other specified thrombophilia – 3B61.Z Thrombophilia, unspecified –– 3B61.00 Hyperhomocysteinaemia –– 3B61.0Y Other specified hereditary thrombophilia –– 3B61.0Z Hereditary thrombophilia, unspecified 3B62 Qualitative platelet defects – 3B62.0 Inherited qualitative platelet defects – 3B62.1 Bleeding diathesis due to thromboxane synthesis deficiency – 3B62.2 Isolated thrombocytopenia – 3B62.3 Dense granule disease – 3B62.4 Alpha-delta dense granule deficiency – 3B62.5 Haemophagocytic syndrome associated with infection – 3B62.Y Other specified qualitative platelet defects – 3B62.Z Qualitative platelet defects, unspecified –– 3B62.00 Alpha-granule diseases –– 3B62.01 Inherited giant platelet disorder –– 3B62.0Y Other specified inherited qualitative platelet defects –– 3B62.0Z Inherited qualitative platelet defects, unspecified 3B63 Thrombocytosis – 3B63.0 Congenital thrombocytosis – 3B63.1 Acquired thrombocytosis – 3B63.Y Other specified thrombocytosis – 3B63.Z Thrombocytosis, unspecified –– 3B63.10 Secondary thrombocytosis –– 3B63.1Y Other specified acquired thrombocytosis –– 3B63.1Z Acquired thrombocytosis, unspecified 3B64 Thrombocytopenia – 3B64.0 Congenital thrombocytopenia – 3B64.1 Acquired thrombocytopenia – 3B64.Z Thrombocytopenia, unspecified –– 3B64.00 Congenital non-inherited thrombocytopenia –– 3B64.01 Hereditary thrombocytopenia –– 3B64.0Z Congenital thrombocytopenia, unspecified –– 3B64.10 Immune thrombocytopenic purpura –– 3B64.11 Secondary thrombocytopenic purpura –– 3B64.12 Drug-induced thrombocytopenic purpura –– 3B64.13 Alloimmune thrombocytopenia –– 3B64.14 Thrombotic thrombocytopenic purpura –– 3B64.1Y Other specified acquired thrombocytopenia 3B65 Thrombotic microangiopathy, not elsewhere classified 3B6Y Other specified coagulation defects, purpura or other haemorrhagic or related conditions 3B6Z Coagulation defects, purpura or other haemorrhagic or related conditions, unspecified 3B80 Congenital disorders of spleen – 3B80.0 Splenomegaly in storage diseases 3B81 Acquired disorders of spleen – 3B81.0 Tumour-like conditions of spleen – 3B81.1 Postsurgical asplenia – 3B81.2 Atrophy of spleen – 3B81.3 Nontraumatic laceration or rupture of spleen – 3B81.4 Splenosis – 3B81.5 Splenic cyst or pseudocyst – 3B81.6 Infarction of spleen – 3B81.7 Infection of spleen – 3B81.8 Torsion of spleen – 3B81.9 Fibrosis of spleen – 3B81.A Perisplenitis – 3B81.B Hypersplenism – 3B81.C Chronic congestive splenomegaly – 3B81.Y Other specified acquired disorders of spleen – 3B81.Z Acquired disorders of spleen, unspecified –– 3B81.50 Pseudocyst of spleen –– 3B81.51 Epithelial cyst of spleen –– 3B81.5Y Other specified splenic cyst –– 3B81.5Z Splenic cyst, unspecified –– 3B81.70 Acute septic splenitis –– 3B81.71 Abscess of spleen –– 3B81.7Y Other specified infection of spleen –– 3B81.7Z Infection of spleen, unspecified 3B8Z Diseases of spleen, unspecified 3C0Y Other specified diseases of the blood or blood-forming organs 3C0Z Diseases of the blood or blood-forming organs, unspecified – 5C50 Inborn errors of amino acid or other organic acid metabolism –– 5C50.0 Phenylketonuria –– 5C50.1 Disorders of tyrosine metabolism –– 5C50.2 Disorders of histidine metabolism –– 5C50.3 Disorders of tryptophan metabolism –– 5C50.4 Disorders of lysine or hydroxylysine metabolism –– 5C50.5 Disorders of the gamma-glutamyl cycle –– 5C50.6 Disorders of serine metabolism –– 5C50.7 Disorders of glycine metabolism –– 5C50.8 Disorders of proline or hydroxyproline metabolism –– 5C50.9 Disorders of ornithine metabolism –– 5C50.A Disorders of urea cycle metabolism –– 5C50.B Disorders of methionine cycle or sulphur amino acid metabolism –– 5C50.C Disorders of beta or omega amino acid metabolism –– 5C50.D Disorders of branched-chain amino acid metabolism –– 5C50.E Organic aciduria –– 5C50.F Disorders of peptide metabolism –– 5C50.G Trimethylaminuria –– 5C50.Y Other specified inborn errors of amino acid or other organic acid metabolism –– 5C50.Z Inborn errors of amino acid or other organic acid metabolism, unspecified ––– 5C50.00 Classical phenylketonuria ––– 5C50.01 Nonclassical phenylketonuria ––– 5C50.02 Embryofetopathy due to maternal phenylketonuria ––– 5C50.0Y Other specified phenylketonuria ––– 5C50.0Z Phenylketonuria, unspecified ––– 5C50.10 Alkaptonuria ––– 5C50.11 Tyrosinaemia type 1 ––– 5C50.12 Tyrosinaemia type 2 ––– 5C50.1Y Other specified disorders of tyrosine metabolism ––– 5C50.1Z Disorders of tyrosine metabolism, unspecified ––– 5C50.20 Histidinaemia ––– 5C50.21 Urocanic aciduria ––– 5C50.2Y Other specified disorders of histidine metabolism ––– 5C50.2Z Disorders of histidine metabolism, unspecified ––– 5C50.70 Glycine encephalopathy ––– 5C50.71 Sarcosinaemia ––– 5C50.7Y Other specified disorders of glycine metabolism ––– 5C50.7Z Disorders of glycine metabolism, unspecified ––– 5C50.A0 Argininosuccinic aciduria ––– 5C50.A1 Carbamoylphosphate synthetase deficiency ––– 5C50.A2 Argininaemia ––– 5C50.A3 Citrullinaemia ––– 5C50.AY Other specified disorders of urea cycle metabolism ––– 5C50.AZ Disorders of urea cycle metabolism, unspecified ––– 5C50.D0 Maple-syrup-urine disease ––– 5C50.DY Other specified disorders of branched-chain amino acid metabolism ––– 5C50.DZ Disorders of branched-chain amino acid metabolism, unspecified ––– 5C50.E0 Classical organic aciduria ––– 5C50.E1 Cerebral organic aciduria ––– 5C50.EY Other specified organic aciduria ––– 5C50.EZ Organic aciduria, unspecified ––– 5C50.F0 Prolidase deficiency ––– 5C50.F1 Carnosinaemia ––– 5C50.F2 Homocarnosinosis ––– 5C50.FY Other specified disorders of peptide metabolism ––– 5C50.FZ Disorders of peptide metabolism, unspecified – 5C51 Inborn errors of carbohydrate metabolism –– 5C51.0 Disorders of the pentose phosphate pathway –– 5C51.1 Disorders of glycerol metabolism –– 5C51.2 Disorders of glyoxylate metabolism –– 5C51.3 Glycogen storage disease –– 5C51.4 Disorders of galactose metabolism –– 5C51.5 Disorders of fructose metabolism –– 5C51.Y Other specified inborn errors of carbohydrate metabolism –– 5C51.Z Inborn errors of carbohydrate metabolism, unspecified ––– 5C51.20 Primary hyperoxaluria type 1 ––– 5C51.2Y Other specified disorders of glyoxylate metabolism ––– 5C51.2Z Disorders of glyoxylate metabolism, unspecified ––– 5C51.40 Galactose-1-phosphate uridyltransferase deficiency ––– 5C51.41 Galactokinase deficiency ––– 5C51.42 Glucose or galactose intolerance of newborn ––– 5C51.4Y Other specified disorders of galactose metabolism ––– 5C51.4Z Disorders of galactose metabolism, unspecified ––– 5C51.50 Hereditary fructose intolerance ––– 5C51.5Y Other specified disorders of fructose metabolism ––– 5C51.5Z Disorders of fructose metabolism, unspecified – 5C52 Inborn errors of lipid metabolism –– 5C52.0 Inborn errors of fatty acid oxidation or ketone body metabolism –– 5C52.1 Inborn errors of sterol metabolism –– 5C52.2 Neutral lipid storage disease –– 5C52.Y Other specified inborn errors of lipid metabolism –– 5C52.Z Inborn errors of lipid metabolism, unspecified ––– 5C52.00 Disorders of carnitine transport or the carnitine cycle ––– 5C52.01 Disorders of mitochondrial fatty acid oxidation ––– 5C52.02 Disorders of ketone body metabolism ––– 5C52.03 Sjögren-Larsson syndrome ––– 5C52.0Y Other specified inborn errors of fatty acid oxidation or ketone body metabolism ––– 5C52.0Z Inborn errors of fatty acid oxidation or ketone body metabolism, unspecified ––– 5C52.10 Disorders of cholesterol synthesis ––– 5C52.11 Bile acid synthesis defect with cholestasis ––– 5C52.1Y Other specified inborn errors of sterol metabolism ––– 5C52.1Z Inborn errors of sterol metabolism, unspecified – 5C53 Inborn errors of energy metabolism –– 5C53.0 Disorders of pyruvate metabolism –– 5C53.1 Disorders of the citric acid cycle –– 5C53.2 Disorders of mitochondrial oxidative phosphorylation –– 5C53.3 Disorders of mitochondrial membrane transport –– 5C53.4 Disorders of creatine metabolism –– 5C53.Y Other specified inborn errors of energy metabolism –– 5C53.Z Inborn errors of energy metabolism, unspecified ––– 5C53.00 Pyruvate kinase deficiency ––– 5C53.01 Lactate dehydrogenase deficiency ––– 5C53.02 Pyruvate dehydrogenase complex deficiency ––– 5C53.03 Pyruvate carboxylase deficiency ––– 5C53.0Y Other specified disorders of pyruvate metabolism ––– 5C53.0Z Disorders of pyruvate metabolism, unspecified ––– 5C53.20 Mitochondrial DNA depletion syndromes ––– 5C53.21 Multiple mitochondrial DNA deletion syndromes ––– 5C53.22 Coenzyme Q10 deficiency ––– 5C53.23 Mitochondrial protein translation defects ––– 5C53.24 Leigh syndrome ––– 5C53.25 Isolated ATP synthase deficiency ––– 5C53.2Y Other specified disorders of mitochondrial oxidative phosphorylation ––– 5C53.2Z Disorders of mitochondrial oxidative phosphorylation, unspecified ––– 5C53.30 Mitochondrial substrate carrier disorders ––– 5C53.31 Mitochondrial protein import disorders ––– 5C53.3Y Other specified disorders of mitochondrial membrane transport ––– 5C53.3Z Disorders of mitochondrial membrane transport, unspecified – 5C54 Inborn errors of glycosylation or other specified protein modification –– 5C54.0 Disorders of protein N-glycosylation –– 5C54.1 Disorders of protein O-glycosylation –– 5C54.2 Disorders of multiple glycosylation or other pathways –– 5C54.Y Other specified congenital disorders of glycosylation and protein modification –– 5C54.Z Congenital disorders of glycosylation and protein modification, unspecified – 5C55 Inborn errors of purine, pyrimidine or nucleotide metabolism –– 5C55.0 Disorders of purine metabolism –– 5C55.1 Disorders of pyrimidine metabolism –– 5C55.2 Disorders of nucleotide metabolism –– 5C55.Y Other specified inborn errors of purine, pyrimidine or nucleotide metabolism –– 5C55.Z Inborn errors of purine, pyrimidine or nucleotide metabolism, unspecified ––– 5C55.00 Xanthinuria ––– 5C55.01 Lesch-Nyhan syndrome ––– 5C55.0Y Other specified disorders of purine metabolism ––– 5C55.0Z Disorders of purine metabolism, unspecified – 5C56 Lysosomal diseases –– 5C56.0 Sphingolipidosis –– 5C56.1 Neuronal ceroid lipofuscinosis –– 5C56.2 Glycoproteinosis –– 5C56.3 Mucopolysaccharidosis –– 5C56.4 Disorders of sialic acid metabolism –– 5C56.Y Other specified lysosomal diseases –– 5C56.Z Lysosomal diseases, unspecified ––– 5C56.00 Gangliosidosis ––– 5C56.01 Fabry disease ––– 5C56.02 Metachromatic leukodystrophy ––– 5C56.0Y Other specified sphingolipidosis ––– 5C56.0Z Sphingolipidosis, unspecified ––– 5C56.20 Mucolipidosis ––– 5C56.21 Oligosaccharidosis ––– 5C56.2Y Other specified glycoproteinosis ––– 5C56.2Z Glycoproteinosis, unspecified ––– 5C56.30 Mucopolysaccharidosis type 1 ––– 5C56.31 Mucopolysaccharidosis type 2 ––– 5C56.32 Mucopolysaccharidosis type 4 ––– 5C56.33 Mucopolysaccharidosis type 6 ––– 5C56.3Y Other specified mucopolysaccharidosis ––– 5C56.3Z Mucopolysaccharidosis, unspecified – 5C57 Peroxisomal diseases –– 5C57.0 Disorders of peroxisome biogenesis –– 5C57.1 Disorders of peroxisomal alpha-, beta- or omega-oxidation –– 5C57.Y Other specified peroxisomal diseases –– 5C57.Z Peroxisomal diseases, unspecified – 5C58 Inborn errors of porphyrin or heme metabolism –– 5C58.0 Disorders of bilirubin metabolism or excretion –– 5C58.1 Porphyrias –– 5C58.Y Other specified inborn errors of porphyrin or heme metabolism –– 5C58.Z Inborn errors of porphyrin or heme metabolism, unspecified ––– 5C58.00 Crigler-Najjar syndrome ––– 5C58.01 Gilbert syndrome ––– 5C58.02 Dubin-Johnson syndrome ––– 5C58.03 Progressive familial intrahepatic cholestasis ––– 5C58.04 Benign recurrent intrahepatic cholestasis ––– 5C58.0Y Other specified disorders of bilirubin metabolism or excretion ––– 5C58.0Z Disorders of bilirubin metabolism or excretion, unspecified ––– 5C58.10 Porphyria cutanea tarda ––– 5C58.12 Erythropoietic porphyrias ––– 5C58.13 Variegate porphyria ––– 5C58.1Y Other specified porphyrias ––– 5C58.1Z Porphyrias, unspecified – 5C59 Inborn errors of neurotransmitter metabolism –– 5C59.0 Disorders of biogenic amine metabolism –– 5C59.1 Disorders of gamma aminobutyric acid metabolism –– 5C59.2 Disorders of pyridoxine metabolism –– 5C59.Y Other specified inborn errors of neurotransmitter metabolism –– 5C59.Z Inborn errors of neurotransmitter metabolism, unspecified ––– 5C59.00 Disorders of catecholamine synthesis ––– 5C59.01 Disorders of pterin metabolism ––– 5C59.0Y Other specified disorders of biogenic amine metabolism ––– 5C59.0Z Disorders of biogenic amine metabolism, unspecified – 5C5A Alpha-1-antitrypsin deficiency – 5C5Y Other specified inborn errors of metabolism – 5C5Z Inborn errors of metabolism, unspecified – 5C60 Disorders of amino acid absorption or transport –– 5C60.0 Oculocerebrorenal syndrome –– 5C60.1 Cystinosis –– 5C60.2 Cystinuria –– 5C60.Y Other specified disorders of amino acid absorption or transport –– 5C60.Z Disorders of amino acid absorption or transport, unspecified – 5C61 Disorders of carbohydrate absorption or transport –– 5C61.0 Glucose-galactose malabsorption –– 5C61.1 Maltase-glucoamylase deficiency –– 5C61.2 Congenital sucrase-isomaltase deficiency –– 5C61.3 Alpha, alpha trehalase deficiency –– 5C61.4 Acquired monosaccharide malabsorption –– 5C61.5 Disorders of facilitated glucose transport –– 5C61.6 Lactose intolerance –– 5C61.Y Other specified disorders of carbohydrate absorption or transport –– 5C61.Z Disorders of carbohydrate absorption or transport, unspecified ––– 5C61.40 Fructose malabsorption ––– 5C61.4Y Other specified acquired monosaccharide malabsorption ––– 5C61.4Z Acquired monosaccharide malabsorption, unspecified ––– 5C61.60 Primary lactase deficiency ––– 5C61.61 Congenital lactase deficiency ––– 5C61.62 Secondary lactase deficiency ––– 5C61.6Z Lactose intolerance, unspecified – 5C62 Disorders of lipid absorption or transport – 5C63 Disorders of vitamin or non-protein cofactor absorption or transport –– 5C63.0 Disorders of cobalamin metabolism or transport –– 5C63.1 Disorders of folate metabolism or transport –– 5C63.2 Disorders of vitamin D metabolism or transport –– 5C63.Y Other specified disorders of vitamin or non-protein cofactor absorption or transport –– 5C63.Z Disorders of vitamin or non-protein cofactor absorption or transport, unspecified ––– 5C63.20 Hypocalcaemic vitamin D dependent rickets ––– 5C63.21 Hypocalcaemic vitamin D resistant rickets ––– 5C63.22 Hypophosphataemic rickets ––– 5C63.2Y Other specified disorders of vitamin D metabolism or transport ––– 5C63.2Z Disorders of vitamin D metabolism or transport, unspecified – 5C64 Disorders of mineral absorption or transport –– 5C64.0 Disorders of copper metabolism –– 5C64.1 Disorders of iron metabolism –– 5C64.2 Disorders of zinc metabolism –– 5C64.3 Disorders of phosphorus metabolism or phosphatases –– 5C64.4 Disorders of magnesium metabolism –– 5C64.5 Disorders of calcium metabolism –– 5C64.6 Disorders of sodium metabolism –– 5C64.7 Disorders of chloride metabolism –– 5C64.Y Disorders of other specified mineral absorption and transport –– 5C64.Z Disorders of mineral absorption or transport, unspecified ––– 5C64.00 Wilson disease ––– 5C64.0Y Other specified disorders of copper metabolism ––– 5C64.0Z Disorders of copper metabolism, unspecified ––– 5C64.10 Iron overload diseases ––– 5C64.1Y Other specified disorders of iron metabolism ––– 5C64.1Z Disorders of iron metabolism, unspecified ––– 5C64.20 Acrodermatitis enteropathica ––– 5C64.21 Zinc deficiency syndromes ––– 5C64.2Y Other specified disorders of zinc metabolism ––– 5C64.2Z Disorders of zinc metabolism, unspecified ––– 5C64.40 Hypermagnesaemia ––– 5C64.41 Hypomagnesaemia ––– 5C64.4Z Disorders of magnesium metabolism, unspecified – 5C6Y Other specified disorders of metabolite absorption or transport – 5C6Z Disorders of metabolite absorption or transport, unspecified – 5C70 Volume depletion –– 5C70.0 Dehydration –– 5C70.1 Hypovolaemia –– 5C70.Y Other specified volume depletion –– 5C70.Z Volume depletion, unspecified – 5C71 Hyperosmolality or hypernatraemia – 5C72 Hypo-osmolality or hyponatraemia – 5C73 Acidosis –– 5C73.0 Acute respiratory acidosis –– 5C73.1 Chronic respiratory acidosis –– 5C73.2 Anion gap metabolic acidosis –– 5C73.Y Other specified acidosis –– 5C73.Z Acidosis, unspecified – 5C74 Alkalosis – 5C75 Mixed disorder of acid-base balance – 5C76 Hyperkalaemia – 5C77 Hypokalaemia – 5C78 Fluid overload – 5C7Y Other specified disorders of fluid, electrolyte or acid-base balance – 5C7Z Disorders of fluid, electrolyte or acid-base balance, unspecified – 5C80 Hyperlipoproteinaemia –– 5C80.0 Hypercholesterolaemia –– 5C80.1 Hypertriglyceridaemia –– 5C80.2 Mixed hyperlipidaemia –– 5C80.3 Hyperalphalipoproteinaemia –– 5C80.Y Other specified hyperlipoproteinaemia –– 5C80.Z Hyperlipoproteinaemia, unspecified ––– 5C80.00 Primary hypercholesterolaemia ––– 5C80.01 Secondary hypercholesterolaemia ––– 5C80.0Z Hypercholesterolaemia, unspecified – 5C81 Hypolipoproteinaemia –– 5C81.0 Hypoalphalipoproteinaemia –– 5C81.1 Hypobetalipoproteinaemia –– 5C81.Y Other specified hypolipoproteinaemia –– 5C81.Z Hypolipoproteinaemia, unspecified – 5C8Y Other specified disorders of lipoprotein metabolism or lipidaemias – 5C8Z Unspecified disorders of lipoprotein metabolism or lipidaemias 5C90 Metabolic or transporter liver disease – 5C90.0 Liver diseases due to urea cycle defects – 5C90.1 Liver diseases due to disorders of porphyrin or bilirubin metabolism or transport – 5C90.2 Liver diseases due to disorders of amino acid metabolism – 5C90.3 Liver disease due to disorders of lysosomal storage – 5C90.4 Liver diseases due to mitochondrial disorders – 5C90.5 Liver diseases due to disorders of mineral metabolism – 5C90.Y Other specified metabolic or transporter liver disease – 5C90.Z Metabolic or transporter liver disease, unspecified – 5D00 Amyloidosis –– 5D00.0 AL amyloidosis –– 5D00.1 AA amyloidosis –– 5D00.2 Hereditary amyloidosis –– 5D00.3 Dialysis-associated amyloidosis –– 5D00.Y Other specified amyloidosis –– 5D00.Z Amyloidosis, unspecified ––– 5D00.20 Hereditary ATTR amyloidosis ––– 5D00.21 Non-neuropathic heredofamilial amyloidosis ––– 5D00.2Y Other specified hereditary amyloidosis ––– 5D00.2Z Hereditary amyloidosis, unspecified – 5D01 Tumour lysis syndrome – 5D0Y Other specified metabolic disorders 5D2Z Metabolic disorders, unspecified – FA00 Osteoarthritis of hip –– FA00.0 Primary osteoarthritis of hip –– FA00.1 Post traumatic osteoarthritis of hip –– FA00.2 Other secondary osteoarthritis of hip –– FA00.Z Osteoarthritis of hip, unspecified – FA01 Osteoarthritis of knee –– FA01.0 Primary osteoarthritis of knee –– FA01.1 Post traumatic osteoarthritis of knee –– FA01.2 Other secondary osteoarthritis of knee –– FA01.Z Osteoarthritis of knee, unspecified – FA02 Osteoarthritis of wrist or hand –– FA02.0 Primary osteoarthritis of wrist or hand –– FA02.1 Post traumatic osteoarthritis of wrist or hand –– FA02.2 Other secondary osteoarthritis of wrist or hand –– FA02.Z Osteoarthritis of wrist or hand, unspecified – FA03 Osteoarthritis of other specified joint –– FA03.0 Primary osteoarthritis of other specified joint –– FA03.1 Post traumatic osteoarthritis of other specified joint –– FA03.2 Other secondary osteoarthritis of other specified joint –– FA03.Z Osteoarthritis of other specified joint, unspecified – FA04 Oligoosteoarthritis – FA05 Polyosteoarthritis – FA0Z Osteoarthritis, unspecified – FA10 Direct infections of joint –– FA10.0 Bacterial infection of joint –– FA10.1 Viral infection of joint –– FA10.2 Fungal infection of joint –– FA10.Z Direct infections of joint, unspecified – FA11 Reactive arthropathies –– FA11.0 Arthropathy following intestinal bypass –– FA11.1 Arthropathy following vaccination –– FA11.2 Arthropathy following genitourinary infection –– FA11.Y Other specified reactive arthropathies –– FA11.Z Reactive arthropathies, unspecified – FA12 Postinfectious arthropathies –– FA12.0 Bacterial postinfectious arthropathy –– FA12.1 Viral postinfectious arthropathies –– FA12.2 Fungal postinfectious arthropathies –– FA12.3 Parasitic postinfectious arthropathies –– FA12.Y Other specified postinfectious arthropathies –– FA12.Z Postinfectious arthropathies, unspecified – FA13 Infectious spondyloarthritis – FA1Y Other specified infection related arthropathies – FA1Z Infection related arthropathies, unspecified – FA20 Rheumatoid arthritis –– FA20.0 Seropositive rheumatoid arthritis –– FA20.1 Seronegative rheumatoid arthritis –– FA20.Z Rheumatoid arthritis, serology unspecified – FA21 Psoriatic arthritis –– FA21.0 Psoriatic spondyloarthritis –– FA21.Y Other specified psoriatic arthritis –– FA21.Z Psoriatic arthritis, unspecified – FA22 Polymyalgia rheumatica – FA23 Adult-onset Still disease – FA24 Juvenile idiopathic arthritis –– FA24.0 Juvenile idiopathic oligoarthritis –– FA24.1 Juvenile idiopathic polyarthritis –– FA24.2 Juvenile psoriatic arthritis –– FA24.3 Juvenile enthesitis related arthritis –– FA24.4 Juvenile systemic arthritis –– FA24.Y Other specified juvenile idiopathic arthritis –– FA24.Z Juvenile idiopathic arthritis, unspecified ––– FA24.00 Juvenile idiopathic oligoarthritis, onset persistent ––– FA24.01 Juvenile idiopathic oligoarthritis, onset extended ––– FA24.0Z Juvenile idiopathic oligoarthritis, onset unspecified – FA25 Gout –– FA25.0 Primary gout –– FA25.1 Secondary gout –– FA25.2 Gout without specification whether primary or secondary ––– FA25.10 Lead-induced gout ––– FA25.11 Drug-induced gout ––– FA25.12 Gouty arthropathy due to enzyme defects or other inherited disorders ––– FA25.1Y Other specified secondary gout ––– FA25.1Z Secondary gout, unspecified ––– FA25.20 Tophaceous gout ––– FA25.2Y Other specified gout without specification whether primary or secondary ––– FA25.2Z Gout, unspecified – FA26 Certain specified crystal arthropathies –– FA26.0 Calcium pyrophosphate dehydrate deposition disease –– FA26.1 Hydroxyapatite deposition disease –– FA26.2 Chondrocalcinosis –– FA26.Y Other specified crystal arthropathies –– FA26.Z Crystal arthropathies, unspecified – FA27 Certain specified inflammatory arthropathies –– FA27.0 Kashin-Beck disease –– FA27.1 Pigmented villonodular synovitis –– FA27.2 Palindromic rheumatism –– FA27.3 Transient synovitis –– FA27.4 Intermittent hydrarthrosis –– FA27.Y Other specified inflammatory arthropathies – FA2Z Inflammatory arthropathies, unspecified – FA30 Acquired deformities of fingers or toes –– FA30.0 Acquired hallux valgus –– FA30.1 Hallux rigidus –– FA30.2 Acquired hammer toe –– FA30.Y Other specified acquired deformities of fingers or toes –– FA30.Z Acquired deformities of fingers or toes, unspecified – FA31 Other acquired deformities of limbs –– FA31.0 Valgus deformity, not elsewhere classified –– FA31.1 Varus deformity, not elsewhere classified –– FA31.2 Flexion deformity –– FA31.3 Acquired wrist drop –– FA31.4 Acquired foot drop –– FA31.5 Acquired pes planus –– FA31.6 Acquired clawhand or clubhand –– FA31.7 Acquired clawfoot or clubfoot –– FA31.8 Acquired unequal limb length –– FA31.Y Other specified acquired deformities of limbs –– FA31.Z Acquired deformities of limbs, unspecified – FA32 Disorders of patella –– FA32.0 Recurrent instability of patella –– FA32.1 Patellofemoral disorders –– FA32.Y Other specified disorders of patella –– FA32.Z Disorders of patella, unspecified – FA33 Internal derangement of knee –– FA33.0 Cystic meniscus –– FA33.1 Discoid meniscus –– FA33.2 Derangement of meniscus due to old tear or injury –– FA33.3 Loose body in knee –– FA33.4 Chronic instability of knee –– FA33.Y Other specified internal derangement of knee –– FA33.Z Internal derangement of knee, unspecified ––– FA33.40 Chronic instability of knee, medial collateral ligament or other or unspecified part of medial meniscus ––– FA33.4Y Other specified chronic instability of knee ––– FA33.4Z Chronic instability of knee, unspecified – FA34 Certain specified joint derangements –– FA34.0 Loose body in joint –– FA34.1 Disorder of ligament –– FA34.2 Recurrent instability of joint –– FA34.3 Contracture of joint –– FA34.4 Ankylosis of joint –– FA34.5 Impingement syndrome of hip –– FA34.Y Other joint derangements – FA35 Wear of articular bearing surface of joint prosthesis –– FA35.0 Wear of articular bearing surface of joint prosthesis of hip –– FA35.1 Wear of articular bearing surface of joint prosthesis of knee –– FA35.2 Wear of articular bearing surface of joint prosthesis of other joint –– FA35.Z Wear of articular bearing surface of joint prosthesis of unspecified joint – FA36 Effusion of joint –– FA36.0 Effusion of joint containing blood –– FA36.Y Other specified effusion of joint –– FA36.Z Effusion of joint, unspecified – FA37 Certain joint disorders, not elsewhere classified –– FA37.0 Osteophyte –– FA37.Y Other specified certain joint disorders, not elsewhere classified –– FA37.Z Certain joint disorders, not elsewhere classified, unspecified – FA38 Arthropathy in diseases classified elsewhere –– FA38.0 Diabetic arthropathy –– FA38.1 Neuropathic arthropathy –– FA38.2 Arthropathy in hypersensitivity reactions classified elsewhere –– FA38.3 Haemophilic arthropathy –– FA38.Y Other specified arthropathy in diseases classified elsewhere –– FA38.Z Unspecified arthropathy in diseases classified elsewhere ––– FA38.10 Diabetic Charcot arthropathy ––– FA38.1Y Other specified neuropathic arthropathy ––– FA38.1Z Neuropathic arthropathy, unspecified – FA3Z Unspecified joint disorders and deformities of limbs FA5Y Other specified arthropathies FA5Z Arthropathies, unspecified – FA70 Spinal deformities –– FA70.0 Kyphosis –– FA70.1 Scoliosis –– FA70.2 Lordosis –– FA70.Z Spinal deformities, unspecified – FA71 Torticollis – FA72 Disorders of vertebra –– FA72.0 Ankylosing hyperostosis –– FA72.1 Kissing spine –– FA72.2 Traumatic spondylopathy –– FA72.3 Fatigue fracture of vertebra –– FA72.4 Collapsed vertebra, not elsewhere classified –– FA72.Y Other specified disorders of vertebra –– FA72.Z Disorders of vertebra, unspecified – FA7Y Other specified structural disorders of spine – FA7Z Structural disorders of spine, unspecified – FA80 Intervertebral disc degeneration –– FA80.0 Intervertebral disc degeneration of cervical spine without prolapsed disc –– FA80.1 Intervertebral disc degeneration of cervical spine with prolapsed disc –– FA80.2 Intervertebral disc degeneration of cervical spine with bony spur at the vertebra –– FA80.3 Intervertebral disc degeneration of cervical spine with nervous system involvement –– FA80.4 Intervertebral disc degeneration of thoracic spine without prolapsed disc –– FA80.5 Intervertebral disc degeneration of thoracic spine with prolapsed disc –– FA80.6 Intervertebral disc degeneration of thoracic spine with bony spur at the vertebra –– FA80.7 Intervertebral disc degeneration of thoracic spine with nervous system involvement –– FA80.8 Intervertebral disc degeneration of lumbar spine without prolapsed disc –– FA80.9 Intervertebral disc degeneration of lumbar spine with prolapsed disc –– FA80.A Intervertebral disc degeneration of lumbar spine with bony spur at the vertebra –– FA80.B Intervertebral disc degeneration of lumbar spine with nervous system involvement –– FA80.Y Other specified intervertebral disc degeneration –– FA80.Z Intervertebral disc degeneration, unspecified – FA81 Spondylolysis –– FA81.0 Spondylolysis with slippage –– FA81.1 Spondylolysis without slippage –– FA81.Z Spondylolysis, unspecified – FA82 Spinal stenosis – FA83 Ossification of spinal ligaments – FA84 Spondylolisthesis –– FA84.0 Spondylolisthesis with pars defect –– FA84.1 Spondylolisthesis without pars defect –– FA84.Z Spondylolisthesis, unspecified – FA85 Spinal endplate defects –– FA85.0 Spinal epiphysiopathy with no determinant –– FA85.1 Spinal epiphysiopathy with determinants –– FA85.Y Other specified spinal endplate defects –– FA85.Z Spinal endplate defects, unspecified ––– FA85.10 Localised central endplate defect ––– FA85.11 Multiple anterior endplate defect ––– FA85.12 Separation of ring apophysis ––– FA85.1Y Other specified spinal epiphysiopathy with determinants ––– FA85.1Z Spinal epiphysiopathy with determinants, unspecified – FA8Y Other specified degenerative condition of spine – FA8Z Degenerative condition of spine, unspecified – FA90 Infection of vertebra –– FA90.0 Infection of vertebra with no determinant –– FA90.1 Infection of vertebra with determinants –– FA90.Y Other specified infection of vertebra –– FA90.Z Infection of vertebra, unspecified – FA91 Infection of intervertebral disc – FA92 Inflammatory spondyloarthritis –– FA92.0 Axial spondyloarthritis –– FA92.1 Peripheral spondyloarthritis –– FA92.Y Other specified inflammatory spondyloarthritis –– FA92.Z Inflammatory spondyloarthritis, unspecified ––– FA92.00 Spinal enthesitis ––– FA92.01 Sacroiliitis, not elsewhere classified ––– FA92.0Y Other specified axial spondyloarthritis ––– FA92.0Z Axial spondyloarthritis, unspecified – FA9Y Other specified inflammation of spine – FA9Z Inflammation of spine, unspecified – FB00 Ankylosis of spinal joint – FB0Y Other specified spondylopathies – FB0Z Spondylopathies, unspecified FB10 Spinal instabilities FB1Y Other specified conditions associated with the spine FB1Z Conditions associated with the spine, unspecified – FB30 Infectious myositis – FB31 Calcification or ossification of muscle –– FB31.0 Progressive osseous heteroplasia –– FB31.1 Fibrodysplasia ossificans progressiva –– FB31.Y Other specified calcification or ossification of muscle –– FB31.Z Calcification or ossification of muscle, unspecified – FB32 Certain specified disorders of muscle –– FB32.0 Diastasis of muscle –– FB32.1 Spontaneous rupture of muscle –– FB32.2 Ischaemic infarction of muscle –– FB32.3 Immobility syndrome –– FB32.4 Contracture of muscle –– FB32.5 Muscle strain or sprain –– FB32.Y Other specified disorders of muscles ––– FB32.20 Idiopathic rhabdomyolysis ––– FB32.2Y Other specified ischaemic infarction of muscle ––– FB32.2Z Ischaemic infarction of muscle, unspecified – FB33 Secondary disorders of muscle – FB3Z Disorders of muscles, unspecified – FB40 Tenosynovitis –– FB40.0 Infectious tenosynovitis –– FB40.1 Plantar fasciitis –– FB40.2 Posterior tibial tendonitis –– FB40.3 Calcific tendinitis –– FB40.4 Trigger finger –– FB40.5 Radial styloid tenosynovitis –– FB40.Y Other specified tenosynovitis –– FB40.Z Tenosynovitis, unspecified – FB41 Spontaneous rupture of synovium or tendon –– FB41.0 Spontaneous rupture of popliteal cyst –– FB41.1 Spontaneous rupture of synovium –– FB41.2 Spontaneous rupture of tendon –– FB41.Y Other specified spontaneous rupture of synovium or tendon –– FB41.Z Spontaneous rupture of synovium or tendon, unspecified – FB42 Certain specified disorders of synovium or tendon –– FB42.0 Acquired short Achilles tendon –– FB42.1 Contracture of tendon sheath –– FB42.2 Ganglion –– FB42.3 Synovial hypertrophy, not elsewhere classified – FB43 Secondary disorders of synovium or tendon – FB4Y Other specified disorders of synovium or tendon – FB4Z Disorders of synovium or tendon, unspecified – FB50 Bursitis –– FB50.0 Infectious bursitis –– FB50.1 Bursitis related to use, overuse or pressure –– FB50.2 Synovial cyst of popliteal space –– FB50.3 Calcium deposit in bursa –– FB50.Y Other specified bursitis –– FB50.Z Bursitis, unspecified – FB51 Fibroblastic disorders –– FB51.0 Palmar fascial fibromatosis –– FB51.1 Knuckle pads –– FB51.2 Fasciitis and fibromatosis –– FB51.3 Fibroblastic rheumatism –– FB51.4 Retroperitoneal fibrosis –– FB51.Y Other specified fibroblastic disorders –– FB51.Z Fibroblastic disorders, unspecified ––– FB51.40 Primary retroperitoneal fibrosis ––– FB51.4Y Other specified retroperitoneal fibrosis ––– FB51.4Z Retroperitoneal fibrosis, unspecified – FB52 Soft tissue disorders in diseases classified elsewhere – FB53 Shoulder lesions –– FB53.0 Adhesive capsulitis of shoulder –– FB53.1 Rotator cuff syndrome –– FB53.2 Impingement syndrome of shoulder –– FB53.Y Other specified shoulder lesions –– FB53.Z Shoulder lesions, unspecified – FB54 Enthesopathies of lower limb –– FB54.0 Iliac crest spur –– FB54.1 Iliotibial band syndrome –– FB54.2 Tibial collateral bursitis –– FB54.3 Calcaneal spur –– FB54.4 Metatarsalgia –– FB54.Y Other specified enthesopathies of lower limb –– FB54.Z Enthesopathies of lower limb, unspecified – FB55 Certain specified enthesopathies –– FB55.0 Medial epicondylitis of elbow –– FB55.1 Lateral epicondylitis of elbow –– FB55.2 Periarthritis of wrist –– FB55.Z Enthesopathies, unspecified – FB56 Specified soft tissue disorders, not elsewhere classified –– FB56.0 Foreign body granuloma of soft tissue, not elsewhere classified –– FB56.1 Residual foreign body in soft tissue –– FB56.2 Myalgia –– FB56.3 Hypertrophy of infrapatellar fat pad –– FB56.4 Pain in limb –– FB56.6 Other specified soft tissue disorders FB6Z Soft tissue disorders, unspecified FB80 Certain specified disorders of bone density or structure – FB80.0 Fibrous dysplasia of bone – FB80.1 Skeletal fluorosis – FB80.2 Osteitis condensans – FB80.3 Hyperostosis of skull – FB80.4 Osteosclerosis – FB80.5 Solitary bone cyst – FB80.6 Aneurysmal bone cyst – FB80.7 Malunion of fracture – FB80.8 Nonunion of fracture – FB80.9 Delayed union of fracture – FB80.A Stress fracture, not elsewhere classified – FB80.B Pathological fracture – FB80.Y Other specified disorders of bone density and structure – FB80.Z Disorder of bone density and structure, unspecified FB81 Osteonecrosis – FB81.0 Idiopathic aseptic osteonecrosis – FB81.1 Osteonecrosis due to dialysis – FB81.2 Drug-induced osteonecrosis – FB81.3 Osteonecrosis due to trauma – FB81.4 Osteonecrosis due to haemoglobinopathy – FB81.5 Osteonecrosis due to ionizing radiation – FB81.6 Alcohol induced osteonecrosis – FB81.Y Other specified osteonecrosis – FB81.Z Osteonecrosis, unspecified FB82 Chondropathies – FB82.0 Chondromalacia – FB82.1 Osteochondrosis or osteochondritis dissecans – FB82.2 Slipped upper femoral epiphysis – FB82.3 Relapsing polychondritis – FB82.Y Other specified chondropathies – FB82.Z Chondropathies, unspecified –– FB82.00 Chondromalacia patellae –– FB82.0Y Other specified chondromalacia –– FB82.0Z Chondromalacia, unspecified FB83 Low bone mass disorders – FB83.0 Osteopenia – FB83.1 Osteoporosis – FB83.2 Adult osteomalacia –– FB83.00 Premenopausal idiopathic osteopenia –– FB83.01 Postmenopausal osteopenia –– FB83.02 Senile osteopenia –– FB83.03 Osteopenia of disuse –– FB83.04 Drug-induced osteopenia –– FB83.0Y Other specified osteopenia –– FB83.0Z Osteopenia, unspecified –– FB83.10 Premenopausal idiopathic osteoporosis –– FB83.11 Postmenopausal osteoporosis –– FB83.12 Osteoporosis of disuse –– FB83.13 Drug-induced osteoporosis –– FB83.14 Osteoporosis due to malabsorption –– FB83.1Y Other specified osteoporosis –– FB83.1Z Osteoporosis, unspecified –– FB83.20 Aluminium bone disease –– FB83.21 Adult osteomalacia due to malnutrition –– FB83.22 Drug-induced adult osteomalacia –– FB83.2Y Other specified adult osteomalacia –– FB83.2Z Adult osteomalacia, unspecified FB84 Osteomyelitis or osteitis – FB84.0 Acute haematogenous osteomyelitis – FB84.1 Other acute osteomyelitis – FB84.2 Subacute osteomyelitis – FB84.3 Chronic multifocal osteomyelitis – FB84.4 Chronic osteomyelitis with draining sinus – FB84.5 Other chronic haematogenous osteomyelitis – FB84.Y Other specified osteomyelitis or osteitis – FB84.Z Osteomyelitis or osteitis, unspecified FB85 Paget disease of bone – FB85.0 Juvenile Paget disease – FB85.1 Paget disease of bone in neoplastic disease – FB85.Y Other specified Paget disease of bone – FB85.Z Paget disease of bone, unspecified FB86 Disorders associated with bone growth – FB86.0 Epiphyseal arrest – FB86.1 Bone hyperplasias – FB86.2 Osteolysis – FB86.Y Other specified disorders associated with bone growth – FB86.Z Disorders associated with bone growth, unspecified –– FB86.10 Hypertrophic osteoarthropathy –– FB86.11 Hypertrophy of bone –– FB86.1Y Other specified bone hyperplasias –– FB86.1Z Bone hyperplasias, unspecified FB8Y Other specified osteopathies or chondropathies FB8Z Osteopathies or chondropathies, unspecified FC00 Certain specified acquired deformities of musculoskeletal system or connective tissue, not elsewhere classified FC00.0 Acquired deformity of nose FC00.1 Acquired deformity of neck FC00.2 Acquired deformity of chest or rib FC00.3 Acquired deformity of pelvis FC00.4 Acquired deformity of trunk FC00.Y Acquired deformities of musculoskeletal system and connective tissue, not classified elsewhere, other specified sites FC01 Postprocedural disorders of the musculoskeletal system FC01.0 Pseudarthrosis after fusion or arthrodesis FC01.1 Postlaminectomy syndrome, not elsewhere classified FC01.2 Post radiation kyphosis FC01.3 Postlaminectomy kyphosis FC01.4 Postsurgical lordosis FC01.5 Post radiation scoliosis FC01.6 Fracture of bone following insertion of orthopaedic implant, joint prosthesis, or bone plate FC01.7 Nonunion after arthrodesis FC01.8 Postsurgical osteolysis FC01.9 Postoophorectomy osteoporosis FC01.A Postsurgical malabsorption osteoporosis – FC01.70 Nonunion after spinal arthrodesis – FC01.7Y Nonunion after arthrodesis of other sites FC0Y Other specified diseases of the musculoskeletal system or connective tissue FC0Z Diseases of the musculoskeletal system or connective tissue, unspecified – LA00 Anencephaly or similar anomalies –– LA00.0 Anencephaly –– LA00.1 Iniencephaly –– LA00.2 Acephaly –– LA00.3 Amyelencephaly –– LA00.Y Other specified anencephaly or similar anomalies –– LA00.Z Anencephaly or similar anomalies, unspecified ––– LA00.00 Craniorachischisis ––– LA00.0Y Other specified anencephaly ––– LA00.0Z Anencephaly, unspecified – LA01 Cephalocele – LA02 Spina bifida –– LA02.0 Spina bifida cystica –– LA02.1 Spina bifida aperta –– LA02.Y Other specified spina bifida –– LA02.Z Spina bifida, unspecified ––– LA02.00 Myelomeningocele with hydrocephalus ––– LA02.01 Myelomeningocele without hydrocephalus ––– LA02.02 Myelocystocele ––– LA02.0Y Other specified spina bifida cystica ––– LA02.0Z Spina bifida cystica, unspecified – LA03 Arnold-Chiari malformation type II – LA04 Congenital hydrocephalus –– LA04.0 Hydrocephalus with stenosis of the aqueduct of Sylvius –– LA04.Y Other specified congenital hydrocephalus –– LA04.Z Congenital hydrocephalus, unspecified – LA05 Cerebral structural developmental anomalies –– LA05.0 Microcephaly –– LA05.1 Megalencephaly –– LA05.2 Holoprosencephaly –– LA05.3 Corpus callosum agenesis –– LA05.4 Arrhinencephaly –– LA05.5 Abnormal neuronal migration –– LA05.6 Encephaloclastic disorders –– LA05.7 Brain cystic malformations –– LA05.8 Colpocephaly –– LA05.Y Other specified cerebral structural developmental anomalies –– LA05.Z Cerebral structural developmental anomalies, unspecified ––– LA05.50 Polymicrogyria ––– LA05.51 Cortical dysplasia ––– LA05.5Y Other specified abnormal neuronal migration ––– LA05.5Z Abnormal neuronal migration, unspecified ––– LA05.60 Porencephaly ––– LA05.61 Schizencephaly ––– LA05.62 Hydranencephaly ––– LA05.6Y Other specified encephaloclastic disorders ––– LA05.6Z Encephaloclastic disorders, unspecified – LA06 Cerebellar structural developmental anomalies –– LA06.0 Dandy-Walker malformation –– LA06.1 Hypoplasia or agenesis of cerebellar hemispheres –– LA06.2 Focal cerebellar dysplasia –– LA06.Y Other specified cerebellar structural developmental anomalies –– LA06.Z Cerebellar structural developmental anomalies, unspecified – LA07 Structural developmental anomalies of the neurenteric canal, spinal cord or vertebral column –– LA07.0 Primary tethered cord syndrome –– LA07.1 Diastematomyelia –– LA07.2 Amyelia –– LA07.3 Primary syringomyelia or hydromyelia –– LA07.4 Arnold-Chiari malformation type I –– LA07.Y Other specified structural developmental anomalies of the neurenteric canal, spinal cord or vertebral column –– LA07.Z Structural developmental anomalies of the neurenteric canal, spinal cord or vertebral column, unspecified – LA0Y Other specified structural developmental anomalies of the nervous system – LA0Z Structural developmental anomalies of the nervous system, unspecified – LA10 Structural developmental anomalies of ocular globes –– LA10.0 Microphthalmos –– LA10.1 Clinical anophthalmos –– LA10.2 Buphthalmos –– LA10.3 Congenital macrophthalmos –– LA10.Y Other specified structural developmental anomalies of ocular globes –– LA10.Z Structural developmental anomalies of ocular globes, unspecified – LA11 Structural developmental anomalies of the anterior segment of eye –– LA11.0 Blue sclera –– LA11.1 Structural developmental anomalies of cornea –– LA11.2 Anterior segment dysgenesis –– LA11.3 Aniridia –– LA11.4 Coloboma of iris –– LA11.5 Congenital corneal opacity –– LA11.6 Structural disorders of the pupil –– LA11.Y Other specified structural developmental anomalies of the anterior segment of eye –– LA11.Z Structural developmental anomalies of the anterior segment of eye, unspecified ––– LA11.60 Irregular pupil of the eye ––– LA11.61 Iridoschisis ––– LA11.62 Anomalies of pupillary function ––– LA11.6Y Other specified structural disorders of the pupil ––– LA11.6Z Structural disorders of the pupil, unspecified – LA12 Structural developmental anomalies of lens or zonula –– LA12.0 Coloboma of lens –– LA12.1 Congenital cataract –– LA12.2 Congenital aphakia –– LA12.3 Spherophakia –– LA12.Y Other specified structural developmental anomalies of lens or zonula –– LA12.Z Structural developmental anomalies of lens or zonula, unspecified – LA13 Structural developmental anomalies of the posterior segment of eye –– LA13.0 Congenital anomalies of the vitreous –– LA13.1 Coloboma of choroid or retina –– LA13.2 Coloboma of macula –– LA13.3 Congenital vitreoretinal dysplasia –– LA13.5 Congenital retinal aneurysm –– LA13.6 Congenital malformations of choroid –– LA13.7 Congenital malformation of optic disc –– LA13.8 Certain congenital malformations of posterior segment of eye –– LA13.Y Other specified structural developmental anomalies of the posterior segment of eye –– LA13.Z Structural developmental anomalies of the posterior segment of eye, unspecified ––– LA13.70 Isolated optic nerve hypoplasia ––– LA13.71 Optic nerve aplasia ––– LA13.72 Congenitally elevated optic disc ––– LA13.73 Optic disc dysplasia ––– LA13.74 Megalopapilla ––– LA13.76 Coloboma of optic disc ––– LA13.7Y Other specified congenital malformation of optic disc ––– LA13.7Z Congenital malformation of optic disc, unspecified ––– LA13.80 Anastomosis of retinal or choroidal vessels – LA14 Structural developmental anomalies of eyelid, lacrimal apparatus or orbit –– LA14.0 Structural developmental anomalies of eyelids –– LA14.1 Structural developmental anomalies of lacrimal apparatus –– LA14.2 Structural developmental anomalies of orbit –– LA14.Y Other specified structural developmental anomalies of eyelid, lacrimal apparatus or orbit –– LA14.Z Structural developmental anomalies of eyelid, lacrimal apparatus or orbit, unspecified ––– LA14.00 Palpebral cleft or coloboma ––– LA14.01 Cryptophthalmia ––– LA14.02 Congenital entropion ––– LA14.03 Congenital ectropion ––– LA14.04 Congenital ptosis ––– LA14.05 Congenital eyelid retraction ––– LA14.06 Epibulbar choristoma ––– LA14.07 Ankyloblepharon filiforme adnatum ––– LA14.0Y Other specified structural developmental anomalies of eyelids ––– LA14.10 Aplasia of lacrimal or salivary glands ––– LA14.11 Agenesis of lacrimal ducts ––– LA14.12 Congenital dacryocele ––– LA14.13 Congenital agenesis of lacrimal punctum ––– LA14.14 Congenital stenosis or stricture of lacrimal duct ––– LA14.1Y Other specified structural developmental anomalies of lacrimal apparatus ––– LA14.1Z Structural developmental anomalies of lacrimal apparatus, unspecified – LA1Y Other specified structural developmental anomalies of the eye, eyelid or lacrimal apparatus – LA1Z Structural developmental anomalies of the eye, eyelid or lacrimal apparatus, unspecified – LA20 Structural anomaly of eustachian apparatus – LA21 Minor anomalies of pinnae –– LA21.0 Macrotia –– LA21.1 Protruding ear –– LA21.2 Low-set ear –– LA21.3 Misshapen ear –– LA21.Y Other specified minor anomalies of pinnae –– LA21.Z Minor anomalies of pinnae, unspecified – LA22 Structural developmental anomalies of ear causing hearing impairment –– LA22.0 Microtia –– LA22.1 Anotia –– LA22.2 Aplasia or hypoplasia of external auditory canal –– LA22.3 Structural developmental anomalies of ear ossicles –– LA22.4 Structural developmental anomalies of inner ear –– LA22.Y Other specified structural developmental anomalies of ear causing hearing impairment –– LA22.Z Structural developmental anomalies of ear causing hearing impairment, unspecified – LA23 Otocephaly – LA24 Accessory auricle – LA2Y Other specified structural developmental anomalies of the ear – LA2Z Structural developmental anomalies of the ear, unspecified – LA30 Structural developmental anomalies of teeth and periodontal tissues –– LA30.0 Anodontia –– LA30.1 Hypodontia –– LA30.2 Oligodontia –– LA30.3 Hyperdontia –– LA30.4 Abnormalities of size or form of teeth –– LA30.5 Anomalies in tooth resorption or loss –– LA30.6 Amelogenesis imperfecta –– LA30.7 Dentine dysplasia –– LA30.8 Dentinogenesis imperfecta –– LA30.9 Odontogenesis imperfecta –– LA30.Y Other specified structural developmental anomalies of teeth and periodontal tissues –– LA30.Z Structural developmental anomalies of teeth and periodontal tissues, unspecified ––– LA30.50 Early exfoliation of teeth ––– LA30.51 Late exfoliation of teeth ––– LA30.5Y Other specified anomalies in tooth resorption or loss ––– LA30.5Z Anomalies in tooth resorption or loss, unspecified – LA31 Structural developmental anomalies of mouth or tongue –– LA31.0 Congenital macroglossia –– LA31.1 Hypoglossia or aglossia –– LA31.2 Ankyloglossia –– LA31.3 Macrostomia –– LA31.4 Microstomia –– LA31.Y Other specified structural developmental anomalies of mouth or tongue –– LA31.Z Structural developmental anomalies of mouth or tongue, unspecified –– LA40 Cleft lip ––– LA40.0 Cleft lip, unilateral ––– LA40.1 Cleft lip, bilateral ––– LA40.2 Cleft lip, median ––– LA40.Z Cleft lip, unspecified –– LA41 Cleft lip and alveolus ––– LA41.0 Cleft lip and alveolus, unilateral ––– LA41.1 Cleft lip and alveolus, bilateral ––– LA41.Z Cleft lip and alveolus, unspecified –– LA42 Cleft palate ––– LA42.0 Cleft hard palate ––– LA42.1 Cleft soft palate ––– LA42.2 Cleft uvula ––– LA42.Z Cleft palate, unspecified –– LA4Y Other specified clefts of lip, alveolus or palate –– LA4Z Clefts of lip, alveolus or palate, unspecified – LA50 Congenital velopharyngeal incompetence – LA51 Facial clefts – LA52 Facial asymmetry – LA53 Macrocheilia – LA54 Microcheilia – LA55 Compression facies – LA56 Pierre Robin syndrome – LA5Y Other specified structural developmental anomalies of the face – LA5Z Structural developmental anomalies of the face, unspecified – LA60 Webbed neck – LA61 Congenital sternomastoid tumour – LA62 Congenital torticollis – LA6Y Other specified structural developmental anomalies of the neck – LA6Z Structural developmental anomalies of the neck, unspecified – LA70 Structural developmental anomalies of the nose or cavum –– LA70.0 Arrhinia –– LA70.1 Bifid nose –– LA70.2 Choanal atresia –– LA70.3 Congenital perforated nasal septum –– LA70.Y Other specified structural developmental anomalies of the nose or cavum –– LA70.Z Structural developmental anomalies of the nose or cavum, unspecified – LA71 Structural developmental anomalies of larynx –– LA71.0 Congenital laryngomalacia –– LA71.1 Laryngocele –– LA71.2 Laryngeal hypoplasia –– LA71.3 Congenital subglottic stenosis –– LA71.Y Other specified structural developmental anomalies of larynx –– LA71.Z Structural developmental anomalies of larynx, unspecified – LA72 Laryngotracheooesophageal cleft – LA73 Structural developmental anomalies of trachea –– LA73.0 Congenital stenosis of trachea –– LA73.1 Congenital tracheomalacia –– LA73.Y Other specified structural developmental anomalies of trachea –– LA73.Z Structural developmental anomalies of trachea, unspecified – LA74 Structural developmental anomalies of bronchi –– LA74.0 Congenital stenosis or atresia of bronchus –– LA74.1 Congenital bronchomalacia –– LA74.Y Other specified structural developmental anomalies of bronchi –– LA74.Z Structural developmental anomalies of bronchi, unspecified – LA75 Structural developmental anomalies of lungs –– LA75.0 Accessory lobe of lung –– LA75.1 Agenesis of lung –– LA75.2 Congenital hypoplasia of lung –– LA75.3 Congenital hyperplasia of lung –– LA75.4 Congenital pulmonary airway malformations –– LA75.5 Congenital lobar emphysema –– LA75.6 Congenital sequestration of lung –– LA75.Y Other specified structural developmental anomalies of lungs –– LA75.Z Structural developmental anomalies of lungs, unspecified – LA76 Structural developmental anomalies of pleura – LA77 Congenital cyst of mediastinum – LA7Y Other specified structural developmental anomalies of the respiratory system – LA7Z Structural developmental anomalies of the respiratory system, unspecified –– LA80 Anomalous position-orientation of heart ––– LA80.0 Laevocardia ––– LA80.1 Dextrocardia ––– LA80.2 Mesocardia ––– LA80.3 Extrathoracic heart ––– LA80.Y Other specified anomalous position-orientation of heart ––– LA80.Z Anomalous position-orientation of heart, unspecified –– LA81 Abnormal ventricular relationships –– LA82 Total mirror imagery –– LA83 Right isomerism –– LA84 Left isomerism –– LA85 Congenital anomaly of an atrioventricular or ventriculo-arterial connection ––– LA85.0 Discordant atrioventricular connections ––– LA85.1 Transposition of the great arteries ––– LA85.2 Double outlet right ventricle ––– LA85.3 Double outlet left ventricle ––– LA85.4 Common arterial trunk ––– LA85.Y Other specified congenital anomaly of an atrioventricular or ventriculo-arterial connection ––– LA85.Z Congenital anomaly of an atrioventricular or ventriculo-arterial connection, unspecified –––– LA85.00 Congenitally corrected transposition of great arteries –––– LA85.0Y Other specified discordant atrioventricular connections –––– LA85.0Z Discordant atrioventricular connections, unspecified –––– LA85.20 Double outlet right ventricle with subpulmonary ventricular septal defect, transposition type –––– LA85.21 Double outlet right ventricle with non-committed ventricular septal defect –––– LA85.22 Double outlet right ventricle with subaortic or doubly committed ventricular septal defect without pulmonary stenosis, ventricular septal defect type –––– LA85.23 Double outlet right ventricle with subaortic or doubly committed ventricular septal defect and pulmonary stenosis, Fallot type –––– LA85.2Y Other specified double outlet right ventricle –––– LA85.2Z Double outlet right ventricle, unspecified –––– LA85.40 Common arterial trunk with aortic dominance –––– LA85.41 Common arterial trunk with pulmonary dominance and interrupted aortic arch –––– LA85.4Y Other specified common arterial trunk –––– LA85.4Z Common arterial trunk, unspecified –– LA86 Congenital anomaly of mediastinal vein ––– LA86.0 Left superior caval vein ––– LA86.1 Unroofed coronary sinus ––– LA86.2 Anomalous pulmonary venous connection ––– LA86.3 Congenital pulmonary venous stenosis or hypoplasia ––– LA86.Y Other specified congenital anomaly of mediastinal vein ––– LA86.Z Congenital anomaly of mediastinal vein, unspecified –––– LA86.20 Total anomalous pulmonary venous connection –––– LA86.21 Partial anomalous pulmonary venous connection –––– LA86.22 Scimitar syndrome –––– LA86.2Y Other specified anomalous pulmonary venous connection –––– LA86.2Z Anomalous pulmonary venous connection, unspecified –– LA87 Congenital anomaly of an atrioventricular valve or atrioventricular septum ––– LA87.0 Congenital anomaly of tricuspid valve ––– LA87.1 Congenital anomaly of mitral valve ––– LA87.3 Common atrioventricular junction without an atrioventricular septal defect ––– LA87.4 Common atrioventricular junction with atrioventricular septal defect ––– LA87.Y Other specified congenital anomaly of an atrioventricular valve or atrioventricular septum ––– LA87.Z Congenital anomaly of an atrioventricular valve or atrioventricular septum, unspecified –––– LA87.00 Congenital tricuspid regurgitation –––– LA87.01 Congenital tricuspid valvar stenosis –––– LA87.02 Dysplasia of tricuspid valve –––– LA87.03 Ebstein malformation of tricuspid valve –––– LA87.0Y Other specified congenital anomaly of tricuspid valve –––– LA87.0Z Congenital anomaly of tricuspid valve, unspecified –––– LA87.10 Congenital mitral regurgitation –––– LA87.11 Congenital mitral valvar stenosis –––– LA87.12 Dysplasia of mitral valve –––– LA87.13 Congenital anomaly of mitral subvalvar apparatus –––– LA87.1Y Other specified congenital anomaly of mitral valve –––– LA87.1Z Congenital anomaly of mitral valve, unspecified –––– LA87.40 Atrioventricular septal defect with communication at the atrial level only –––– LA87.41 Atrioventricular septal defect with communication at the ventricular level only –––– LA87.42 Atrioventricular septal defect with communication at atrial level and restrictive communication at ventricular level –––– LA87.43 Atrioventricular septal defect with communication at atrial level and unrestrictive communication at ventricular level –––– LA87.44 Atrioventricular septal defect with ventricular imbalance –––– LA87.45 Atrioventricular septal defect and tetralogy of Fallot –––– LA87.4Y Other specified common atrioventricular junction with atrioventricular septal defect –––– LA87.4Z Common atrioventricular junction with atrioventricular septal defect, unspecified –– LA88 Congenital anomaly of a ventricle or the ventricular septum ––– LA88.0 Congenital right ventricular outflow tract obstruction ––– LA88.1 Double chambered right ventricle ––– LA88.2 Tetralogy of Fallot ––– LA88.3 Congenital left ventricular outflow tract obstruction ––– LA88.4 Ventricular septal defect ––– LA88.Y Other specified congenital anomaly of a ventricle or the ventricular septum ––– LA88.Z Congenital anomaly of a ventricle or the ventricular septum, unspecified –––– LA88.20 Tetralogy of Fallot with absent pulmonary valve syndrome –––– LA88.21 Tetralogy of Fallot with pulmonary atresia –––– LA88.22 Tetralogy of Fallot with pulmonary atresia and systemic-to-pulmonary collateral artery –––– LA88.2Y Other specified tetralogy of Fallot –––– LA88.2Z Tetralogy of Fallot, unspecified –––– LA88.40 Trabecular muscular ventricular septal defect –––– LA88.41 Perimembranous central ventricular septal defect –––– LA88.42 Ventricular septal defect haemodynamically insignificant –––– LA88.4Y Other specified ventricular septal defect –––– LA88.4Z Ventricular septal defect, unspecified –– LA89 Functionally univentricular heart ––– LA89.0 Double inlet atrioventricular connection ––– LA89.1 Tricuspid atresia ––– LA89.2 Mitral atresia ––– LA89.3 Hypoplastic left heart syndrome ––– LA89.Y Other specified functionally univentricular heart ––– LA89.Z Functionally univentricular heart, unspecified –– LA8A Congenital anomaly of a ventriculo-arterial valve or adjacent regions ––– LA8A.0 Congenital anomaly of pulmonary valve ––– LA8A.1 Congenital pulmonary atresia ––– LA8A.2 Congenital anomaly of aortic valve ––– LA8A.3 Congenital supravalvar aortic stenosis ––– LA8A.4 Aneurysm of aortic sinus of Valsalva ––– LA8A.5 Congenital subaortic stenosis ––– LA8A.6 Congenital subpulmonary stenosis ––– LA8A.Y Other specified congenital anomaly of a ventriculo-arterial valve or adjacent regions ––– LA8A.Z Congenital anomaly of a ventriculo-arterial valve or adjacent regions, unspecified –––– LA8A.00 Congenital pulmonary valvar stenosis –––– LA8A.01 Congenital pulmonary regurgitation –––– LA8A.0Y Other specified congenital anomaly of pulmonary valve –––– LA8A.0Z Congenital anomaly of pulmonary valve, unspecified –––– LA8A.10 Pulmonary atresia with intact ventricular septum –––– LA8A.1Y Other specified congenital pulmonary atresia –––– LA8A.1Z Congenital pulmonary atresia, unspecified –––– LA8A.20 Congenital aortic valvar stenosis –––– LA8A.21 Congenital aortic regurgitation –––– LA8A.22 Bicuspid aortic valve –––– LA8A.23 Aortic valvar atresia –––– LA8A.24 Unicuspid aortic valve –––– LA8A.2Y Other specified congenital anomaly of aortic valve –––– LA8A.2Z Congenital anomaly of aortic valve, unspecified –– LA8B Congenital anomaly of great arteries including arterial duct ––– LA8B.0 Congenital aortopulmonary window ––– LA8B.1 Congenital anomaly of pulmonary arterial tree ––– LA8B.2 Congenital anomaly of aorta or its branches ––– LA8B.3 Tracheo-oesophageal compressive syndrome ––– LA8B.4 Patent arterial duct ––– LA8B.Y Other specified congenital anomaly of great arteries including arterial duct ––– LA8B.Z Congenital anomaly of great arteries including arterial duct, unspecified –––– LA8B.21 Coarctation of aorta –––– LA8B.22 Interrupted aortic arch –––– LA8B.23 Congenital anomaly of descending thoracic or abdominal aorta –––– LA8B.24 Congenital anomaly of aortic arch branch –––– LA8B.2Y Other specified congenital anomaly of aorta or its branches –––– LA8B.2Z Congenital anomaly of aorta or its branches, unspecified –– LA8C Congenital anomaly of coronary artery ––– LA8C.0 Anomalous origin of coronary artery from pulmonary arterial tree ––– LA8C.1 Anomalous aortic origin or course of coronary artery ––– LA8C.2 Congenital coronary arterial fistula ––– LA8C.Y Other specified congenital anomaly of coronary artery ––– LA8C.Z Congenital anomaly of coronary artery, unspecified –– LA8D Congenital pericardial anomaly –– LA8E Congenital anomaly of atrial septum ––– LA8E.0 Patent oval foramen ––– LA8E.1 Atrial septal defect within oval fossa ––– LA8E.2 Sinus venosus defect ––– LA8E.3 Interatrial communication through coronary sinus orifice ––– LA8E.Y Other specified congenital anomaly of atrial septum ––– LA8E.Z Congenital anomaly of atrial septum, unspecified –– LA8F Congenital anomaly of right atrium –– LA8G Congenital anomaly of left atrium ––– LA8G.0 Divided left atrium ––– LA8G.Y Other specified congenital anomaly of left atrium ––– LA8G.Z Congenital anomaly of left atrium, unspecified –– LA8Y Other specified structural developmental anomaly of heart or great vessels –– LA8Z Structural developmental anomaly of heart or great vessels, unspecified – LA90 Structural developmental anomalies of the peripheral vascular system –– LA90.0 Capillary malformations –– LA90.1 Lymphatic malformations –– LA90.2 Peripheral venous malformations –– LA90.3 Peripheral arteriovenous malformations –– LA90.4 Peripheral arterial malformations –– LA90.5 Pulmonary arteriovenous fistula –– LA90.Y Other specified structural developmental anomalies of the peripheral vascular system –– LA90.Z Structural developmental anomalies of the peripheral vascular system, unspecified ––– LA90.00 Hereditary haemorrhagic telangiectasia ––– LA90.0Y Other specified capillary malformations ––– LA90.0Z Capillary malformations, unspecified ––– LA90.10 Macrocystic lymphatic malformation ––– LA90.11 Microcystic lymphatic malformation ––– LA90.12 Lymphatic malformations of certain specified sites ––– LA90.13 Cystic hygroma in fetus ––– LA90.1Y Other specified lymphatic malformations ––– LA90.1Z Lymphatic malformations, unspecified ––– LA90.20 Vein of Galen aneurysm ––– LA90.21 Congenital portosystemic shunt ––– LA90.2Y Other specified peripheral venous malformations ––– LA90.2Z Peripheral venous malformations, unspecified ––– LA90.30 Portal vein-hepatic artery fistula ––– LA90.31 Arteriovenous malformation of precerebral vessels ––– LA90.32 Uterine arteriovenous malformations ––– LA90.3Y Other specified peripheral arteriovenous malformations ––– LA90.3Z Peripheral arteriovenous malformations, unspecified ––– LA90.40 Congenital renal artery stenosis ––– LA90.41 Congenital precerebral nonruptured aneurysm ––– LA90.42 Congenital cerebral nonruptured aneurysm ––– LA90.4Y Other specified peripheral arterial malformations ––– LA90.4Z Peripheral arterial malformations, unspecified – LA9Y Other specified structural developmental anomalies of the circulatory system – LA9Z Structural developmental anomalies of the circulatory system, unspecified – LB00 Structural developmental anomalies of diaphragm –– LB00.0 Congenital diaphragmatic hernia –– LB00.1 Absence of diaphragm –– LB00.Y Other specified structural developmental anomalies of diaphragm –– LB00.Z Structural developmental anomalies of diaphragm, unspecified – LB01 Omphalocele – LB02 Gastroschisis – LB03 Structural developmental anomalies of umbilical cord –– LB03.0 Allantoic duct remnants or cysts –– LB03.1 Single umbilical cord artery –– LB03.Y Other specified structural developmental anomalies of umbilical cord –– LB03.Z Structural developmental anomalies of umbilical cord, unspecified – LB0Y Other specified structural developmental anomalies of the diaphragm, abdominal wall or umbilical cord – LB0Z Structural developmental anomalies of the diaphragm, abdominal wall or umbilical cord, unspecified – LB10 Structural developmental anomalies of salivary glands or ducts – LB11 Congenital diverticulum of pharynx – LB12 Structural developmental anomalies of oesophagus –– LB12.0 Congenital oesophageal web or ring –– LB12.1 Atresia of oesophagus –– LB12.2 Oesophageal fistula without atresia –– LB12.3 Congenital stenosis or stricture of oesophagus –– LB12.4 Congenital diverticulum of oesophagus –– LB12.5 Congenital dilatation of oesophagus –– LB12.Y Other specified structural developmental anomalies of oesophagus –– LB12.Z Structural developmental anomalies of oesophagus, unspecified ––– LB12.10 Atresia of oesophagus with oesophagobronchial fistula ––– LB12.1Y Other specified atresia of oesophagus ––– LB12.1Z Atresia of oesophagus, unspecified – LB13 Structural developmental anomalies of stomach –– LB13.0 Congenital hypertrophic pyloric stenosis –– LB13.1 Congenital hiatus hernia –– LB13.2 Congenital antral web –– LB13.Y Other specified structural developmental anomalies of stomach –– LB13.Z Structural developmental anomalies of stomach, unspecified – LB14 Structural developmental anomalies of duodenum – LB15 Structural developmental anomalies of small intestine –– LB15.0 Meckel diverticulum –– LB15.1 Atresia of small intestine –– LB15.2 Congenital short bowel –– LB15.3 Congenital diverticulitis of small intestine –– LB15.4 Congenital diverticulosis of small intestine –– LB15.5 Congenital diverticulum of small intestine –– LB15.Y Other specified structural developmental anomalies of small intestine –– LB15.Z Structural developmental anomalies of small intestine, unspecified – LB16 Structural developmental anomalies of large intestine –– LB16.0 Congenital absence, atresia or stenosis of large intestine –– LB16.1 Hirschsprung disease –– LB16.2 Immature ganglionosis of large intestine –– LB16.3 Congenital hypoganglionosis of large intestine –– LB16.Y Other specified structural developmental anomalies of large intestine –– LB16.Z Structural developmental anomalies of large intestine, unspecified – LB17 Structural developmental anomalies of anal canal –– LB17.0 Anorectal malformations –– LB17.1 Ectopic anus –– LB17.2 Persistent cloaca –– LB17.3 Cloacal exstrophy –– LB17.4 Perineal groove –– LB17.Y Other specified structural developmental anomalies of anal canal –– LB17.Z Structural developmental anomalies of anal canal, unspecified – LB18 Congenital anomalies of intestinal fixation – LB1Y Other specified structural developmental anomalies of the digestive tract – LB1Z Structural developmental anomalies of the digestive tract, unspecified – LB20 Structural developmental anomalies of gallbladder, bile ducts or liver –– LB20.0 Structural developmental anomalies of liver –– LB20.1 Structural developmental anomalies of gallbladder –– LB20.2 Structural developmental anomalies of bile ducts –– LB20.Y Other specified structural developmental anomalies of gallbladder, bile ducts or liver –– LB20.Z Structural developmental anomalies of gallbladder, bile ducts or liver, unspecified ––– LB20.00 Fibropolycystic liver disease ––– LB20.0Y Other specified structural developmental anomalies of liver ––– LB20.0Z Structural developmental anomalies of liver, unspecified ––– LB20.10 Agenesis, aplasia or hypoplasia of gallbladder ––– LB20.1Y Other specified structural developmental anomalies of gallbladder ––– LB20.1Z Structural developmental anomalies of gallbladder, unspecified ––– LB20.20 Choledochal cyst ––– LB20.21 Biliary atresia ––– LB20.22 Congenital stenosis or stricture of bile ducts ––– LB20.23 Structural developmental anomalies of cystic duct ––– LB20.24 Accessory bile duct ––– LB20.2Y Other specified structural developmental anomalies of bile ducts ––– LB20.2Z Structural developmental anomalies of bile ducts, unspecified – LB21 Structural developmental anomalies of pancreas –– LB21.0 Annular pancreas –– LB21.1 Pancreas divisum –– LB21.2 Accessory pancreas –– LB21.3 Agenesis-aplasia of pancreas –– LB21.4 Partial agenesis of pancreas –– LB21.5 Hypoplasia of pancreas –– LB21.Y Other specified structural developmental anomalies of pancreas –– LB21.Z Structural developmental anomalies of pancreas, unspecified – LB22 Structural developmental anomalies of spleen –– LB22.0 Congenital asplenia –– LB22.1 Polysplenia –– LB22.2 Ectopic spleen –– LB22.Y Other specified structural developmental anomalies of spleen –– LB22.Z Structural developmental anomalies of spleen, unspecified – LB2Y Other specified structural developmental anomalies of the liver, biliary tract, pancreas or spleen – LB2Z Structural developmental anomalies of the liver, biliary tract, pancreas or spleen, unspecified – LB30 Structural developmental anomalies of kidneys –– LB30.0 Renal agenesis or other reduction defects of kidney –– LB30.1 Renal dysplasia –– LB30.2 Congenital single renal cyst –– LB30.3 Renal tubular dysgenesis –– LB30.4 Oligomeganephronia –– LB30.5 Accessory kidney –– LB30.6 Fusion anomaly of kidneys –– LB30.7 Ectopic or pelvic kidney –– LB30.8 Medullary sponge kidney –– LB30.9 Multicystic renal dysplasia –– LB30.Y Other specified structural developmental anomalies of kidneys –– LB30.Z Structural developmental anomalies of kidneys, unspecified ––– LB30.00 Renal agenesis ––– LB30.0Y Other specified renal agenesis or other reduction defects of kidney ––– LB30.0Z Renal agenesis or other reduction defects of kidney, unspecified ––– LB30.60 Lobulated kidney ––– LB30.61 Fused pelvic kidney ––– LB30.62 Horseshoe kidney ––– LB30.6Y Other specified fusion anomaly of kidneys ––– LB30.6Z Fusion anomaly of kidneys, unspecified – LB31 Structural developmental anomalies of urinary tract –– LB31.0 Congenital hydronephrosis –– LB31.1 Congenital primary megaureter –– LB31.2 Fetal lower urinary tract obstruction –– LB31.3 Exstrophy of urinary bladder –– LB31.4 Congenital diverticulum of urinary bladder –– LB31.5 Duplication of urethra –– LB31.6 Congenital megalourethra –– LB31.7 Megacystis-megaureter –– LB31.8 Atresia or stenosis of ureter –– LB31.9 Agenesis of ureter –– LB31.A Duplication of ureter –– LB31.B Malposition of ureter –– LB31.C Congenital absence of bladder or urethra –– LB31.D Congenital vesico-uretero-renal reflux –– LB31.Y Other specified structural developmental anomalies of urinary tract –– LB31.Z Structural developmental anomalies of urinary tract, unspecified – LB3Y Other specified structural developmental anomalies of the urinary system – LB3Z Structural developmental anomalies of the urinary system, unspecified – LB40 Structural developmental anomalies of vulva –– LB40.0 Absence of vulva –– LB40.1 Embryonic cyst of vulva –– LB40.2 Fusion of labia –– LB40.Y Other specified structural developmental anomalies of vulva –– LB40.Z Structural developmental anomalies of vulva, unspecified – LB41 Structural developmental anomalies of clitoris –– LB41.0 Agenesis of clitoris –– LB41.1 Duplication of clitoris –– LB41.2 Clitoromegaly –– LB41.Y Other specified structural developmental anomalies of clitoris –– LB41.Z Structural developmental anomalies of clitoris, unspecified – LB42 Structural developmental anomalies of vagina –– LB42.0 Absence of vagina –– LB42.1 Septate vagina –– LB42.2 Congenital rectovaginal fistula –– LB42.3 Tight hymenal ring –– LB42.4 Imperforate hymen –– LB42.5 Stricture or atresia of vagina –– LB42.Y Other specified structural developmental anomalies of vagina –– LB42.Z Structural developmental anomalies of vagina, unspecified – LB43 Structural developmental anomalies of cervix uteri –– LB43.0 Embryonic cyst of cervix –– LB43.1 Agenesis or aplasia of cervix –– LB43.Y Other specified structural developmental anomalies of cervix uteri –– LB43.Z Structural developmental anomalies of cervix uteri, unspecified – LB44 Structural developmental anomalies of uterus, except cervix –– LB44.0 Agenesis or aplasia of uterine body –– LB44.1 Hypoplasia of uterus –– LB44.2 Unicornuate uterus –– LB44.3 Bicornuate uterus –– LB44.4 Septate uterus –– LB44.5 Congenital fistulae between uterus and digestive and urinary tracts –– LB44.6 Uterovaginal malformation due to diethylstilbestrol syndrome –– LB44.Y Other specified structural developmental anomalies of uterus, except cervix –– LB44.Z Structural developmental anomalies of uterus, except cervix, unspecified – LB45 Structural developmental anomalies of ovaries, fallopian tubes or broad ligaments –– LB45.0 Congenital absence of ovary –– LB45.1 46,XX gonadal dysgenesis –– LB45.2 Developmental ovarian cyst –– LB45.3 Congenital torsion of ovary –– LB45.4 Accessory ovary –– LB45.5 Congenital absence of fallopian tube –– LB45.6 Atresia of fallopian tube –– LB45.7 Accessory fallopian tube –– LB45.8 Embryonic cyst of fallopian tube –– LB45.9 Embryonic cyst of broad ligament –– LB45.Y Other specified structural developmental anomalies of ovaries, fallopian tubes or broad ligaments –– LB45.Z Structural developmental anomalies of ovaries, fallopian tubes or broad ligaments, unspecified – LB4Y Other specified structural developmental anomalies of the female genital system – LB4Z Structural developmental anomalies of the female genital system, unspecified – LB50 Micropenis or penis agenesis – LB51 Anorchia or microorchidia – LB52 Cryptorchidism –– LB52.0 Ectopic testis –– LB52.1 Undescended testicle, unilateral –– LB52.2 Undescended testicle, bilateral –– LB52.Y Other specified cryptorchidism –– LB52.Z Cryptorchidism, unspecified – LB53 Hypospadias –– LB53.0 Hypospadias, balanic –– LB53.1 Hypospadias, penile –– LB53.2 Hypospadias, penoscrotal –– LB53.3 Hypospadias, scrotal –– LB53.4 Hypospadias, perineal –– LB53.Y Other specified hypospadias –– LB53.Z Hypospadias, unspecified ––– LB53.00 Hypospadias, coronal ––– LB53.01 Hypospadias, glandular ––– LB53.0Y Other specified hypospadias, balanic ––– LB53.0Z Hypospadias, balanic, unspecified – LB54 Congenital chordee – LB55 Epispadias – LB56 Bifid scrotum – LB57 Agenesis of vas deferens – LB58 Polyorchidism – LB59 Hypoplasia of testis or scrotum – LB5Y Other specified structural developmental anomalies of the male genital system – LB5Z Structural developmental anomalies of the male genital system, unspecified – LB60 Breast aplasia – LB61 Absent nipple – LB62 Supernumerary breasts – LB63 Accessory nipple – LB6Y Other specified structural developmental anomalies of the breast – LB6Z Structural developmental anomalies of the breast, unspecified – LB70 Structural developmental anomalies of cranium –– LB70.0 Craniosynostosis –– LB70.1 Wormian bones –– LB70.2 J-shaped sella turcica –– LB70.3 Macrocephaly –– LB70.Y Other specified structural developmental anomalies of cranium –– LB70.Z Structural developmental anomalies of cranium, unspecified ––– LB70.00 Plagiocephaly ––– LB70.0Y Other specified craniosynostosis ––– LB70.0Z Craniosynostosis, unspecified – LB71 Structural developmental anomalies of facial bones –– LB71.0 Hypotelorism –– LB71.1 Hypertelorism –– LB71.Y Other specified structural developmental anomalies of facial bones –– LB71.Z Structural developmental anomalies of facial bones, unspecified – LB72 Structural developmental anomalies of shoulder girdle –– LB72.0 Cervical rib –– LB72.1 Sprengel deformity –– LB72.2 Deformation of scapula –– LB72.Y Other specified structural developmental anomalies of shoulder girdle –– LB72.Z Structural developmental anomalies of shoulder girdle, unspecified – LB73 Structural developmental anomalies of spine or bony thorax –– LB73.0 Occult spinal dysraphism –– LB73.1 Structural developmental anomalies of chest wall –– LB73.2 Structural developmental anomalies of spine –– LB73.Y Other specified structural developmental anomalies of spine or bony thorax –– LB73.Z Structural developmental anomalies of spine or bony thorax, unspecified ––– LB73.10 Poland syndrome ––– LB73.11 Bifid rib ––– LB73.12 Accessory rib ––– LB73.13 Structural developmental anomalies of sternum ––– LB73.1Y Other specified structural developmental anomalies of chest wall ––– LB73.1Z Structural developmental anomalies of chest wall, unspecified ––– LB73.20 Klippel-Feil anomaly ––– LB73.21 Occipitalisation of atlas ––– LB73.22 Atlanto-axial instability or subluxation ––– LB73.23 Aplasia or hypoplasia of the odontoid process of axis ––– LB73.24 Segmentation anomalies of vertebrae ––– LB73.25 Congenital scoliosis due to congenital bony malformation ––– LB73.26 Sacralisation of the last lumbar vertebra ––– LB73.27 Lumbarisation of the first sacral vertebra ––– LB73.28 Sacrum agenesis or hypoplasia ––– LB73.29 Caudal appendage ––– LB73.2A Congenital spondylolisthesis ––– LB73.2Y Other specified structural developmental anomalies of spine ––– LB73.2Z Structural developmental anomalies of spine, unspecified – LB74 Structural developmental anomalies of pelvic girdle –– LB74.0 Developmental dysplasia of hip –– LB74.1 Congenital subluxation of hip –– LB74.2 Unstable hip –– LB74.3 Congenital coxa vara –– LB74.4 Congenital coxa valga –– LB74.5 Wide symphysis pubis –– LB74.Y Other specified structural developmental anomalies of pelvic girdle –– LB74.Z Structural developmental anomalies of pelvic girdle, unspecified – LB75 Brachydactyly –– LB75.0 Brachydactyly of fingers –– LB75.1 Brachydactyly of toes –– LB75.2 Symbrachydactyly of hands or feet –– LB75.Y Other specified brachydactyly –– LB75.Z Brachydactyly, unspecified – LB76 Triphalangeal thumb – LB77 Hyperphalangy – LB78 Polydactyly –– LB78.0 Polydactyly of the thumb –– LB78.1 Polysyndactyly –– LB78.2 Postaxial polydactyly of fingers –– LB78.3 Polydactyly of toes –– LB78.Y Other specified polydactyly –– LB78.Z Polydactyly, unspecified – LB79 Syndactyly –– LB79.0 Fused fingers –– LB79.1 Webbed fingers –– LB79.2 Fused toes –– LB79.3 Webbed toes –– LB79.Y Other specified syndactyly –– LB79.Z Syndactyly, unspecified –– LB80 Congenital deformities of fingers ––– LB80.0 Clinodactyly of fingers ––– LB80.2 Radial deviation of fingers ––– LB80.Y Other specified congenital deformities of fingers ––– LB80.Z Congenital deformities of fingers, unspecified –– LB81 Congenital deformities of toes ––– LB81.0 Clinodactyly of toes ––– LB81.Y Other specified congenital deformities of toes ––– LB81.Z Congenital deformities of toes, unspecified – LB90 Joint formation defects –– LB90.0 Humero-radio-ulnar synostosis –– LB90.1 Humero-radial synostosis –– LB90.2 Humero-ulnar synostosis –– LB90.3 Radio-ulnar synostosis –– LB90.4 Madelung deformity –– LB90.5 Congenital digital clubbing –– LB90.6 Tibio-fibular synostosis –– LB90.7 Cubitus valgus –– LB90.8 Cubitus varus –– LB90.Y Other specified joint formation defects –– LB90.Z Joint formation defects, unspecified – LB91 Congenital shoulder dislocation – LB92 Congenital elbow dislocation – LB93 Congenital knee dislocation –– LB93.0 Congenital genu recurvatum –– LB93.1 Congenital genu flexum –– LB93.Y Other specified congenital knee dislocation –– LB93.Z Congenital knee dislocation, unspecified – LB94 Congenital patella dislocation – LB95 Patella aplasia or hypoplasia – LB96 Congenital bowing of long bones –– LB96.0 Congenital bowing of femur –– LB96.1 Congenital bowing of tibia –– LB96.Y Other specified congenital bowing of long bones –– LB96.Z Congenital bowing of long bones, unspecified – LB97 Limb overgrowth –– LB97.0 Macrodactyly of fingers –– LB97.1 Macrodactyly of toes –– LB97.2 Upper limb hypertrophy –– LB97.3 Lower limb hypertrophy –– LB97.Y Other specified limb overgrowth –– LB97.Z Limb overgrowth, unspecified – LB98 Congenital deformities of feet –– LB98.0 Congenital varus deformities of feet –– LB98.1 Congenital pes planus –– LB98.2 Congenital valgus deformities of feet –– LB98.3 Congenital pes cavus –– LB98.4 Congenital vertical talus –– LB98.5 Congenital hammer toe –– LB98.Y Other specified congenital deformities of feet –– LB98.Z Congenital deformities of feet, unspecified ––– LB98.00 Talipes equinovarus ––– LB98.01 Talipes calcaneovarus ––– LB98.02 Metatarsus varus ––– LB98.0Y Other specified congenital varus deformities of feet ––– LB98.0Z Congenital varus deformities of feet, unspecified ––– LB98.20 Congenital hallux valgus ––– LB98.21 Metatarsus valgus ––– LB98.22 Talipes calcaneovalgus ––– LB98.2Y Other specified congenital valgus deformities of feet ––– LB98.2Z Congenital valgus deformities of feet, unspecified – LB99 Reduction defects of upper limb –– LB99.0 Amelia of upper limb –– LB99.1 Humeral agenesis or hypoplasia –– LB99.2 Radial hemimelia –– LB99.3 Ulnar hemimelia –– LB99.4 Congenital absence of upper arm or forearm with hand present –– LB99.5 Congenital absence of both forearm and hand –– LB99.6 Acheiria –– LB99.7 Adactyly of hands –– LB99.8 Split hand –– LB99.Y Other specified reduction defects of upper limb –– LB99.Z Reduction defects of upper limb, unspecified – LB9A Reduction defects of lower limb –– LB9A.0 Amelia of lower limb –– LB9A.1 Tibial hemimelia –– LB9A.2 Fibular hemimelia –– LB9A.3 Congenital absence of thigh or lower leg with foot present –– LB9A.4 Apodia –– LB9A.5 Adactyly of feet –– LB9A.6 Split foot –– LB9A.7 Congenital absence of both lower leg and foot –– LB9A.8 Femoral agenesis or hypoplasia –– LB9A.Y Other specified reduction defects of lower limb –– LB9A.Z Reduction defects of lower limb, unspecified – LB9B Reduction defects of upper and lower limbs – LB9Y Other specified structural developmental anomalies of the skeleton – LB9Z Structural developmental anomalies of the skeleton, unspecified –– LC00 Keratinocytic epidermal hamartoma ––– LC00.0 Epidermal naevus ––– LC00.Y Other specified keratinocytic epidermal hamartoma ––– LC00.Z Keratinocytic epidermal hamartoma, unspecified –– LC01 Pilosebaceous hamartoma –– LC02 Complex epidermal hamartoma –– LC0Y Other specified developmental hamartomata of the epidermis and epidermal appendages –– LC10 Dermal melanocytosis –– LC1Y Other specified developmental anomalies of skin pigmentation –– LC20 Connective tissue hamartoma –– LC2Y Other specified hamartomata derived from dermal connective tissue –– LC30 Developmental defects of hair or hair growth –– LC31 Developmental defects of the nail apparatus – LC40 Dermoid cyst –– LC50 Developmental capillary vascular malformations of the skin ––– LC50.0 Salmon patch ––– LC50.1 Port-wine stain ––– LC50.Y Other specified cutaneous capillary vascular malformation –– LC51 Developmental venous malformations involving the skin –– LC52 Complex or combined developmental vascular malformations involving the skin –– LC5Y Other specified developmental anomalies of cutaneous vasculature –– LC5Z Developmental anomalies of cutaneous vasculature, unspecified –– LC60 Aplasia cutis congenita – LC7Y Other specified structural developmental anomalies of the skin – LC7Z Structural developmental anomalies of the skin, unspecified – LC80 Congenital adrenal hypoplasia – LC8Y Other specified structural developmental anomalies of the adrenal glands – LC8Z Structural developmental anomalies of the adrenal glands, unspecified LD0Y Other specified structural developmental anomalies primarily affecting one body system LD0Z Structural developmental anomalies primarily affecting one body system, unspecified LD20 Syndromes with central nervous system anomalies as a major feature – LD20.0 Syndromes with cerebellar anomalies as a major feature – LD20.1 Syndromes with lissencephaly as a major feature – LD20.2 Syndromes with microcephaly as a major feature – LD20.3 Syndromes with holoprosencephaly as a major feature – LD20.4 Syndromes with brain calcifications as a major feature – LD20.Y Other specified syndromes with central nervous system anomalies as a major feature – LD20.Z Syndromes with central nervous system anomalies as a major feature, unspecified –– LD20.00 Joubert syndrome –– LD20.01 Pontocerebellar hypoplasia –– LD20.0Y Other specified syndromes with cerebellar anomalies as a major feature –– LD20.0Z Syndromes with cerebellar anomalies as a major feature, unspecified LD21 Syndromes with eye anomalies as a major feature – LD21.0 Syndromes with microphthalmia as a major feature – LD21.Y Other specified syndromes with eye anomalies as a major feature – LD21.Z Syndromes with eye anomalies as a major feature, unspecified LD22 Syndromes with dental anomalies as a major feature LD23 Syndromes with vascular anomalies as a major feature LD24 Syndromes with skeletal anomalies as a major feature – LD24.0 Syndromes with micromelia – LD24.1 Bone diseases with increased bone density – LD24.2 Bone diseases with disorganised development of skeletal components – LD24.3 Spondyloepiphyseal or spondyloepimetaphyseal dysplasias – LD24.4 Spondylometaphyseal dysplasias – LD24.5 Spondylodysplastic dysplasias – LD24.6 Multiple epiphyseal dysplasia or pseudoachondroplasia – LD24.7 Multiple metaphyseal dysplasias – LD24.8 Acromelic dysplasias – LD24.9 Acromesomelic dysplasias – LD24.A Mesomelic or rhizomesomelic dysplasias – LD24.B Short rib syndromes – LD24.C Bent bone dysplasias – LD24.D Slender bone dysplasias – LD24.E Bone dysplasias with multiple joint dislocations – LD24.F Progressive ossification of skin, skeletal muscle, fascia, tendons or ligaments – LD24.G Syndromic craniosynostoses – LD24.H Dysostoses with predominant vertebral and costal involvement – LD24.J Patellar dysostoses – LD24.K Genetic bone diseases with decreased bone density – LD24.Y Other specified syndromes with skeletal anomalies as a major feature – LD24.Z Syndromes with skeletal anomalies as a major feature, unspecified –– LD24.00 Achondroplasia –– LD24.01 Hypochondroplasia –– LD24.02 Thanatophoric dysplasia –– LD24.03 Diastrophic dysplasia –– LD24.04 Chondrodysplasia punctata –– LD24.0Y Other specified syndromes with micromelia –– LD24.0Z Syndromes with micromelia, unspecified –– LD24.10 Osteopetrosis –– LD24.11 Osteopoikilosis –– LD24.1Y Other specified bone diseases with increased bone density –– LD24.1Z Bone diseases with increased bone density, unspecified –– LD24.20 Multiple osteochondromas –– LD24.21 Exostoses with anetodermia and brachydactyly type E –– LD24.22 Cherubism –– LD24.23 Yunis-Varon disease –– LD24.2Y Other specified bone diseases with disorganised development of skeletal components –– LD24.2Z Bone diseases with disorganised development of skeletal components, unspecified –– LD24.50 Achondrogenesis –– LD24.51 Hypochondrogenesis –– LD24.5Y Other specified spondylodysplastic dysplasias –– LD24.5Z Spondylodysplastic dysplasias, unspecified –– LD24.60 Pseudoachondroplasia –– LD24.61 Multiple epiphyseal dysplasias –– LD24.6Y Other specified multiple epiphyseal dysplasia or pseudoachondroplasia –– LD24.6Z Multiple epiphyseal dysplasia or pseudoachondroplasia, unspecified –– LD24.80 Langer-Giedion syndrome –– LD24.8Y Other specified acromelic dysplasias –– LD24.8Z Acromelic dysplasias, unspecified –– LD24.B0 Short rib-polydactyly syndrome –– LD24.B1 Asphyxiating thoracic dystrophy –– LD24.BY Other specified short rib syndromes –– LD24.BZ Short rib syndromes, unspecified –– LD24.G0 Pfeiffer syndrome –– LD24.G1 Crouzon disease –– LD24.G2 Apert syndrome –– LD24.GY Other specified syndromic craniosynostoses –– LD24.GZ Syndromic craniosynostoses, unspecified –– LD24.J0 Nail-patella syndrome –– LD24.JY Other specified patellar dysostoses –– LD24.JZ Patellar dysostoses, unspecified –– LD24.K0 Osteogenesis imperfecta –– LD24.KY Other specified genetic bone diseases with decreased bone density –– LD24.KZ Genetic bone diseases with decreased bone density, unspecified LD25 Syndromes with face or limb anomalies as a major feature – LD25.0 Oromandibular-limb anomaly syndrome – LD25.1 Fronto-otopalatodigital syndromes – LD25.2 Acrofacial dysostoses – LD25.3 Craniofacial dysostoses – LD25.Y Other specified syndromes with face or limb anomalies as a major feature – LD25.Z Syndromes with face or limb anomalies as a major feature, unspecified –– LD25.00 Oral-facial-digital syndrome –– LD25.0Y Other specified oromandibular-limb anomaly syndrome –– LD25.0Z Oromandibular-limb anomaly syndrome, unspecified LD26 Syndromes with limb anomalies as a major feature – LD26.0 Combined reduction defects of upper and lower limbs – LD26.1 Complex brachydactylies – LD26.2 Syndromes with limb duplication, polydactyly, syndactyly or triphalangism – LD26.3 Syndromes with synostoses of limbs – LD26.4 Arthrogryposis syndromes – LD26.5 Constriction rings – LD26.6 Congenital vascular bone syndromes – LD26.Y Other specified syndromes with limb anomalies as a major feature – LD26.Z Syndromes with limb anomalies as a major feature, unspecified –– LD26.40 Multiple pterygium syndrome –– LD26.41 Arthrogryposis multiplex congenita –– LD26.4Y Other specified arthrogryposis syndromes –– LD26.4Z Arthrogryposis syndromes, unspecified –– LD26.60 Angio-osteohypertrophic syndrome –– LD26.6Y Other specified congenital vascular bone syndromes –– LD26.6Z Congenital vascular bone syndromes, unspecified LD27 Syndromes with skin or mucosal anomalies as a major feature – LD27.0 Ectodermal dysplasia syndromes – LD27.1 Xeroderma pigmentosum – LD27.2 Syndromic ichthyosis – LD27.3 Genetic syndromes with hypertrichosis – LD27.4 Genetic syndromes affecting nails – LD27.5 Genetic hamartoneoplastic syndromes affecting the skin – LD27.6 Genetic lipodystrophy – LD27.Y Other specified syndromes with skin or mucosal anomalies as a major feature – LD27.Z Syndromes with skin or mucosal anomalies as a major feature, unspecified –– LD27.00 Incontinentia pigmenti –– LD27.01 Cronkhite-Canada syndrome –– LD27.02 Hypohidrotic ectodermal dysplasia –– LD27.03 Hidrotic ectodermal dysplasia, Clouston type –– LD27.0Y Other specified ectodermal dysplasia syndromes –– LD27.60 Congenital generalised lipodystrophy –– LD27.6Z Genetic lipodystrophy, unspecified LD28 Syndromes with connective tissue involvement as a major feature – LD28.0 Marfan syndrome or Marfan-related disorders – LD28.1 Ehlers-Danlos syndrome – LD28.2 Genetically-determined cutis laxa – LD28.Y Other specified syndromes with connective tissue involvement as a major feature – LD28.Z Syndromes with connective tissue involvement as a major feature, unspecified –– LD28.00 Congenital contractural arachnodactyly –– LD28.01 Marfan syndrome –– LD28.0Y Other specified Marfan syndrome or Marfan-related disorders –– LD28.0Z Marfan syndrome or Marfan-related disorders, unspecified –– LD28.10 Ehlers-Danlos syndrome, classical type –– LD28.1Y Other specified types of Ehlers-Danlos syndrome LD29 Syndromes with obesity as a major feature LD2A Malformative disorders of sex development – LD2A.0 Ovotesticular disorder of sex development – LD2A.1 46,XY gonadal dysgenesis – LD2A.2 Testicular agenesis – LD2A.3 46,XY disorder of sex development due to a defect in testosterone metabolism – LD2A.4 46,XY disorder of sex development due to androgen resistance – LD2A.Y Other specified malformative disorders of sex development – LD2A.Z Malformative disorders of sex development, unspecified LD2B Syndromes with premature ageing appearance as a major feature LD2C Overgrowth syndromes LD2D Phakomatoses or hamartoneoplastic syndromes – LD2D.0 Peutz-Jeghers syndrome – LD2D.1 Neurofibromatoses – LD2D.2 Tuberous sclerosis – LD2D.3 Gardner syndrome – LD2D.4 Gorlin syndrome – LD2D.Y Other specified phakomatoses or hamartoneoplastic syndromes – LD2D.Z Phakomatoses or hamartoneoplastic syndromes, unspecified –– LD2D.10 Neurofibromatosis type 1 –– LD2D.11 Neurofibromatosis type 2 –– LD2D.12 Neurofibromatosis type 3 –– LD2D.1Y Other specified neurofibromatoses –– LD2D.1Z Neurofibromatosis, unspecified LD2E Syndromes with structural anomalies due to inborn errors of metabolism LD2F Syndromes with multiple structural anomalies, without predominant body system involvement – LD2F.0 Toxic or drug-related embryofetopathies – LD2F.1 Syndromes with multiple structural anomalies, not of environmental origin – LD2F.Y Other specified syndromes with multiple structural anomalies, without predominant body system involvement – LD2F.Z Syndromes with multiple structural anomalies, without predominant body system involvement, unspecified –– LD2F.00 Fetal alcohol syndrome –– LD2F.01 Fetal hydantoin syndrome –– LD2F.02 Embryofetopathy due to oral anticoagulant therapy –– LD2F.03 Fetal Valproate Spectrum Disorder –– LD2F.0Y Other specified toxic or drug-related embryofetopathies –– LD2F.0Z Toxic or drug-related embryofetopathies, unspecified –– LD2F.10 Prune belly syndrome –– LD2F.11 VATER association –– LD2F.12 Sirenomelia –– LD2F.13 Meckel-Gruber syndrome –– LD2F.14 MURCS association –– LD2F.15 Noonan syndrome –– LD2F.16 Otomandibular dysplasia –– LD2F.1Y Other specified syndromes with multiple structural anomalies, not of environmental origin –– LD2F.1Z Syndromes with multiple structural anomalies, not of environmental origin, unspecified LD2G Conjoined twins LD2H Syndromic genetic deafness – LD2H.0 Fraser syndrome – LD2H.1 Neuropathy with hearing impairment – LD2H.2 Progressive deafness with stapes fixation – LD2H.3 Waardenburg-Shah syndrome – LD2H.4 Usher syndrome – LD2H.Y Other specified syndromic genetic deafness – LD2H.Z Syndromic genetic deafness, unspecified LD2Y Other specified multiple developmental anomalies or syndromes LD2Z Multiple developmental anomalies or syndromes, unspecified LD40 Complete trisomies of the autosomes – LD40.0 Complete trisomy 21 – LD40.1 Complete trisomy 13 – LD40.2 Complete trisomy 18 – LD40.Y Other specified complete trisomies of the autosomes – LD40.Z Complete trisomies of the autosomes, unspecified LD41 Duplications of the autosomes – LD41.0 Duplications of chromosome 1 – LD41.1 Duplications of chromosome 2 – LD41.2 Duplications of chromosome 3 – LD41.3 Duplications of chromosome 4 – LD41.4 Duplications of chromosome 5 – LD41.5 Duplications of chromosome 6 – LD41.6 Duplications of chromosome 7 – LD41.7 Duplications of chromosome 8 – LD41.8 Duplications of chromosome 9 – LD41.9 Duplications of chromosome 10 – LD41.A Duplications of chromosome 11 – LD41.B Duplications of chromosome 12 – LD41.C Duplications of chromosome 13 – LD41.D Duplications of chromosome 14 – LD41.E Duplications of chromosome 15 – LD41.F Duplications of chromosome 16 – LD41.G Duplications of chromosome 17 – LD41.H Duplications of chromosome 18 – LD41.J Duplications of chromosome 19 – LD41.K Duplications of chromosome 20 – LD41.L Duplications of chromosome 21 – LD41.M Duplications of chromosome 22 – LD41.N Extra ring or dicentric chromosomes – LD41.P Duplications with other complex rearrangements – LD41.Q Extra marker chromosomes – LD41.Y Other specified duplications of the autosomes – LD41.Z Duplications of the autosomes, unspecified –– LD41.00 Duplications of the long arm of chromosome 1 –– LD41.01 Duplications of the short arm of chromosome 1 –– LD41.0Y Other specified duplications of chromosome 1 –– LD41.0Z Duplications of chromosome 1, unspecified –– LD41.10 Duplications of the long arm of chromosome 2 –– LD41.11 Duplications of the short arm of chromosome 2 –– LD41.1Y Other specified duplications of chromosome 2 –– LD41.1Z Duplications of chromosome 2, unspecified –– LD41.20 Duplications of the long arm of chromosome 3 –– LD41.21 Duplications of the short arm of chromosome 3 –– LD41.2Y Other specified duplications of chromosome 3 –– LD41.2Z Duplications of chromosome 3, unspecified –– LD41.30 Duplications of the long arm of chromosome 4 –– LD41.31 Duplications of the short arm of chromosome 4 –– LD41.3Y Other specified duplications of chromosome 4 –– LD41.3Z Duplications of chromosome 4, unspecified –– LD41.40 Duplications of the long arm of chromosome 5 –– LD41.41 Duplications of the short arm of chromosome 5 –– LD41.4Y Other specified duplications of chromosome 5 –– LD41.4Z Duplications of chromosome 5, unspecified –– LD41.50 Duplications of the long arm of chromosome 6 –– LD41.51 Duplications of the short arm of chromosome 6 –– LD41.5Y Other specified duplications of chromosome 6 –– LD41.5Z Duplications of chromosome 6, unspecified –– LD41.60 Duplications of the long arm of chromosome 7 –– LD41.61 Duplications of the short arm of chromosome 7 –– LD41.6Y Other specified duplications of chromosome 7 –– LD41.6Z Duplications of chromosome 7, unspecified –– LD41.70 Duplications of the long arm of chromosome 8 –– LD41.71 Duplications of the short arm of chromosome 8 –– LD41.7Y Other specified duplications of chromosome 8 –– LD41.7Z Duplications of chromosome 8, unspecified –– LD41.80 Duplications of the long arm of chromosome 9 –– LD41.81 Duplications of the short arm of chromosome 9 –– LD41.8Y Other specified duplications of chromosome 9 –– LD41.8Z Duplications of chromosome 9, unspecified –– LD41.90 Duplications of the long arm of chromosome 10 –– LD41.91 Duplications of the short arm of chromosome 10 –– LD41.9Y Other specified duplications of chromosome 10 –– LD41.9Z Duplications of chromosome 10, unspecified –– LD41.B0 Duplications of the long arm of chromosome 12 –– LD41.B1 Duplications of the short arm of chromosome 12 –– LD41.BY Other specified duplications of chromosome 12 –– LD41.BZ Duplications of chromosome 12, unspecified –– LD41.F0 Duplications of the long arm of chromosome 16 –– LD41.F1 Duplications of the short arm of chromosome 16 –– LD41.FY Other specified duplications of chromosome 16 –– LD41.FZ Duplications of chromosome 16, unspecified –– LD41.G0 Duplications of the long arm of chromosome 17 –– LD41.G1 Duplications of the short arm of chromosome 17 –– LD41.GY Other specified duplications of chromosome 17 –– LD41.GZ Duplications of chromosome 17, unspecified –– LD41.H0 Duplications of the long arm of chromosome 18 –– LD41.H1 Duplications of the short arm of chromosome 18 –– LD41.HY Other specified duplications of chromosome 18 –– LD41.HZ Duplications of chromosome 18, unspecified –– LD41.J0 Duplications of the long arm of chromosome 19 –– LD41.J1 Duplications of the short arm of chromosome 19 –– LD41.JY Other specified duplications of chromosome 19 –– LD41.JZ Duplications of chromosome 19, unspecified –– LD41.K0 Duplications of the long arm of chromosome 20 –– LD41.K1 Duplications of the short arm of chromosome 20 –– LD41.KY Other specified duplications of chromosome 20 –– LD41.KZ Duplications of chromosome 20, unspecified LD42 Polyploidies – LD42.0 Triploidy – LD42.1 Tetraploidy – LD42.Y Other specified polyploidies – LD42.Z Polyploidies, unspecified LD43 Complete monosomies of the autosomes – LD43.0 Complete monosomy of autosome – LD43.1 Mosaic monosomy of autosome – LD43.Y Other specified complete monosomies of the autosomes – LD43.Z Complete monosomies of the autosomes, unspecified LD44 Deletions of the autosomes – LD44.1 Deletions of chromosome 1 – LD44.2 Deletions of chromosome 2 – LD44.3 Deletions of chromosome 3 – LD44.4 Deletions of chromosome 4 – LD44.5 Deletions of chromosome 5 – LD44.6 Deletions of chromosome 6 – LD44.7 Deletions of chromosome 7 – LD44.8 Deletions of chromosome 8 – LD44.9 Deletions of chromosome 9 – LD44.A Deletions of chromosome 10 – LD44.B Deletions of chromosome 11 – LD44.C Deletions of chromosome 12 – LD44.D Deletions of chromosome 13 – LD44.E Deletions of chromosome 14 – LD44.F Deletions of chromosome 15 – LD44.G Deletions of chromosome 16 – LD44.H Deletions of chromosome 17 – LD44.J Deletions of chromosome 18 – LD44.K Deletions of chromosome 19 – LD44.L Deletions of chromosome 20 – LD44.M Deletions of chromosome 21 – LD44.N Deletions of chromosome 22 – LD44.P Deletions with other complex rearrangements – LD44.Y Other specified deletions of the autosomes – LD44.Z Deletions of the autosomes, unspecified –– LD44.10 Deletions of the long arm of chromosome 1 –– LD44.11 Deletions of the short arm of chromosome 1 –– LD44.1Y Other specified deletions of chromosome 1 –– LD44.1Z Deletions of chromosome 1, unspecified –– LD44.20 Deletions of the long arm of chromosome 2 –– LD44.21 Deletions of the short arm of chromosome 2 –– LD44.2Y Other specified deletions of chromosome 2 –– LD44.2Z Deletions of chromosome 2, unspecified –– LD44.30 Deletions of the long arm of chromosome 3 –– LD44.31 Deletions of the short arm of chromosome 3 –– LD44.3Y Other specified deletions of chromosome 3 –– LD44.3Z Deletions of chromosome 3, unspecified –– LD44.40 Deletions of the long arm of chromosome 4 –– LD44.41 Deletions of the short arm of chromosome 4 –– LD44.4Y Other specified deletions of chromosome 4 –– LD44.4Z Deletions of chromosome 4, unspecified –– LD44.50 Deletions of the long arm of chromosome 5 –– LD44.51 Deletions of the short arm of chromosome 5 –– LD44.5Y Other specified deletions of chromosome 5 –– LD44.5Z Deletions of chromosome 5, unspecified –– LD44.60 Deletions of the long arm of chromosome 6 –– LD44.61 Deletions of the short arm of chromosome 6 –– LD44.6Y Other specified deletions of chromosome 6 –– LD44.6Z Deletions of chromosome 6, unspecified –– LD44.70 Deletions of the long arm of chromosome 7 –– LD44.71 Deletions of the short arm of chromosome 7 –– LD44.7Y Other specified deletions of chromosome 7 –– LD44.7Z Deletions of chromosome 7, unspecified –– LD44.80 Deletions of the long arm of chromosome 8 –– LD44.81 Deletions of the short arm of chromosome 8 –– LD44.8Y Other specified deletions of chromosome 8 –– LD44.8Z Deletions of chromosome 8, unspecified –– LD44.90 Deletions of the long arm of chromosome 9 –– LD44.91 Deletions of the short arm of chromosome 9 –– LD44.9Y Other specified deletions of chromosome 9 –– LD44.9Z Deletions of chromosome 9, unspecified –– LD44.A0 Deletions of the long arm of chromosome 10 –– LD44.A1 Deletions of the short arm of chromosome 10 –– LD44.AY Other specified deletions of chromosome 10 –– LD44.AZ Deletions of chromosome 10, unspecified –– LD44.B0 Deletions of the long arm of chromosome 11 –– LD44.B1 Deletions of the short arm of chromosome 11 –– LD44.BY Other specified deletions of chromosome 11 –– LD44.BZ Deletions of chromosome 11, unspecified –– LD44.C0 Deletions of the long arm of chromosome 12 –– LD44.C1 Deletions of the short arm of chromosome 12 –– LD44.CY Other specified deletions of chromosome 12 –– LD44.CZ Deletions of chromosome 12, unspecified –– LD44.G0 Deletions of the long arm of chromosome 16 –– LD44.G1 Deletions of the short arm of chromosome 16 –– LD44.GY Other specified deletions of chromosome 16 –– LD44.GZ Deletions of chromosome 16, unspecified –– LD44.H0 Deletions of the long arm of chromosome 17 –– LD44.H1 Deletions of the short arm of chromosome 17 –– LD44.HY Other specified deletions of chromosome 17 –– LD44.HZ Deletions of chromosome 17, unspecified –– LD44.J0 Deletions of the long arm of chromosome 18 –– LD44.J1 Deletions of the short arm of chromosome 18 –– LD44.JY Other specified deletions of chromosome 18 –– LD44.JZ Deletions of chromosome 18, unspecified –– LD44.K0 Deletions of the long arm of chromosome 19 –– LD44.K1 Deletions of the short arm of chromosome 19 –– LD44.KY Other specified deletions of chromosome 19 –– LD44.KZ Deletions of chromosome 19, unspecified –– LD44.L0 Deletions of the long arm of chromosome 20 –– LD44.L1 Deletions of the short arm of chromosome 20 –– LD44.LY Other specified deletions of chromosome 20 –– LD44.LZ Deletions of chromosome 20, unspecified –– LD44.N0 CATCH 22 phenotype –– LD44.NY Other specified deletions of chromosome 22 –– LD44.NZ Deletions of chromosome 22, unspecified LD45 Uniparental disomies – LD45.0 Uniparental disomies of maternal origin – LD45.1 Uniparental disomies of paternal origin – LD45.Y Other specified uniparental disomies – LD45.Z Uniparental disomies, unspecified LD46 Imprinting errors – LD46.0 Maternal imprinting error – LD46.1 Paternal imprinting error – LD46.Y Other specified imprinting errors – LD46.Z Imprinting errors, unspecified LD47 Balanced rearrangements or structural rearrangements – LD47.0 Balanced translocation and insertion in normal individual – LD47.1 Chromosome inversion in normal individual – LD47.2 Balanced autosomal rearrangement in abnormal individual – LD47.3 Balanced sex or autosomal rearrangement in abnormal individual – LD47.4 Autosomal fragile site – LD47.Y Other specified balanced rearrangements or structural rearrangements – LD47.Z Balanced rearrangements or structural rearrangements, unspecified – LD50 Number anomalies of chromosome X –– LD50.0 Turner syndrome –– LD50.1 Karyotype 47,XXX –– LD50.2 Mosaicism, lines with various numbers of X chromosomes –– LD50.3 Klinefelter syndrome –– LD50.Y Other specified number anomalies of chromosome X –– LD50.Z Number anomalies of chromosome X, unspecified ––– LD50.00 Karyotype 45, X ––– LD50.01 Karyotype 46, X iso Xq ––– LD50.02 Karyotype 46, X with abnormal sex chromosome, except iso Xq ––– LD50.03 Mosaicism, 45, X, 46, XX or XY ––– LD50.04 Mosaicism, 45, X or other cell line with abnormal sex chromosome ––– LD50.30 Klinefelter syndrome with karyotype 47,XXY, regular ––– LD50.31 Klinefelter syndrome, male with more than two X chromosomes ––– LD50.3Y Other specified Klinefelter syndrome ––– LD50.3Z Klinefelter syndrome, unspecified – LD51 Structural anomalies of chromosome X, excluding Turner syndrome – LD52 Number anomalies of chromosome Y –– LD52.0 Male with 46,XX karyotype –– LD52.1 Male with double or multiple Y –– LD52.Y Other specified number anomalies of chromosome Y –– LD52.Z Number anomalies of chromosome Y, unspecified – LD53 Structural anomalies of chromosome Y – LD54 Male with sex chromosome mosaicism – LD55 Fragile X chromosome – LD56 Chimaera 46, XX, 46, XY –– LD56.0 Androgenetic chimaera –– LD56.1 Gynogenetic chimaera –– LD56.Y Other specified chimaera 46, XX, 46, XY –– LD56.Z Chimaera 46, XX, 46, XY, unspecified – LD5Y Other specified sex chromosome anomalies – LD5Z Sex chromosome anomalies, unspecified LD7Y Other specified chromosomal anomalies, excluding gene mutations LD7Z Chromosomal anomalies, excluding gene mutations, unspecified LD90 Conditions with disorders of intellectual development as a relevant clinical feature LD90.0 Angelman syndrome LD90.1 Early-onset parkinsonism - intellectual deficit LD90.2 Pelizaeus-Merzbacher-like disease LD90.3 Prader-Willi syndrome LD90.4 Rett syndrome LD90.Y Other specified conditions with disorders of intellectual development as a relevant clinical feature LD90.Z Conditions with disorders of intellectual development as a relevant clinical feature, unspecified LD9Y Other specified developmental anomalies LD9Z Developmental anomalies, unspecified –– PB20 Unintentional exposure to or harmful effects of opioids or related analgesics –– PB21 Unintentional exposure to or harmful effects of sedative hypnotic drugs or other CNS depressants –– PB22 Unintentional exposure to or harmful effects of psychostimulants –– PB23 Unintentional exposure to or harmful effects of cannabinoids or hallucinogens –– PB24 Unintentional exposure to or harmful effects of analgesics, antipyretics or nonsteroidal anti-inflammatory drugs –– PB25 Unintentional exposure to or harmful effects of antidepressants –– PB26 Unintentional exposure to or harmful effects of antipsychotics –– PB27 Unintentional exposure to or harmful effects of antiepileptics or antiparkinsonism drugs –– PB28 Unintentional exposure to or harmful effects of other or unspecified drug, medicament or biological substance –– PB29 Unintentional exposure to or harmful effects of multiple drugs, medicaments or biological substances –– PB30 Unintentional exposure to or harmful effects of alcohols –– PB31 Unintentional exposure to or harmful effects of organic solvents –– PB32 Unintentional exposure to or harmful effects of carbon monoxide –– PB33 Unintentional exposure to or harmful effects of pesticides –– PB34 Unintentional exposure to or harmful effects of corrosive substances –– PB35 Unintentional exposure to or harmful effects of halogen derivatives of aliphatic or aromatic hydrocarbons –– PB36 Unintentional exposure to or harmful effects of other or unspecified substances chiefly nonmedicinal as to source –– PC90 Intentional self-harm by exposure to or harmful effects of opioids or related analgesics –– PC91 Intentional self-harm by exposure to or harmful effects of sedative hypnotic drugs or other CNS depressants –– PC92 Intentional self-harm by exposure to or harmful effects of psychostimulants –– PC93 Intentional self-harm by exposure to or harmful effects of cannabinoids or hallucinogens –– PC94 Intentional self-harm by exposure to or harmful effects of analgesics, antipyretics or nonsteroidal anti-inflammatory drugs –– PC95 Intentional self-harm by exposure to or harmful effects of antidepressants –– PC96 Intentional self-harm by exposure to or harmful effects of antipsychotics –– PC97 Intentional self-harm by exposure to or harmful effects of antiepileptics or antiparkinsonism drugs –– PC98 Intentional self-harm by exposure to other and unspecified drug, medicament and biological substance –– PC99 Intentional self-harm by exposure to or harmful effects of multiple drugs, medicaments or biological substances –– PD00 Intentional self-harm by exposure to or harmful effects of alcohols –– PD01 Intentional self-harm by exposure to or harmful effects of organic solvents –– PD02 Intentional self-harm by exposure to or harmful effects of carbon monoxide –– PD03 Intentional self-harm by exposure to or harmful effects of pesticides –– PD04 Intentional self-harm by exposure to or harmful effects of corrosive substances –– PD05 Intentional self-harm by exposure to or harmful effects of other or unspecified substances chiefly nonmedicinal as to source –– PE80 Assault by exposure to or harmful effects of opioids or related analgesics –– PE81 Assault by exposure to or harmful effects of sedative, hypnotic drugs or other CNS depressants –– PE82 Assault by exposure to or harmful effects of psychostimulants –– PE83 Assault by exposure to or harmful effects of cannabinoids or hallucinogens –– PE84 Assault by exposure to or harmful effects of analgesics, antipyretics or nonsteroidal anti-inflammatory drugs –– PE85 Assault by exposure to or harmful effects of antidepressants –– PE86 Assault by exposure to or harmful effects of antipsychotics –– PE87 Assault by exposure to or harmful effects of antiepileptics or antiparkinsonism drugs –– PE88 Assault by exposure to or harmful effects of other or unspecified drug, medicament or biological substance –– PE89 Assault by exposure to or harmful effects of multiple drugs, medicaments or biological substances –– PE8Y Other specified assault by exposure to or harmful effects of drugs, medicaments or biological substances –– PE8Z Assault by exposure to or harmful effects of drugs, medicaments or biological substances, unspecified –– PE90 Assault by exposure to or harmful effects of alcohols –– PE91 Assault by exposure to or harmful effects of organic solvents –– PE92 Assault by exposure to or harmful effects of carbon monoxide –– PE93 Assault by exposure to or harmful effects of pesticides –– PE94 Assault by exposure to or harmful effects of corrosive substances –– PE95 Assault by exposure to or harmful effects of other or unspecified substances chiefly nonmedicinal as to source –– PH40 Exposure to or harmful effects of undetermined intent of opioids or related analgesics –– PH41 Exposure to or harmful effects of undetermined intent of sedative hypnotic drugs or other CNS depressants –– PH42 Exposure to or harmful effects of undetermined intent of psychostimulants –– PH43 Exposure to or harmful effects of undetermined intent of cannabinoids or hallucinogens –– PH44 Exposure to or harmful effects of undetermined intent of analgesics, antipyretics or nonsteroidal anti-inflammatory drugs –– PH45 Exposure to or harmful effects of undetermined intent of antidepressants –– PH46 Exposure to or harmful effects of undetermined intent of antipsychotics –– PH47 Exposure to or harmful effects of undetermined intent of antiepileptics or antiparkinsonism drugs ––– PH47.0 Harmful effects of or exposure to mixed antiepileptics, not elsewhere classified, undetermined intent ––– PH47.Z Undetermined intent: Harmful effects of and exposure to noxious substances: Drugs, medicaments or biological substances: Unspecified antiepileptics or antiparkinsonism drugs –– PH48 Exposure to or harmful effects of undetermined intent of other or unspecified drugs, medicaments or biological substances –– PH49 Exposure to or harmful effects of undetermined intent of multiple drugs, medicaments or biological substances –– PH50 Exposure to or harmful effects of undetermined intent of alcohols –– PH51 Exposure to or harmful effects of undetermined intent of organic solvents –– PH52 Exposure to or harmful effects of undetermined intent of carbon monoxide –– PH53 Exposure to or harmful effects of undetermined intent of pesticides –– PH54 Exposure to or harmful effects of undetermined intent of corrosive substances –– PH55 Exposure to or harmful effects of undetermined intent of halogen derivatives of aliphatic or aromatic hydrocarbons –– PH56 Exposure to or harmful effects of undetermined intent of other or unspecified substances chiefly nonmedicinal as to source – PL00 Drugs, medicaments or biological substances associated with injury or harm in therapeutic use – PL01 Complementary or traditional medicines associated with injury or harm in therapeutic use –– PL01.0 Complementary or traditional medicines associated with injury or harm in therapeutic use, Herbal Preparations or Formulas –– PL01.1 Complementary or traditional medicines associated with injury or harm in therapeutic use, Dietary Supplements, Vitamins or Minerals –– PL01.2 Complementary or traditional medicines associated with injury or harm in therapeutic use, Complementary or Traditional Medicines, not elsewhere classified –– PL01.Y Other specified complementary or traditional medicines associated with injury or harm in therapeutic use –– PL01.Z Complementary or traditional medicines associated with injury or harm in therapeutic use, unspecified – PL0Z Substances associated with injury or harm in therapeutic use, unspecified
Thank you for choosing Find-A-Code, please Sign In to remove ads.
Quick, Current, Complete - www.findacode.com